The influence of internal determinants of palestinian pharmacetical firms on export performance by Alagah, Wesam
Islamic University of Gaza 
Deanery of Graduate Studies 
Faculty of Commerce 
Business Administration 
Division 
ـالمية   ـة اإلس ـزة–الجامع    غ
  عمــادة الدراســات العليــا 
ــارة ــة التجــــ   كليــــ





The Influence of Internal Determinants of 













Dr. Rushdy A. Wady 
 
 
This Thesis is submitted as a partial fulfillment of the requirement for the 




brought to you by COREView metadata, citation and similar papers at core.ac.uk















  إعداد الباحث
























To the soul of my Father, who persistently encouraged me to strive for excellence 
"May God have mercy on him and make him live in His vastest paradise. " 








First, I thank the Almighty God for making it possible for me to come to a 
successful completion of my thesis, I am very grateful to my advisor, Dr. Rushy 
Wady for his help and assistance in achieving this study, and for his advice and 
support. I also wish to thank my other committee members, Dr. Majid El-Fara  , Dr. 
Mohammed I. AL-Madhoun, for their contributions to the success of this thesis, and 
their encouragement,  and insightful comments.  
I would like to extend a special thanks to Dr. Majid El Fara, Dr. Salem Sabah, 
Dr. Saif Owda, Dr. Adnan Qubbaja, for their insights and advice. My sincere 
appreciation to Dr. Samir Safi and Ali Son'allah, They statistically analyzed this 
study and provided me with valuable advice. I sincerely thank Dr. Ahmad S. 
Abdelhadi for his assistance in editing the thesis. 
I am indebted to my great friends and colleagues Ali Ali, Abdullah S. Alagha, 
Awad Abu Alia, Aaid Dwikat, Tawfiq Abuleil, and Khaled M. Alagha, for their 
assistance during my data collections and thesis process. 
Special thanks are also due to Gaza Islamic University, the Faculty of 
Commerce, staff library, the digital library staff at Cairo university, and to the staff 
memberS at Palestinian Pharmaceutical Industry in assisting me to complete this 
study. 








The purpose of this research is to describe the influence of  internal 
determinants of Palestinian Pharmaceutical firms on export performance. Palestinian 
Pharmaceutical firms have difficulties to market their products in the international 
market.The production capacity and the good quality of product offer opportunities 
to the firms to gain from the internationalization process, especially through export 
as mode of entry.  
After reviewing the literature and expert opinions, the most important 
determinants were identified. The study that consists of five determinants: mode of 
entry, strategic planning, international marketing research, international strategic 
marketing, and export performance, was tested in relation to their effect on export 
performance. A questionnaire was designed and distributed to measure the variables 
and their effect on the export performance, and responses from 59 respondents were 
retrieved.  
The main conclusion reveals that firms enter international market in gradual 
successive stages, that represent higher degrees of increasing commitment to 
international markets. The process starts with exporting, contracting, and investing 
according to Uppsala model. The planning, market research and marketing strategy 
affect positively export performance in various levels, The highest effect is for the 
marketing strategy. Firm characteristics show the firm with small size positively 
affects performance, and older firm has stronger motivation to export, The 
demographic characteristics show that the respondents who graduated from 
Palestinian Universities and those who have post graduate degrees and respondents 
who have pharmacy back ground positively affect export performance.  
The study recommends that the Palestinian pharmaceutical firms need to 
strengthen their cooperation to cope with challenges in global markets, and the firms 
need to pay more attention to strategic planning, marketing research, and to improve 







  ملخص الرسالة
  
 المحددات الداخلية لشركات الصيدلة الفلـسطينية تأثيروصف إلى  هذه الدراسة هدفت
 فـي  صعوبات يوجد لدي شركات الصيدلة الفلسطينية حيث  التصديري، األداء على اوتأثيره
وفر فرصة للـشركات  و جودة المنتجات ت اإلنتاجيةتسويق منتجاتها في السوق الدولي، القدرة 
  . خصوصا من خالل التصدير كمدخل للسوق،  لالستفادة من التحول للعالميةنيةالصيدال
 الخبراء تم اختيار المحددات الهامة، نموذج الدراسـة استشارة و األدبيات مراجعةبعد 
 التسويق العـالمي، أبحاثطريقة الدخول، التخطيط االستراتيجي، ( يتكون من خمس محددات 
 األداء علـى تأثيرهـا ، تم اختبار عالقـة ) التسويقي األداءمية، و  التسويقية العال اإلستراتيجية
 59 أعاد التصديري، األداء على وتأثيرهاالتسويقي، االستبيان صمم ووزع لقياس المتغيرات 
  .ةاالستبان مستجيب
دخـول :  كشفت عن التـالي  في هذا البحث  المحددات الداخلية  لتأثيرالنتائج الرئيسية 
ي عملية تمر بمراحل تدريجية متعاقبة تظهر درجة عالية من االلتـزام الشركات للسوق الدول 
التخطيط  وبساال،أ لنموذج االستثمار وفقاً ثم في السوق العالمي، العملية تبدأ بالتصدير، التعاقد 
 التـصديري بمـستويات األداء فـي  التسويقية تؤثر ايجابيـاً اإلستراتيجيةبحوث التسويق و و
 الحجـم الـصغير أن التسويقية، خصائص الشركة تظهر لإلستراتيجية ىالتأثير األعل مختلفة، 
ـ أقوى لديها حافز األقدم والشركة األداء في يؤثر ايجابياً   الديمغرافيـة صائص للتصدير، الخ
ذين تخرجوا من جامعات فلسطينية، والحاصلين على درجة تعلـيم  المستجوبين ال أن أظهرت
  .  التصديرياألداءيؤثرون ايجابيا في عالي، والذين لديهم خلفية صيدالنية 
 ة تقوية تعاونها لمواجه إلى الشركات الصيدالنية الفلسطينية بحاجة أنتوصى الدراسة 
،  للتخطـيط االسـتراتيجي أكثر تقوم الشركات بمنح اهتمام أنالتحديات في السوق الدولي، و 
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1.1 Introduction:  
A Profitable business success depends on determinants such as marketing, 
high quality product, good services, operation, accounting, finance. Business will 
function in proper way if there is an effective and efficient marketing, "Marketing is 
managing profitable customer relationships", it becomes more significant if business 
is global oriented. Marketing plays crucial role to achieve business goal (kotler, 
2006)  
The world shrinks rapidly with the introduction of faster movement of good, 
communication, transportation, and financial flows, International trade has boomed 
over the last three decades, International competition also intensifies. International 
firms expands aggressively into new international markets, and the opportunity in 
domestic market decreases, thus; local firms look to expand its market through 
internationalization process, The internationalization strategy can be achieved by 
different modes of entry to international market. (kotler, 2006; Kotler & Armstrong, 
2012) 
In international business, the pharmaceutical industry is one of the most 
“lucrative industries” in the international business in the world (Hoang, 1999), the 
World Health Organization indicates that from 1985 to 1999 there was trend in 
increasing the production of pharmaceutical industries, during this period the growth 
increases four times more rapidly than world income. Multinational pharmaceutical 
corporation MNPC produces more than sixty percentage (60%) of global production 
in pharmaceutical. Most of these corporations are located in five industrialized 
countries. (United State of America, Japan, Germany, France, united kingdom), the 
branches of these MNC are distributed over the world. The include factories for 
production, fabricating, packaging, sale and distribution, but the Research and 
Development R&D located in the Corporate head quarter, global pharmaceutical 
production exceeds on 320 billion US dollars in year 1999 (World Health 
Organization, 2004).  
The increasing production in pharmaceutical industries not only reflected the expansion 
of business, but it also indicated the trend in increasing the profit, Fortune magazine in 
its report “Fortune 500” of largest corporations show trend of the pharmaceutical 
corporations that occupied the third rank in profit in industries after oil production and 
information technology. Profits registered by the 10 pharmaceutical corporations were 
equal to more than half of the $69.6 billion in profits gained by the entire list of 
Fortune 500 corporations, revenue for each dollar reach 17 cent comparing with the 
entire list of fortune 500 with median of 3.1 cent per dollar of revenue. A return in assets 
of 14. 1 percent compared to 2. 3 percent, these data explicit the significant role of 
pharmaceutical industry in global business (Fortune, 2003). 
Marketing is essential for pharmaceutical industries, high cost of the R&D 
force the MNC to exert tremendous effort on marketing to return the cost. 
Promotional expenditure some time exceeds the expenditure on  R&D , Its value is 
around 20-30 percent of sale (Brekke, & Kuhn, 2006), thus; local national industry 
has to think globally besides to defending its local market, the international market 
contains many opportunities for business (Kotler, Keller. 2006). 
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Palestinian's  pharmaceutical industry is unique in terms of innovation and 
evolution. The industry boomed after the war in 1967 resulted in closed borders with 
the Arab countries. Prior to the war, pharmaceutical products were imported from 
foreign companies via importers in Amman, Jordan and in Cairo in Egypt. After 
1967, however, imports from Jordan and Egypt became problematic. The only 
products available were either Israeli or products imported through Israeli agents. 
The market was subjected to intensive competition. This situation made pressure on 
Palestinian to think to start manufacturing pharmaceutical products (Massar, 2002).  
 
This study will focus on the determinants which affect export process. This 
can include  internal determinants of export of Palestinian pharmaceutical firms. 
 
1.2 Research problem statement: 
Pharmaceutical business is characterized by its globalization, therefore; the local 
pharmaceutical business copes with competition of MNC that works constantly to 
increase its global market share by increasing their competition in sole local market in 
different countries, especially in emerging market like Palestine (Kotler& Armstrong, 1999). 
Palestinian pharmaceutical industry struggles to provide domestic market with 
the increasing medical needs and to commence to extend its market by entering to 
international market. This aim faces tremendous difficulties because of the intensive 
competition in global market, and due to the situation in Palestine where the Israeli 
occupation has an impact on the development of economy in general and prevent the 
industry from improving its capability to import sophisticated machine and raw material 
under what they called "security reason". In addition there is an absence of government 
subsidies and the Palestinian market is relatively open for Israeli pharmaceutical product 
as well as MNC products (Abu Alia. 2007;Masar, 2002). 
Palestinian pharmaceutical covers 35-40% of the Palestinian market while the 
remainder is provided by "Israeli" and imported products. The Palestinian 
pharmaceutical industry constitutes 7% of total Palestinian industrial output and 
contributes roughly 1% to GDP. According to a Massar survey conducted in 1998 by 
Massar (Massar, 2002). Despite the difficulties that face Palestinian pharmaceutical 
industry, the industry expanded, the growth of industry flourished constantly, the 
standard of quality of the production is acceptable. According to international standard, 
local market is relatively too small to absorb the production of industry, thus; Palestinian 
pharmaceutical corporation has to go for export.  
 
The study main question: 
- What are the effects of internal determinants of Palestinian pharmaceutical firm 
on export performance?  
 
1.3 Research hypotheses:  
This study aims to test the following hypotheses:  
Hypothesis. 1.1: There is no significant differences among respondents at Level 
α=0.05 towards the export determinants and Export performance Due To Firms 
Characteristic "traits" (Firm size, firm age, firm sale).  
Hypothesis. 1.2: There is no significant differences among respondents at Level 
α=0.05 towards the export determinants and export performance Due To 
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management "Characteristic" traits (Education Level, Place Of Education, 
Instruction Language, Education Background, Overseas Trip).  
Hypothesis 2.: There is no statistical relationship at significant level α=0.05 between 
internal determinants and export performance in Palestinian pharmaceutical industry.  
This main hypothesis can lead to the following sub-hypothesis:  
Hypothesis 2. 1: There is no significant relationship at level α=0.05 between Mode 
of entry of Palestinian pharmaceutical firms and export performance.  
Hypothesis 2. 2: There is no statistical relationship at significant level α=0.05 
between Export planning of Palestinian pharmaceutical firms and export 
performance.  
Hypothesis 2. 3: There is no statistical relationship at significant level α=0.05 
between Market research of Palestinian pharmaceutical firms and export 
performance.  
Hypothesis 2. 4: There is no statistical relationship at significant level α=0.05 
between Market strategy adaptation of Palestinian pharmaceutical firms and 
export performance.  
Hypothesis 3.: There is no statistical effect at significant level α=0.05 of export 
internal determinants on export performance on Palestinian pharmaceutical 
industry 
 
1.4 Research variables: 
The dependent variable: 
• Export Performance 
    The independent variables:  
• Firms Characteristic "traits" (Firm; size, age, sale).  
• Management Characteristic traits (education level, education place, language. 
international experience).  
• Mode of entry.  
• Export planning.  
• Market research.  
• Market strategy adaptation.  
 
1.5 Research objectives:  
 
• Determine the best strategy for mode of entry for Palestinian pharmaceutical 
firms.  
• Explaining how export planning could influence export strategy for Palestinian 
pharmaceutical firms.  
• Explaining how market research could influence export strategy for Palestinian 
pharmaceutical firms.  
• Explaining how market adaptation could influence export strategy for 
Palestinian pharmaceutical firms.  
• Addressing the reality of export strategy in Palestinian firms for Palestinian 
pharmaceutical firms.  
• Proposing some recommendations that could assist Palestinian pharmaceutical 




1.6 Research importance:  
This is a genuine study conducted in the Palestinian pharmaceutical industry. 
To research knowledge, this study is the first to adapt Zou & Stan (1998) in the 
Palestinian pharmaceutical firms in order to investigate the effect of internal 
determinants on export performance.  
The study result will provide assistance for local pharmaceutical companies 
to plan to increase their export more efficiently. To increase the profitability and 
increase their market share.  
The study will provide conceptual framework of export determinants, thus 
helping Palestinian industry to conduct internationalization process especially export 
as one of mode of entry for Palestinian pharmaceutical industry.  
 
































Figure (1. 1) Research Conceptual Frame 
Conceptualized by researcher according to (zou & stan, 1998) 
 


























Product adaptation  
Price adaptation  
Promotion adaptation  
Distribution channel adaptation  
Management traits 
• Education Level 





• Overseas Trip 
Market research utilization  









1.8 Scope of  limitation  
The researcher intends in this study to investigate deeply the effect of internal 
determinants of pharmaceutical firms on export performance, Only exporting 
companies exporting to international market were included in this study. All the 
activities involved in this study process were completed within three year period 
(2011 to 2013) the questionnaires were distributed within the period from November 
2012 to March 2013. The empirical analysis is based upon 4 exporter companies in 
Palestine.  
Due to the siege on Gaza Strip and the difficulties to travel to the West Bank, 
the researcher used the questionnaire as a tool of collecting data, Thus; possible 
limitation concerns the impact of the communication of respondents that was taking 
place as the questionnaires were being conducted. The questionnaire took a long time 
to be completed. in addition. The export performance is influenced by external and 
internal determinants. The researcher emphasis that this research is limited to internal 
determinants only 
 
1.9 Research structure:  
This study consists of five independent but interrelated chapters. The 
framework for the study is designed to cover the subject and to test the hypothesis as 
well as to get clear idea about the challenge of exporting for pharmaceutical 
corporation in Palestine.  
The research consists of five chapters divided as follows:  
A) Chapter One: Background context and previous studies  
Introduction 
Study Objectives 
Hypothesis Of The Research 
Question 
Objective And Limitation Of Study.  
Previous Study.  
 
B) Chapter Two: literature review (Theoretical framework) 
Literature Review Introduction 
The concepts of pharmaceutical marketing 
pharmaceutical sector in Palestine.  
international Pharmaceutical market.  
C) Chapter Three: Research methodology  
D) Chapter Four: Data analysis, interpretation and hypothesis testing 
A) Chapter Five: Conclusions and recommendations.  
 
1.10 Previous studies: 
This section includes previous studies related to the research subject, the 
topic of these studies includes " internal determinants of internationalization, mode 
of entry, export determinants strategy, Palestinian pharmaceutical firm. The previous 
studies provide guideline for researcher to follow the latest research in the founded 
field, and build on the accumulative literature and find the results in the previous 
research. The following previous studies are arranged in systematic manner 
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according to chronologically base on date. No local or regional studies to the 
knowledge of the researcher dealing with export strategy of Palestinian 
pharmaceutical firms have been found, which obliged the researcher to depend on 
international studies mainly. 
 
1.10.1 Hazboun (2006) “Strategic Application of CRM, The case of the 
Palestinian Pharmaceutical Industry”  
Purpose: The objective of study is to provide insight on the Customer Relationship 
Management (CRM) concept and a managerial reality of customer relationship 
management for the pharmaceutical industry in Palestine.  
Design/methodology/ 
The research methodology is concerned with research design and hypothesis besides 
collection and analysis of information. In this paper, the study will be based on 
primary and secondary data.  
population: pharmaceutical industry is analyzed by choosing two companies as a 
case example.  
Tools: a questionnaire directed to appropriate staff and management members within 
two pharmaceutical companies. In addition, direct communication via e-mail and 
telephone was established with key members of the staff to obtain additional needed 
information.  
Findings:  
The general conclusion of the analysis is that both companies’ (subjected to study) 
current marketing performance is relatively satisfactory. However, it is believed that 
need to be improved in the attitude and behavior of employees within both 
companies.  
Recommendation  
Improving customer knowledge and insight 
Improving organizational processes  
Improving communication  
Improving marketing measurement frameworks  
Becoming customer culture oriented 
 
1.10.2 Farra (2007) "Measuring the customer satisfaction on sales person 
performance at Palestinian pharmaceutical companies in the Gaza 
Strip Market". 
Purpose: The objective of study: This study aimed at recognizing the level of 
customer “Pharmacists” satisfaction on sales person performance at Palestinian 
pharmaceutical companies in the Gaza Strip.  
Design/methodology: The research methodology is descriptive analysis, the study 
intended to investigate the relation between sales person performance at Palestinian 
pharmaceutical companies in the Gaza Strip Market and following variables: 
appearance, technical and theoretical knowledge, Skills, presentation ability, 
negotiation ability and the level of service quality.  
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population: community pharmacists in Gaza strip – Palestine.  
Tools: a questionnaire directed to appropriate staff and management members.  
Findings: there is good level of customer satisfaction, There is significance 
difference among respondents related to variable of study.  
Recommendation: research recommended the firm to improve their sales person 
performance.  
 
1.10.3 AlShibly. and Alzyadad (2009). "International Export Strategic 
Marketing in Jordanian firm."  
Purpose: The aim of this study is to identify the export strategy for Jordanian firms.  
Design/methodology/approach:  
The paper used the descriptive analysis methodology to study the relation between 
the export strategy and the use of marketing mix,  
Population: directors and firm managers.  
Tool: simple random sample, (180) questionnaires consisting of 26 items, with (64) 
returned and subjected to analysis by using (SPSS).  
Findings: There is a strong relation between the marketing mix except for price 
strategy.  
Recommendation: Firm has to increase its marketing mix strategy (adaptation, 
standardization, and integration). 
 
1.10.4 Adili (2009) " Determinants and requirements of entering the 
Palestinian pharmaceutical industry into the international 
markets" 
The study objective is to identify the motives that lie behind the 
internationalization of the Palestinian pharmaceutical companies, and determine the 
most important external and internal environmental factors that impact and guide 
these companies in the selection of international markets. Since there is not much 
information concerning this phenomenon, this study shall follow exploratory 
curriculum.  
Data of this exploratory study was collected from secondary sources such as 
books and relevant previous studies, and primary sources based on face-to-face 
interviews and via e-mail.  
The study population was applied on three Palestinian pharmaceutical 
companies entered the international markets, and these companies were Beit Jala 
Pharmaceutical Company, Jepharm, and Pharmacare ltd.  
Finding: The study find that there are threats to Palestinian pharmaceutical 
companies in the local market such as small market size and intensive competition. 
Surplus of pharmaceutical production in the domestic market form the most 
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important motives that encourages these companies to export to international 
markets. in addition, the companies selecting strategy take account to international 
markets the economic factors (per capita income, infrastructure, and exchange rate 
stability), the most important determinants and requirements that impact the selection 
of international markets by Palestinian pharmaceutical companies, whereas the 
cultural and social factors in the international markets do not impact the selection. 
The attractiveness factors of the global market such as (market size and the rate of 
growth, competition, availability of agents, and the cost of servicing the market) 
impact these companies in selecting international markets, whereas the geographical 
distance did not.  
As for the effect of internal factors, the study found that the following factors 
(financial resources, human resources, experience in the international market, 
product adaptation, competitive advantage, top management, strategic planning, 
production capacity, production cost, size of the company, product quality and access 
to market information) positively impact the Palestinian pharmaceutical companies 
in selecting international markets. The study recommended that there is need to guide 
the Palestinian pharmaceutical companies towards integration rather than 
competition in the local market, and to work on increasing their market share in the 
Palestinian market.  
 
1.10.5 Masroujeh (2009) ”Critical factors for Customer satisfaction and 
delight in the Palestinian Pharmaceutical market”.  
Purpose: The aim of this research is to present the effect of critical factors for 
customer satisfaction and delight in the Palestinian Pharmaceutical Market. 
Design/methodology/approach:  
The researcher followed the descriptive analytical approach in conducting the 
research. A model that consisted of five critical satisfaction factors (Availability of 
service, Responsiveness of service, Reliability of service, completeness of service, 
and professionalism of service) was tested in relation to their effect on achieving the 
customer satisfaction & delight in the Palestinian pharmaceutical market.  
Findings: Results show that professionalism of service was ranked the most 
important among the five factors. Completeness of service received the lowest 
ranking among the factors. Availability of service, responsiveness of service, and 
reliability of service were in the middle of the importance ranking.  
Recommendation: Companies have to transform from being product and process 
oriented to becoming customer oriented, and company must build customer 
knowledge competence. 
 
1.10.6 Dwikat (2012) "The relationship between strategic planning and 
excellence in performance of the Palestinian pharmaceutical 
sector" master thesis, Alquds university, Palestine.  
Objective of the study: This study aimed to identify the relationship between the 
elements of strategic planning and excellence in performance of the pharmaceutical 
industry in Palestine industry.  
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Methodology: descriptive study 
Data tool collection: questionnaire that included 77 statements.  
The population of this study included all strategic managers in the pharmaceutical 
firms in the West Bank and the number of firms was five.  
The sample size of the study included strategic managers in the following positions: 
board members, general managers/deputy general managers and the managers of 
functional departments and their number was 78.  
The result of the study revealed the following:  
Results and findings: the majority of the Palestinian pharmaceutical companies are 
applying strategic planning process in a scientific way,  
There is a statistical significant relation between the elements of strategic planning 
and the qualitative excellence in performance. There is a positive difference in the 
level of performance according to the availability of formal and written strategic plan 
comparing to those who do not have formal strategic plans.  
Recommendations: The pharmaceutical companies should increase their interest in 
the comprehensive continuous improvement particularly in the quality systems since 
they have a substantial positive impact on excellence in performance, the 
pharmaceutical companies should systemize the process of monitoring and 
evaluating the implementation of strategic plans, the pharmaceutical companies 
should adopt the strategic planning approach in all its stages and aspects on scientific 
and integrated basis.  
 
International studies: 
1.10.7 Johanson. And Wiedersheim-Paul (1975). "The 
Internationalization Of The Firm - Four Swedish Cases." 
This article focused on the process of internationalization process, it 
described the internationalization of four Swedish firm, All of them sell more than 
two-thirds of their turnover abroad and have production facilities in more than one 
foreign country. they have decided to distinguish between four different stages in 
internationalization process, 
The study suggested model of internationalization process of the firm. They 
conceptualized the term "psychic distance" that explain the importance of the 
difference in language, culture, distance in flow of information between country of 
origin and others country in which firm intend to enter. The conclusion of article 
suggested the internationalization process is occurring through development of the 
firms according to incremental process, while strategic decisions heavily influence 
the internationalization.  
 
1.10.8 Johanson. and Vahlne. (1977). "The Internationalization Process of 
the Firm A Model of Knowledge Development and Increasing 
foreign market commitment". 
Objective: to study the internationalization of the firm 
Study suggested model of internationalization process of the firm to be developed. 
They conceptualized the term "psychic distance" that explain the importance of the 
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difference in language, culture, distance in flow of information between country of 
origin and international market in each country.  
Results: the study has observed that the absence of market knowledge has forced the 
Swedish manufacturing firms to develop their international operations in gradual 
steps, through incremental commitment decisions and entering at the beginning to 
psychically close market countries in to avoid the market uncertainty.  
 
1.10.9 Aaby & Slater (1989), "Management Influences on Export 
Performance: A Review of the Empirical Literature 1978-1988" 
This is highly cited research on the role of management on export 
performance, the aim of the research is to explore the determinants of export 
performance of international marketing research published in the time between 1978-
1988, they classified four independent variable categories influence export 
performance: The external environment, competencies, marketing export strategy, 
and firm characteristics.  
The Conclusions of the research find that there is no clear-cut formula for 
developing a successful export performance. With regards to firm characteristics they 
concluded as follows:  
• Company size by itself is not an important factor, but it could exert influence if 
it linked to other aspects like financial strength and economies of scale.  
• Management committed to export positively encourages export performance.  
• Firms that have planned export activities are more successful on export.  
• Export experience is important.  
• Competencies are important comparing to firm characteristics.  
• Management has an international vision, with consistent export goals, with clear 
perceptions and attitudes towards export, is positively encourage on engaging in 
export activities.  
• Non-exporters have less perception on export and less risk-taking.  
 
1.10.10 Cavusgil & Zou (1994) "Marketing Strategy-Performance 
Relationship: An Investigation of the Empirical Link in Export 
Market Ventures".  
The study object is to study the relationship between marketing strategy and 
export performance, this research continues the investigation of Aaby and Slater (1989). 
It provided a broader overview of export performance, studied both internal and external 
factors together, . The research assessed export performance at two broad levels, the 
external environment level and the internal level. The main hypothesis suggested that 
export venture performance is determined by export marketing strategies and 
management's capability to implement the strategies, A confirmatory factor analysis 
(CFA).  
The research results support the contention that marketing strategy 
implementation Can lead to good achievement of export performance.  
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The study provided constructs and The measurements developed for export 
performance, The study has contributed to comprehensive understanding of the 
success factors in export marketing strategy.  
 
1.10.11 Shaoming zou and Simona stan  (1998). "The determinants of export 
performance: a review of the empirical literature between 1987 and 
1997. " 
A major purpose of this review is to synthesize the literature in a significant 
way, The research  intends to improve the earlier research and the work done as 
example by (e. g. Aaby and Slater, 1989; Chetty and Hamilton, 1993; Madsen, 
1987). and to discuss directions for future research aimed at developing better 
theories and advancing knowledge of export marketing. Article added the external 
environment to the internal environment and updating the information of the 
variables. They collected fifty (50) articles (1987-1997) and studied them on a 
conceptual level. They classified the export performance measure into seven 
categories. Meta-analysis had been used as research approach.  
 
1.10.12Leonidou. Katsikeas. & Piercy (1998). Identifying managerial 
influences on exporting: Past research and future directions". 
The study object: is to provide integrated review of studies related to export. 
The article attempts to provide integrated review of extant studies related to export 
literature, it aims to address the research question, what are the weakness and 
strength of the methodology, conceptual and empirical aspects? What is the role of 
management on export?  
Methodology: Studies were selected for review on the basis of five eligibility 
criteria, the research pointed management as principle force influencing export. The 
review covered the period between 1960-1995. The article studied 46 research on 
international marketing concerning on managerial influence on export.  
Results of the article showed that only certain managerial characteristic influence 
export performance. However, with the exception of the positive role of decision 
maker, education background, language proficiency, and experience abroad in 
initiating exports, received weak empirical support. Some characteristic of specific 
subjective nature such as managerial perception of risks, cost, and profit on overseas 
markets, show strong association with exporting.  
 
1.10.13 Suárez-Ortega. and Álamo-Vera (2005). "SMES' 
internationalization: firms and managerial factors" 
Objective of the study is to examine the particular organizational and managerial 
determinants of the different aspects of a firm's export development process: 
intention, propensity, and intensity.  
Methodology: The study analyzed firm's resources and capabilities, managerial 
characteristics, and managerial attitude and perceptions, the sample of study 286 
firms, Statistical analyses using SPSS were carried out to support or reject eight 
study hypotheses.  
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Findings: Results observed that factors influencing export involvement are not the 
same along the process of export development.  
 
1.10.14 Puljeva and Widen (2007)" The influence of internal and external 
factors on entry modes".  
Purpose: the research purpose of this thesis is to provide a better understanding of the 
impact of internal and external factors on SMEs’ choice of international market entry 
strategies.  
Design/methodology/approach: This thesis is exploratory, describing and useing  
explanatory approach,  The research employed the qualitative research in the 
thesis, Researchers chose to perform a case study due to its suitability to their 
theses. The study tool used interviews over the telephone.  
 
Findings and recommendations:  
The study finds  that the factor company size/ resources influences the 
choice of market entry mode. SME’s tends to initiate their internationalization 
through export before using more resourced intense market entry modes, 
management risk attitudes should be less risk averse when being financially 
successful, The study finds that firm with few resources prefer low committing entry 
mode. Special attention should be paid for product differentiation. firms have to take 
their product features into consideration when choosing market entry mode. Study 
also finds that the goals can be both short-term and long-term and in a long-term 
perspective the goal of growth will develop a need to internationalize the company 
and create sales and production platforms outside the domestic market.  
 
1.10.15 Sousa. Martínez-López, et al. (2008). "The determinants of export 
performance: A review of the research in the literature between 
1998 and 2005".  
The objective of the article attempts to review and synthesize and extant the 
knowledge on the determinants of export performance, This study reviews and 
evaluates 52 articles published, the size of the firm has been studied is varies. The 
studies reviewed in this article used mail surveys for data collection, majority of the 
export studies continue to focus on small to medium-sized firms and most studies 
conducted in united states and most of the studies data were collected from the 
individual for international marketing, increasing studies have included the external 
environment, market orientation find as a key determinant of export performance 
emerges in this review research. The export marketing strategy has been widely used 
as a determinant of export performance. The marketing mix variables were most 
frequently cited. To less extent firm-specific variables were also widely used as 
determinants of export performance(size of the firm, the international experience of 
the firm, and the firm’s capabilities ).  
 
1.10.16 Wheeler. Ibeh, K. & Dimitratos. (2008). UK Export Performance 
Research 
Purpose: to review and analyze of research on export performance in the UK for the 
period 1990 –2005. The research problem is the plenty of Previous research on 
export performance that has been criticized for being a mosaic and for their lack of 
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theoretical development. The research proposed framework identifies two broad 
categories of Determinants, that is internal and external groups of export 
determinants.  
Results: The research shows management and policy implications for the UK emerging 
from the review and synthesis of the literature and the integrated model are discussed.  
 
1.10.17 Malik and chaudhary (2010). Factors Affecting Small and Medium 
Enterprises, Selection of Market Entry Mode.  
Purpose: To investigate and critically assess impact of internal and external factors 
on small and medium enterprises on selection of international market entry mode 
strategies in Pakistan.  
Design/methodology/approach:  
The researchers employed the qualitative research approach in the thesis.  
Researchers studied internal and external factors influence mode of entry. The 
authors designed the research question containing the comparison of Pakistani firms, 
Data sources used in the research study were primary and secondary.  
Tool: Questionnaire was designed in order to meet the demand of the research 
question and purpose of the research 
Sample: Top 10 Companies were selected from the industrial sector in Pakistan 
Findings and recommendation: While making the selection of entry mode; 
managers should consider the following:  
• importance of company size when selecting market entry modes.  
• Managers should ignore image support requirements  
• Managers should adapt the choice of entry mode towards the speed of market 
growth in overseas economies.  
• Managers should not focus on profit targets when making.  
• Managers should keep in mind characteristics of product such as weight and 
packaging when making decision for entry mode.  
 
1.10.18 Stoian, Maria–Christina (2010) "internationalization and 
international marketing: export behavior, international marketing 
strategy and export performance in Spanish small and medium sized 
enterprise".  
Objective: to study the importance of the export activities and performance.  
Methodology: data was collected through online survey address to the decision 
maker in Charge of the export in the firm, multivariate analysis with (SPSS) and 
structural equation modeling (SEM), analysis of moment structure (AMOS) were 
performed.  
Findings and recommendation: there is importance of the decision maker 
international out look to be crucial for SME, export process. Management 
characteristics seem to have stronger impact on export. Results show a positive 
relation between objective export performance (export intensity and number of 
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export markets) and subjective export performance (managerial satisfaction with 
export position, export profitability and new market entry). The successful export 
could be achieved by adopting international export strategy.  
 
1.11 Comment on previous studies: 
Most previous studies on the pharmaceutical industry in Palestine seem to 
study topic that is not focusing on export. Most Palestinian studies have tested the 
difficulties face industry in domestic market. The most recent study on the 
determinants of entering of Palestinian pharmaceutical industry into international 
market has been performed by Adili (2009). He intended to identify the motives of 
internationalization of  PPI. The study has used interview to collect data. AlShibly, 
and Alzyadad (2009) studied the international export strategic Marketing in 
Jordanian firm.  
A review of the internationalization literature shows that previous studies 
have addressed a wide range of topics, including   internal determinants of export 
(Puljeva and Widen 2007). A second group focused on the internationalization 
process of firms (Johanson and Vahlne, 1977; Johanson and Wiedersheim-Paul, 
1975; Suárez-Ortega. and Álamo-Vera 2005;  Stoian, Maria–Christina 2010). A third 
group focused on export performance (Aaby and Slater 1989;  Zou and Stan 1998; 
Wheeler. Ibeh, K. & Dimitratos, 2008).). More  contribution to export marketing  
literature has investigated  variety of topics. This includes the Market Entry Mode 
(Malik and chaudhary 2010), and a review of the research in the literature of 
determinants of export performance  (Leonidou. Katsikeas. & Piercy 1998; 
Shaoming zou and Simona stan  1998;Sousa. Martínez-López, et al. 2008).  
 
The previous studies  have investigated the potential determinants of export 
on  initial stage of export. The process of internationalization has been extensively 
researched,  
Furthermore,  most previous studies have used multinational companies MNCs. 
Relatively few of the previous studies have conducted research in Palestine and 
Arabic culture.  Most of the studies have been conducted in united states and Europe. 
 
This  study focuses on the effect of internal determinant on Palestinian 
pharmaceutical firms. The study empirically has assessed the influence of variety of 
determents on export performance, while  most of the previous studies investigated 
one of the internal determinants, the study employed  the measure of export 
performance from previous studies. The firms in the present study are all active 
exporters, the study pay more attention to the role of managers characteristics and 
firm characteristics affecting the export performance. 
 
1.12 Summary 
This chapter has presented the introduction, background to the study, stated the 
research problem, and the important of the research. It presented research questions, 
objectives, hypotheses of the study, and presents limitations. It has indicated the 
research methodology, the method data collection, and the tool of data collection and 




















































2.1 Introduction:  
In This chapter the research will review literature studies related to the research 
questions regarding the internal & external determinants influencing firm’s export 
performance in international market. That challenges the entry to international market, 
to build clear and comprehensive picture of the environment related to 
internationalization, with special emphasis on internal as variables to this study.  
 
2.2 Pharmaceutical industry in International Business  
Palestinian pharmaceutical companies preparing to compete in the 21st 
century are increasingly challenged with the task of crafting strategies that anticipate 
and respond to the rapid pace of change in global markets, Business in globalization 
era needs to compete on a global basis if they want to compete and maximize their 
profit in international market. International Businesses today face a number of 
challenges and opportunities, including high competition, the effects of advances in 
technology, and free trade in open international market. To survive in these 
circumstances business must "think global" and "act local" and to internationalized 
the business. (Kotler, and Keller, 2009).  
The tremendous growth of international trade over the past several decades 
has been pushed the globalization. The volume of world trade after world war II has 
increased by twenty-fold. (WTO. 2008), World trade has the broad and simultaneous 
impact on nations, firms, and individuals, Within five years alone, world trade in 
merchandise has expanded from $6.2 trillion in 2000 to over $9 trillion in 2005. 
World trade in services has expanded from $1.5 trillion to $2.1 trillion in the same 
period of time. That represents a growth of nearly 150 percent for trade in both 
merchandise and services. (Czinkota and Ronkainen, 2007).  
This increase in the international business has spurred tremendous competition 
across the globe, as a result pushing the firm to gain from the opportunities of 
international business. Furthermore, international business across borders is no more the 
expensive privilege of only multinational companies, Small and medium firm can 
internationalize their business. Internationalization process is necessary because national 
economy integrated to the world market, and separation became impossible. Failure to 
participate in the international market cause declining economic position and 
competitive advantage of a nation (Czinkota & Ronkainen, 2004).  
 
2.3 International business: 
"International business is all commercial transaction ;private and governmental; 
sales, investments, and transportation, that take place between two or more countries; 
private firm undertake such transaction for profit"; in general governments support 
exporting to increase the national wealth (Daniels, Radebaugh et al. 2006), 
International business can be defined as "the performance of trade and investment 
activities by firms across national borders". The term emphasizes on crossing 
national border, it also refers to international business activities conduct value adding 
on an international standard. They seek international customers. In international 
business, there will be exchange of physical and intellectual assets, including 
products, services, capital, technology, and labor force. (Cavusgil, 2012).  
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2.3.1 International marketing: 
"International marketing is the process of planning and conducting 
transactions across national borders to create exchanges that satisfy the objectives of 
individuals and organizations". International marketing has many different faces 
ranging from export–import trade to licensing, joint ventures, wholly owned 
subsidiaries, turnkey operations, and management contracts. Globalization makes 
International marketing more important because the world has become relatively 
more free market. (Czinkota and Ronkainen, 2007) 
International marketing is necessary because it affects consumers in many 
ways. It offers consumer with his need in high quality and reasonable price. For the 
nation, the Failure to participate in the global market assures a nation of declining 
competitive advantage, and its citizens of a decrease in their quality of living. 
Successful international marketing, can hold the promise of an improved quality of 
life, a better society, although, some criticize international marketing and figure to 
the negative aspects of international business. They accuse multinational corporation 
of monopoly of market, polluted environment, Many of these accusations are being 
discussed seriously. (Onkvisit 1993).  
 
2.3.2 International Markets: 
International markets can be defined according to the following approach 
which suggests two dimensions for the definition:  
1. "The international market as a country or a group of countries".  
This definition emphasizes that of the country is national political state identity.  
2. "The international market as a group of customers with nearly have the same 




Globalization of the business and an increasing of interdependence between 
countries force many firms to Internationalization process. Internationalization offers 
potentially more profitable markets for firm; helps increase the firm’s competitiveness; 
and facilitates access to gain new knowledge, innovations and the sophisticated 
technology.The internationalization term stands for "Doing business in many countries 
of the world, but often limited to a certain region". (Hollensen 2008). 
Internationalization subjected to many researchers have tried to explain its process. One 
of the most famous model is Uppsala Internationalization Model, (Johanson & Vahlne 
1977, 1990, 2006) emphasis on the gradual process of internationalization (Johanson & 
Vahlne, 1977, 1990, 2006).  
 
2.3.4 The internationalization stages of the firms: 
The Uppsala Internationalization Model (U-M) of (Johanson & Vahlne 1977, 
1990, 2006) described internationalization process of the individual firm (Andersen 
1993), It has been argued that in the manufacturing sector the internationalization 
process of the firm occurs in a number of evolutionary stages (Roberts 1999) Jan 
Johanson And Finn Wiedersheim-Paul (1975) studied the internationalization 
process of Swedish firms at the University of Uppsala. Their work has distinguished 
between four different modes of entering an international market, where 
internationalization process pass on gradual successive stages that represent higher 
degrees of international engagement of the firm, following is the four stages:  
Stage 1: No regular export activities.  
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Stage 2: Export via independent representatives (agents).  
Stage 3: Establishment of an overseas sales subsidiary.  
Stage 4: international production/manufacturing  
They think these stages are important because there is difference regarding the 
degree of engagement of the company in the market, and they are often referred to 
people in business. (Johanson and Wiedersheim-Paul 1975).  
 
2.3.5 Firm Characteristics of Internationalization process: 
Cavusgil, S. T. (2012) identifies certain patterns and characteristics 
associated with the process of the firm path to internationalization:  
1. Push and pull factors serve as initial triggers, where push factors include; 
influence of domestic market such demand volume, competition.  
2. Initial internationalization can be occured accidently, or haphazard. 
3. Risk and return must be measured between risk and profits.  
4. Internationalization is an evolutionary ongoing learning experience.  
5. Firms may evolve and progress through stages of internationalization. 
 
2.4 International Market Entry: 
The concept of international market entry is related to the obstacle or easiness 
of entering country's market, entry to international market is serious challenge to firm 
ability to compete in global basis, firm needs resource, management commitment, 
control of its operation overseas. (Bradley 2005) 
Market entry strategies include decisions on:  
• The choice of a target product/market; 
• The objectives and goals in the target market; 
• The choice of an entry mode to penetrate the market; 
• The marketing plan to penetrate the market; and 
















Figure (2. 1) Potential Determinants Of The Firm's Choice Of Foreign Markets 
source :Adopted from (Hollensen, 2008)163. 
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2.5 International Entry Mode Strategies: 
An international market entry is an institutional arrangement to facilitate the 
firm access to international market, Once a company has decided upon a suitable 
international market for its operations, it needs to choose an proper market entry 
strategy (Root, 1994). The foreign market entry strategies takes various form. That 
includes exporting, contractual and investment entry modes (Bradley,1995). 
According to (Hill, Hwang et al. 1990) the entry mode depends on many 
internal and external factors like the international marketing strategy, environment 
factors, cost consideration, and global strategic objective, all of these variables 
influence entry mode according to elective theory.  
Once the firm has determined its target objectives in target market, the next 
step is to choose the best way to enter the market. It cannot be stated categorically 
which mode is the best. There are many internal and external conditions which affect 
this choice, following characteristics are connected to three types of entry modes:  
Export modes (agent, distributor): low control, low risk, high flexibility.  
Contractual (Intermediate) mode (joint venture, strategic alliance ): shared control 
and risk, split ownership.  
Investment (Hierarchical) modes (own subsidiary): high control, high risk, low 
flexibility. (Hollensen, 2008) 
 
2.5.1 Entry Modes strategies: 
2.5.1.1 Exporting as a Foreign Market Entry Strategy: 
Because it entails limited risk, expense, and knowledge of foreign markets and 
transactions, exporting is what most companies prefer as their primary foreign market 
entry strategy. Typically, the focal firm retains its manufacturing activities in its home 
market but conducts marketing, distribution, and customer service activities in the export 
market, either itself or through an independent distributor or agent. (Cavusgil, 2012) 
Exporting entry modes is the most useful strategy of entry for manufacturing 
companies for their initial internationalization process (Bradley, 1995). Exporting 
minimize the risk of foreign market involvement. Exporting is control the 
"experience effect of shifting from exporting to foreign production in foreign 
country. (Yung-Chul and Leonard, 1993). there is direct and indirect export, and 
other type of export form. (Root,1994). 
 
2.5.1.2 Contractual Entry Modes 
Contract manufacturing is outsourced to an external partner of the firm. It 
utilize the specializing production and production technology of the firm (Hollensen 
2011). This includes Licensing., Franchising, management contract, technical 
assistance, Licensing is another way in which the firm can establish local production 
in foreign markets without capital investment (Hollensen 2011) Franchising is a term 
when franchisor gives a right to the franchisee against payment, e. g. a right to use a 
total business concept/system, including use of trade marks (brands), against some 






Licensing is a means of establishing a foothold in foreign markets without 
large capital outlays is licensing. Patent rights, trademark rights, and the rights to use 
technological processes are granted in foreign licensing. It is a favorite strategy for 
small and medium-sized companies. The main advantage of licensing is the 
circumvention of import barriers. In addition, licensing helps the firm to overcome 
the problem of high transportation costs that might occur in exporting. Licensing also 
implies lower political risk than the investment entry modes. (Root, 1994) 
 
Franchising: 
Franchising is a rapidly growing form of licensing in which the franchiser 
provides a standard package of products, systems, and management services, and the 
franchisee provides market knowledge, capital, and personal involvement in 
management. (Bradley 2005) Franchising is when an individual or an organization in 
a country is granted the right to use the company name, trademark and technology. 
However, the franchisor also assists the franchisee in organization, marketing, and 
general management under an arrangement that is intended to be permanent. The 
advantages of franchising are rapid expansion to new markets with low investment, 
standardized method of marketing with a distinctive image, highly motivated 
franchisees, and low political risk. The disadvantages of franchising are mainly the 
same as for licensing. Further, licensing and franchising are suitable modes of entry 
when the company sells a service that cannot be exported. (Root, 1994) 
 
Consortia: 
Consortia is similar to joint ventures and could be classified as such except 
for two unique characteristics: (1) They typically involve a large number of 
participants and (2) they frequently operate in a country or market in which none of 
the participants is currently active. Consortia are developed to pool financial and 
managerial resources and to lessen risks. Often, huge construction projects are built 
under a consortium arrangement in which major contractors with different specialties 
form a separate company specifically to negotiate for and produce one job. One firm 
usually acts as the lead firm, or the newly formed corporation may exist 
independently of its originators. (Bradley, 2005) 
Contractual relationships usually take the form of licensing and franchising, 
in which the firm allows a foreign partner to use its intellectual property in return for 
royalties or other compensation. (Cavusgil, 2012), contractual entry modes can be 
separated from the exporting modes since the previous are transfers of knowledge 
and skills and the latter involve transfers of products. However, contractual entry 
modes can later lead to export opportunities. (Root,1994) 
 
2.5.1.3 Investment Entry Modes: 
This means investment within a foreign country. Companies may invest in 
another market due to low cost labor, to avoid high import taxes, to reduce the high costs 
of transportation to market, to gain access to raw materials and technology, or as a means 
of gaining market entry. (Bradley, 2005) 




Joint venture: is different from other types of strategic alliances or collaborative 
relationships in that a joint venture is a partnership of two or more participating 
companies that have joined forces to create a separate legal entity, joint venture is when 
two companies share the ownership of a firm in order to complement assets and/or skills 
(Brassington and Pettitt,2000). A joint venture occurs either when a foreign and a 
domestic firm together start up a completely new company within the new market, or 
through an acquisition or a partial ownership of an existing local company by the foreign 
firm. (Root,1994) 
Acquisition: Acquisition is to acquire a foreign company in order to get access to 
distribution channels and specific assets, to create product/geographical/financial 
diversification and the sourcing of raw materials for sale outside the host country. The 
advantages of acquisitions differ depending on how successful the selection of the 
acquired company is, and a poor selection can turn any advantage into a disadvantage. 
(Root, 1994).  
Merger: when combining two or more entities into one, without the creation of a new 
entity (Investing Glossary, 2003) Merger activity is likely to lead to economies of scale 
and a rapid expansion of market share. Further, it allows for decisions to be made 
without having to wait for consensus by another part. In addition, mergers can be used as 
means to spread risks to various activities, and as ways to achieve managerial prestige, 
access to brands contracts and networks. Finally, mergers decrease competition in the 
market place and are therefore best suited in industries where competition is intense. 
(Floyd, 2002) 
 
2.5.1.4 Electronic Entry Mode: 
Finally, the electronic entry mode means that a service firm extends its 
accessibility through the use of advanced electronic technology. The Internet presents 
ways to communicate offerings and to put them up for sale, and the ability to collect data 
on buying habits and patterns of its customer, and the possibility to use network partners 
to arrange delivery and payment. However, the company still has to rely on, for example, 
postal and other delivery services for the strategy to work. This strategy might in some 




















Figure (2. 2) An international market entry mode for pharmaceutical companies 
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2.6 Determinants Influencing the Entry Strategy Decision: 
The selection between the entry modes depends on the risk the company is 
prepared to take and its desired degree of control on its internationalization process 
(Farhang, 1990). According to Root (1994)  it depends on whether the managers of 
the international firm follow the naive, the pragmatic or the strategy rule when 
deciding which mode of entry should be used when entering foreign markets.  
Root (1994) further states that the naive rule implies that the firm only 
consider one way to enter foreign markets, no matter of which country the firm is 
entering. To follow the pragmatic rule means that the company does not set aside 
time to investigate other modes when a mode of entry that is working has been 
found. Finally, companies following the strategic rule systematically compare other 
modes of entry in order to eventually find the most suitable one.  
On the other hand, Albaum and Strandskov (1994) argue that the decision can 
be based on either, or both, of two broad approaches, which are experience or 
analysis. That is, the company can decide what mode of entry is desirable for its 
products from its own experience, or from other firms’ experiences. In contrast, the 
choice can also be made after making an analysis of the marketing task, needs, and 
buying habits of potential customers, and the competence of marketing organizations 
to perform various activities. 
The decision of entry mode revolves around both external and internal factors 
(Albaum and Strandskov, 1994). The influence of internal and external determinants 
is illustrated in many models; Foreign Market Entry Mode Decision, Factors in the 
Entry Mode Decision (root,1994), Factor affecting the foreign market entry mode 
decision (hollesen, 2008), (Aaby and Slater, 1989), an operational model of the 
determinant of service firms export success adopted from (Cavusgil, 1984). 
A company's choice of its entry mode for a target country is the net result of 
many determinants. The need to anticipate the strength and direction of these 
determinants forces makes the entry mode decision a complex process, In general, 
the choice of entry mode should be based on the expected contribution to profit.  
There is four groups of determinants are believed to impudence the entry 
mode decision:  
1. Internal factors; 
2. External factors; 
3. Desired mode characteristics; 
4. Transaction-specific behavior.  
As shown in Figure (2.3) four groups of determinants are believed to 
impudence the entry, figure shows the positive-negative influence for each 























Figure (2. 3) Factors affecting the foreign market entry mode decision 
Source (Hollensen, 2008: 206) 
 
2.7 Internal and external determinants: 
Internationalization is influenced mainly by firm internal and external 
determinants, Many researchers have studied the influence of internal and external 
stimuli on mode entry (wiedersheim-paul et al, 1978; cavusgil and nevin, 1980; 
welch and wiedersheim-paul, 1980;root, 1994;adam, 2001;) The Organization of 
Exporting Activities (Dalli, 1995). 
Root (1994) finds there are external and internal factors affect export 
performance. These factors can be divided into product factors and 
resource/commitment factors. Table (2. 1).  
 
Table (2.1) design foreign market entry mode decision 
Source :(Root, 1994) 
 
Koch (2001) provides a model shows the main determinants which affect 
Internationalization process i. e. "market and Market Entry Mode Selection 
process" (MEMS). He suggested that All factors proposed to influence the entry 
EXTERNAL INTERNAL 
Target Country Market Factors Company Product Factors 
Target Country Environmental Factors Commitment Factors 
Target Country Production Factors Company Resource 































+ = Increasing   
      Internalization  
- = Decreasing 
      Internalization 
      (= increasing  
      Externalization) 
External 
factors 





































+ + + + 
+ + - + - - 
 
 25 
mode selection process fall into three broad categories: external, internal, and the 
mixed, internal/external category. Some of the proposed categories of factors may 
influence some others, adding to the complexity of the decision process. These are 
factors that derive from both environmental and company specific factors, and some 
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Figure (2.4) Market entry mode selection 
Source: (Koch, 2001) 
 
 (Aaby and Slater 1989) suggest a model for firm internationalization. The 
model explains the internal and external determinants that influence the firm export 
performance. They distinguish an export performance factor, three internal factors, 
and one external factor, the internal determinants are described in detail.  
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Figure (2. 5) Aaby & slater (1989) General model for assessing export 
performance and variable. 
Source: (Aaby and Slater, 1989) 
 
Other researchers focus on the firm's attempts to identify and exploit export 
market opportunities. They have classified export stimuli into proactive and reactive 
(Johnston and Czinkota, 1982; Leonidou, 1988). In this context, proactive stimuli are 
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opportunities (pull factors); whereas, reactive stimuli are those associated with the 
firm's reaction to changing conditions and reflect a passive attitude in looking for 
export opportunities, although possibly leading to an accidental or fortuitous export 
involvement (push factors). Moreover, Albaum et al. (1989) argue that a proactive or 
reactive export stimulus may originate from either the internal or external 
environment of the firm. Accordingly, they point to four different groups of export 
motives including: proactive/internal (e. g., unique products, managerial urge); 
proactive/external (e. g., foreign market opportunities, attractive export incentives); 
reactive/internal (e. g., excess production capacity, opportunity to reduce inventories); 
and, reactive/external (e. g., unsolicited (e. g., unsolicited orders from abroad, 
saturated domestic markets). (Katsikeas, C. S., S. L. Deng, et al, 1997). 
 
Welch and Wiedersheim-Paul (1980) suggested determinants influence export 
performance as following:  
- Domestic environment and location of the firm. 
- Goals of the firm. 
- Product line. 
- History of the firm and extra regional expansion. 
- Unique competence. 
- Excess capacity. 
- Competition. 
- Government incentives. 
- Fortuitous export orders or inquiries. 
(Welch and Wiedersheim-Paul, 1980) 
 













Figure (2. 6) Proposed causal Relationships among the internal 
Determinants of export behavior 
Source: (Cavusgil and Nevin, 1981) 
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2.7.1 Internal determinants: 
Many studies attempt to identify the key determinant that contribute to the 
success of export performance, Comprehensive review of studies suggests number 
of internal determinants affect firms behavior in export marketing (Bilkey 1978). 
These internal determinants may include, Firm Characteristics, differential firm 
advantages, products (Wiedersheim-Paul, Olson, et al 1978). These internal determinants 
are the main factors affecting export, many other determinants and variable share 
the decision making for export, this study is focusing on selected general 
determinant that affect the export performance according to the classification of 
Zou and Stan (1998).  
Zou and Stan (1998) classify the internal and external determinants of 
export performance, classify the internal determinants into three main 
determinants table (2.2), exporting marketing strategy, management, and firm 
characteristic, as following:  
 
Table (2. 2) Internal Determinants of Export Performance "Classification of the 
dependent and independent factors" 
Controllable uncontrollable 
Export Marketing Strategy  Firm’s Characteristics and 
Competencies 
 General export strategy  
Export planning 
Export organization  
Market research utilization  
Product adaptation  
Product strengths  
Price adaptation  
Price competitiveness  
Price determination  
Promotion adaptation  
Promotion intensity  
Distribution channel adaptation  
Distribution channel relationships  
Distribution channel type  
Firm’s size  
Firm’s international competence  
Firm’s age  
Firm’s technology  
Firm’s characteristics  
Firm’s capabilities/ competencies 
Management determinants 
management Attitudes and Perceptions management Characteristics 
Export commitment and support MEC 
International orientation IO Composite scales 
COM 
Proactive export motivation EM 
Perceived export advantages MPA 
Perceived export barriers 
Manag. international experience  
Manag. education / experience 
 
Source: (Zou & Stan, 1998) 
 
In their research of the UK export performance Wheeler, C., Ibeh, K., & 
Dimitratos, P. (2008) provided a summary framework represents the main internal 
determinants influencing export performance. They blended the most determinants 
according to the previous relevant models, notably Aaby and Slater’s (1989), 


















































Figure (2.7). A Summary of Aggregate Findings on the Determinants of Export 
Performance Among UK Firms 
Source: (Wheeler, C., Ibeh, K., & Dimitratos, P. 2008) 
 
2.7.1.1 Export planning: 
Strategic planning entails the following field: "defining the business 
mission, objective, goal, analyzing internal strengths and weaknesses, analyzing 
external opportunities and threats, formulating goals, formulating strategy, 
formulating concern programs, implementing the programs, and gathering feedback 
and exercising control". (kotler and keller, 2006). Goals indicate what a business 
unit wants to achieve; strategy is a game plan for getting there. Every business 
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must design a strategy for achieving its goals, consisting of a marketing strategy, 
and a compatible technology strategy and sourcing strategy (Michael Porter, 1990) 
Firm with strategic plan for internationalization with specific applicable 
Objective is more intended to export (Wiedersheim-Paul et al. 1978) Firms deliberate 
marketing strategy plan can achieve better performance in international markets 
(Cavusgil and zou, 1994) Firm export strategy help firm to enhance export 
performance (Aaby and Slater, 1989).  
Strategy shapes export marketing plan (Lamont,  2002). The strategic 
marketing plan assign the target markets and the product proposition that will be 
offered, based on an analysis of the best host market opportunities, Successful firms 
may require to adopt a new view of how to design their strategies plan, (Kotler killer, 
2006) 
Business viewS export as higher profit than domestic business, (Simpson 
and Kujawa, 1974). As a result, firms plan its strategies to seek profits from 
exporting, Profit goals are usually indicative of active export behavior, (Leonidou, 
L. C., 1998). Profit plan is important to the firm that are at a stage of initial interest 
in exporting. Over the time, the firm’s attitude towards growth will be influenced 
by the type of Strategy. Profit gained from export can influence the firm growth, 
The stronger the firm’s motivation to grow, the greater will be the activities to find 
means of fulfilling export goals the greater will be the growth and profit for the 
firm (Hollensen, 2008). 
Export plan is essential to achieve firm profit, Firm Profit can be 
determinant of the export. Firms exporters recognize only their unique product and 
possible profit advantages as motivator to export (Czinkota and Johnston, 1983), 
Aaby and Slater (1989) find that the importance of a profit motivation for export 
behavior is unclear. (Simpson and Kujawa, 1974) find that exporters had a higher 
profit perception and a lower risk than did the non-exporters. the export plan can 
help to increase the profit and decrease the risk.  
 
2.7.1.2 Export organization 
The firm considers Export Organization when it has a department/division 
responsible for exports, (Gertner, Gertner et al, 2007). Export organization intends 
to export must encourage staff to work in export effort directed to the international 
strategy of the firm (Gomez-Mejia, 1988). The export organization requires the 
active cooperation of all department and sections in firm. Cooperation emphasizes 
on design, schedules of export orders, fixing problems of machine, handle complex 
credit arrangements for foreign customers, documentation of overseas payment; 
and of the office to handle overseas orders. Firms  must be able to engage the entire 
organization in export activities (Tookey, 1964). 
Export Organization with high level of good performance tends to do well 
in international marketing, should be competent marketers, work to skimming 
profit, adapt the product and use the marketing mix, look for strategies to compete 
in foreign market and perceive the important of the international business. 
(Ogunmokun and Ng, 2004) 
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2.7.1.3 Market research utilization  
In intense global competition, marketing research are important to produce 
product with uniqueness, technical intensive product, and competitive advantage 
(Leonidou, L. C., 1998), Marketing research is important activity in facilitating 
exporting, the shortage knowledge of foreign markets is often a major obstacle in 
exporting to international market (Johanson and Vahlne, 1977). The firm needs to 
invest in marketing research, the information can be utilized in responding to 
customer need, This creates scale to R&D costs and to allow the use of advanced 
production technology to provide the product can satisfy the people needs in 
international market (Porter, 1990). 
 
2.7.1.4 Export Marketing Strategy 
Firm strategy is important determinant influencing export performance 
(Aaby and Slater, 1989), The firm strategy can include assessment of key business 
policies and capabilities within the firm's control that are needed for export, Yip 
(1989) indicates that marketing strategy of the firm intend to export can assist firm 
to reduce the cost, improve quality of product and programing, enhance customer 
preference and increase firm competitive.  
A global strategy is one in which a firm sells its product in many nations In 
a global strategy, a firm sells in many if not all of the nations that represent 
significant markets for its product. (Porter, 1990). Export marketing strategy is 
developed as firm responds to the global business. This process involves all aspects 
of the international marketing plan, including marketing mix for product, 
promotion, pricing, and distribution. (Douglas and Craig, 1989). 
Michael Porter (1990) has proposed three strategies that offer clear starting 
plan for strategic thinking: cost leadership, differentiation, and focus.  
• Cost strategy: The business works hard to achieve the lowest production and 
distribution costs so that it can price lower than its competitors and win a large 
market share.  
• Differentiation strategy: Firm concentrates on achieving superior performance. 
Thus the firm seeking quality leadership, use best components, inspect them 
carefully, and effectively communicate their quality.  
• Focus strategy: The business focuses on one or more narrow market segments.  
 
2.7.1.5 Marketing Mix: 
The export marketing mix positively affects export performance (Madsen, 
1989), Marketing mix elements; product, price, promotion, and place, is essential for 
internationalization. management must adjust strategy for each elements in the 
marketing strategy, a useful tool in this prospect is gap analysis method, in which 
firm estimate a potential sales by each sole market, and identify the segment for each 
individual market (Radebaugh et al, 2006). 
The marketing mix decisions depend on product profile, distribution and 
availability in the market, Pricing, and promotion correlates with export 





Export marketing mix policies: 
1. Product adaptation. 
2. Acceptance of retailers' specifications. 
3. FOB/CIF quotations. 
4. Sterling quotations. 
5. Home trade price-plus. 
6. Level of sales promotion (last market). 
7. distribution through: 
a. chain stores/multiples. 
b. wholesalers/middlemen. 
(Amine Lyn S and Cavusgil S Tamer (1993) 
 
2.7.1.5.1 Product determinants: 
The process of export of defined product should start with Preliminary 
Screening, Preliminary screening involves defining the physical, political, economic, 
and cultural environment. (Cavusgil, 1985), Products can be described in different 
dimensions; e. g., degree of standardization, degree of complexity, and quality, 
(Wiedersheim-Paul, Olson et al. 1978), Products factors play crucial role in Export 
Performance (number, quality, design, New Product Characteristics, Relative 
Advantage, and, Product Age, adaptation) Many researchers attributed to product 
factors and its influence on export (McGuiness & Little, 1981; Cavusgil & Nevin, 
1981), product Price Competitiveness has affect Export Performance (Bilkey,1985) 
product categories, product line (Adam, 1997), comprehensive product package 
(Wiedersheim-Paul, Olson et al, 1978). 
Perhaps the most important concern of export market research is how to satisfy 
the needs of attractive foreign markets (Cavusgil, 1985), Product determines the success 
of the firm by the satisfying customer and challenge competitors, product brand that 
reflect the complex bundle of image in consumer mind related to the product image and 
its equity, international product brand is prepare for export to international market, global 
brand has the same name image and similar image and positioning through international 
market (Cavusgil, 1985). Product positioning refers to the perceptions or image that 
target customers have of a product or service (Johansson, 2009). 
 
Product Mix  
Product line: A group of products within a product class that are closely related 
because they perform a similar function, A product line may be composed of 
different brands or a single family brand or individual brand that has been line 
extended, (Kotler. and Keller, 2006), These group of are sold to the same customer 
groups, are marketed through the same types of outlets, or fall within given price 
ranges (Kotler, P., & Armstrong, G., 2012).  
An organization with several product lines has a product mix. A product mix 
(or product portfolio) consists of all the product lines and items that a particular seller 
offers for sale. A company’s product mix has four important dimensions: width, 
length, depth, and consistency.  




Product mix length refers to the total number of items a company carries within its 
product lines. Colgate typically carries many brands within each line 
Product mix depth refers to the number of versions offered for each product in the 
line 
Consistency of the product mix refers to how closely related the various product 
lines are in end use (Kotler, P., & Armstrong, G., 2012). 
These four product mix dimensions permit the company to expand its 
business in four ways. It can add new product lines, thus widening its product mix. It 
can lengthen each product line. It can add more product variants to each product and 
deepen its product mix. Finally, a company can pursue more product-line 
consistency. To make these product and brand decisions, it is useful to conduct 
product-line analysis. (Kotler, P. and K. L. Keller, 2006).  
 
Table (2. 3) Product Mix Pricing 
Pricing Situation   Description 
Product line  pricing Setting prices across an entire product line 
Optional product pricing Pricing optional or accessory products sold with the main 
product 
Captive product pricing Pricing products that must be used with the main product 
By-product pricing Pricing low-value by-products to get rid of them 
Product bundle pricing Pricing bundles of products sold together 
Source: adopted from (Kotler, and Keller, 2006) 
There are no general formula for marketing mix, debate of the standardization or 
adaptation of the marketing mix program has been old one, in international business the 
product adaptation needed if the environment in the host market required the adaptation, 
meanwhile there is no difference between domestic market and international in general 
especially in the product that has international standardization. (Cavusgil, Zou, and Naidu, 
1993) 
 
Product Characteristics and Attributes: 
Product Specific characteristics such as design, quality and technical structure, 
were seen to influence the firm's export behavior (Cavusgil and Naor, 1987), Product  
possession of a uniqueness is regarded to play a definitive role in enhancing exports, 
while product quality was viewed as important for the continuity of the export effort 
(Christensen et al, 1987). 
Developing a product or service involves defining the benefits that it will 
offer. These benefits are communicated and delivered by product attributes such as 
quality, features, and style and design.  
 
Product Quality: 
Product quality is one of the marketer’s major positioning tools. Quality has a 
direct impact on product or service performance; thus, it is closely linked to customer 
value and satisfaction (Leonidou, 1998), Firms that want to secure stable export 
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activities with high performance should offer a strong, high quality product, be 
cautious of selling at low prices (Madsen, 1989).  
 
Product Style and Design: 
Another way to add customer value is through distinctive product style and 
design. Design is a larger concept than style. Style simply describes the appearance of a 
product. Styles can be eye catching or yawn producing Packaging involves designing 
and producing the container or wrapper for a product Labeling and logos can enhance a 
brand’s positioning and Personality Labels range from simple tags attached to products 
to complex graphics that are part of the packaging. They perform several functions. At 
the very least, the label identifies the product or brand, (Leonidou, 1998). 
Packaging is an important consideration when the product shipping to export, 
labeling design to attract attention to help product brand positioning, multi language need 
to explain to the customer the purpose of product and instruction of usage. (Keegan and 
Green, 2005). 
A brand is a name, term, sign, symbol, or design, or a combination of these. 
That identifies the maker or seller of a product or service of one seller or group of sellers 
and differentiates them from those of competitors. (Kotler. & Armstrong, 2012). 
Patented product was also assumed to encourage engagement in export activities and 
secure business performance in international markets (Leonidou, 1998). 
 
Uniqueness product: 
A firm intends to export has to produce product that are not widely available 
from international competitors or may have technological advances and should be 
differentiated, Unique product can certainly provides a sustainable competitive 
advantage and result in major business success abroad. superior products is more likely 
to receive enquiries from international markets because of the perceived competence of 
its offerings. (Hollensen, 2008) 
Product strength affects export performance, product strengthprovide better 
satisfaction of customer needs. product strength increase firm's ability to find good 
agents/distributors on the international market.  strong product enables the firm to attract 
better agents which again has a positive impact on Export performance. a strong product 
builds strong commitment in the firm itself which leads to better export performance. 
(Madsen, 1989) 
Root (1994) states that highly differentiated products give firm a significant 
degree of export. export can reduce high value of unit transportation costs and high 
import duties and still remain competitive in a host country. high product differentiation 
favor is to export, while low differentiation product make marketing strategy more 
expensive. Technologically intensive products give companies an option and alternative 
mode of entry, especially license technology in the foreign target county. Products that 
require considerable adaptation to be marketed abroad favor entry modes like (branch/ 
subsidiary exporting) or into local production. The product complexity and 
differentiation of the product decrease the cost of shipping, economies of scale, tariff. 
(Hollensenm 2001), qualities of the product affect the firm performance of export 
(Bruhno and Schilt, 2001). Possession of a unique product can helped firm to compete 
more successfully in international market. (Cavusgil and Nevin, 1981). Hollensen (2008) 




Product adaptation strategy affects export performance positively (Cavusgil 
and Zou, 1994; Leonidou et al., 2002; Zou and Cavusgil, 2002) 
Product adaptation strategy can be defined as "a firm’s consistent and planned 
activities to meet local consumers preferences and values " Generally, standardization 
appears more likely where the foreign market is most similar to the domestic market, 
while adaptation is preferred when markets are viewed as dissimilar (Cavusgil and Zou, 
1994), This strategy is primarily determined by characteristics of the firm and external 
business environments (Cavusgil et al., 1993; Leonidou et al., 2002), if firm adopted 
international product strategy, this can leads to sales growth in local and international 
market, (Johnson and Arunthanes, 1995; Leonidou et al., 2002). adaptation strategy 
facilitates the sales growth, return on investment and profitability of firm (Zou and 
Cavusgil, 2002). Therefore, it is expected that export performance is influenced 
positively by product adaptation. (Cavusgil and Zou, 1994) 
Country of origin plays an important role in exporting. The customer in 
international market has perception and attitude towards product in base the country of 
origin that can be positive or negative, as the firm is going to export, the Country of 
origin issue become relevant consideration. A country stereotype and reputation can 
represent advantage or disadvantage to competition in international market. (Keegan and 
Green, 2005), The impact of country of origin may be considerably more complex than 
is typically assumed, and that familiarity and other factors affecting information or 
experience with a product should be taken into consideration in addition to nationality 
and other demographic characteristics. (Johansson, Douglas et al., 1985) 
Wheeler, Tagg and Taggart (2002) suggested a number of Product characteristics that 
influence export ,as shows in table (2.4) : 
  
Table (2. 4) Some variable of product variable influence export 




Gilly et al. 
2011) 
(Cavusgil 1985) (McDonald, Tüselmann et al. 2002) 
(Leonidou, L. C., 
C. S. Katsikeas, 
et al. (2002). 
Product Functions Brand name Customer needs and desires 




Constituents/Content Feature Local production, imports, consumption Age of Product 
Quality 
 
Positioning Packagig Exposure to and acceptance of product 
Extent of establishment 
with firm Branding 




Availability of linking 
products 
Extent of establishment 
with firm Packaging/labeling 
Brand Standards Industry-specific key indicators of demand 
Extent of establishment 




products of foreign 
origin 
Product’s technical 
complexity Product advantage 
Product 
Constituents/Content adaptation Competitive offerings 
Training needs of sales 
force Of product New/unique 
Service, Maintenance, 
After Sale   
Strength of product 
patent Product’s unit 
price 
Product/brand mix 
Country of Origin  Functions, Attributes, Features Product features Customer service 
   Degree of product uniqueness Warranty 
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Finding in research literature indicates that unique or very sophisticated 
products, design, good product quality and patents were found decisively associated 
with success in exporting. Product uniqueness and innovation also proves its 
acceptance in the marketplace help to increase export success. (Kaynak and Kuan, 
1993) 
 
2.7.1.5.2 Product Mix Pricing: 
Firm needs to act vigorous to achieve low-cost advantage. An exporter can 
offer its product in market at a lower price than its rivals (Porter, 1980). The strategy 
for a product’s price is determined according to market mix. Empirical results show 
that distribution and communication capabilities positively influence low-cost 
advantage (Zou, S., Fang, E., & Zhao, S., 2003), In this case, the firm looks for a set 
of prices that maximizes its profits on the total product mix.  
 
2.7.1.5.3 Promotion: 
Firms can either adopt the same Promotion strategy they use in the domestic 
market or adapt it for each host market. Take advertising messages as example; some 
global firms use a standardized advertising theme around the globe. No doubt, even 
in highly standardized communications campaigns, some modification might be 
required for language and cultural differences.  
Global firms often have difficulty crossing the language barrier, with results 
ranging from mild embarrassment to outright failure. In international promotion, the 
brand names and advertising phrases can take an unintended or hidden meanings 
when translated into other foreign languages. Some companies apply a strategy of 
communication adaptation, Communication adaptation is A global communication 
strategy of fully adapting advertising messages to local markets. (Kotler & Armstrong, 
2012) 
 
2.7.1.5.4 Distribution Channels: 
An international company must take a whole-channel view of the problem of 
distributing Products to final consumer Channels of distribution within countries 
vary greatly from host market to another. There are big differences in the numbers 
and types of intermediaries serving each in host market and in the transportation 
infrastructure serving these intermediaries (Kotler & Armstrong, 2012). Different 
distribution systems prevailing in foreign domestic markets require serious 
adjustments to the firm’s distribution strategy in each market (Leonidou, 
Palihawadana, & Theodosiou, 2011).  
 
2.7.1.6 Firm Characteristics: 
The firm characteristics are used here to explain its relation with the export 
performance, the study expect firm characteristics has influence on export, 
Researchers have identified firm specific factors according to various prospective, 
Export marketing researchers have consistently emphasis on firm characteristics 
that influence export motivation. The literature suggests that highly influential 
factors in the export decision initiation process include: firm size (Samiee,1990); 
firm differential advantages (Wiedersheim-Paul et al. 1978; Cavusgil et al. 1979; 
Bilkey and Tesar 1979; Cavusgil and Nevin, 1981), competitive advantages 
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(Cavusgil, 1994) production character (Wiedersheim-Paul et al. 1978; Johnston 
and Czinkota 1982; Diamantopoulos et al. 1990), production capacity 
(Weidersheim-Paul et al., 1978; Johnston and Czinkota, 1982), inventory surplus 
(Johnston and Czinkota 1982; Leonidou, 1988) management of export (Cavusgil 
and Nevin, 1981), firm size (Reid, 1984;Bonaccorsi, 1992), customer orientation 
(Cavusgil, 1994).  
Wiedersheim-Paul, Olson et al. (1978) studied characteristics of a firm 
determinants that could have an effect on the pre-export behavior of the firm, out 
of several characteristics they have selected four determinant: goals of the firm, 
product line, history of the firm, and extra regional expansion (Wiedersheim-Paul, 
Olson et al. 1978).  
Aaby and Slater (1989) divided firm characteristics into three categories. 
These include variables related to firm size, variables related to management export 
commitment, and management perceptions toward export variables. These 
characteristics as firm size, degree of export involvement, and exporting experience 
should be considered to have different degree on the export motivation, this depend 
on the significant differences in perceptions of the management of the firm 





















Figure (2. 8) an operational model of the determinant of service firms export 
success adopted from  
Source:(Sichtmann, Griese, & Klein, 2007) 
 
Zou. and Stan. (1998) consider the following elements as Firm’s 
Characteristics: 
• Firm’s size. 
• Firm’s international competence. 
Firm Characteristics and 
Competencies 
 
• Capability to internationalize 
• Export commitment and 
capability of the management 
• Qualified and competent 
export staff 
• Market research utilization 




Performance Export Market 
 
• Economic 
• Legal similarity 
• Cultural similarity 
• Technology intensity 
• Technology intensity 
• Intensity of competition 
Export Marketing strategy 
 
Strategic planning 
Adaptation of marketing mix 




Adaptation to customers' 
Willingness 




• Firm’s age. 
• Firms technology. 
• Firm’s capabilities/competencies (Shaoming Zou and Simona Stan 1998). 
Wheeler, Tagg and Taggart (2002), suggested a Firm Characteristics that 
influence export as following:  
Firm Characteristics. 
International competence. 
Number of full-time employees. 
Annual sales volume of firm. 
Amount of firm’s international experience. 
Years of IB involvement of firm. 
Number of foreign markets operated. 
Resources for export development. 
Commitment to venture. 
Extent of careful entry planning. 
Extent of management commitment. 
Extent of resource commitment. 
International business intensity. 
Firm’s relative position in industry. 
Percentage of sales from IB. 

















Figure (2. 9) Factors influencing internationalization of the firm  
(Bradley, 2005: 56) 
 
2.7.1.6.1 Firm size and Age: 
Samiee (1990) stated that firm size is an important determinant of export 
behavior. Her findings indicate that firm size generally has a positive influence on 
exporting activities. size has a positive relation to the export behavior of the firm, 




Size of firm location 





on of firm 
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researchers (Czinkota and Johnston 1983). Cavusgil (1984) provide little support for 
the hypothesis of a strong relationship between firm size and export activity; Baldauf. 
Cravens, et al. (2000) provide partial support for their hypotheses "Higher export 
performers are the larger firms with somewhat less international experience", 
meanwhile Ried (1985) rejects the influence of firm size on export; (Czinkota and 
Johnston's. 1983) conclude that firm size is not relevant to export development (Reid 
1985). 
Firm size can be measured by the number of employees, (Samiee 1990), 
sale volume, number of product. (Eickelpasch and Vogel 2009), Other factors like 
firm age and firm size were similarly tested, and results indicate that younger and 
larger firms are likely to invest and export compared to older and smaller firms 
(Dueñas-Caparas, 2006). Root (1994) find that a company size is playing a critical 
factor in export, ultimately (Root 1994), states that Some studies report that export 
activity is positively related to the age of a firm, Firm age is measured as number 
of years that has passed since the firm was founded (Anderson, S., J. Gabrielsson, 
et al, 2004), Czinkota and Ursic (1984) find younger firms are much more 
favorably toward international marketing than older firms. They explained that 
younger firms are more favorably disposed toward international market to escape 
the domestic competition. (Czinkota and Ursic, 1984).  
Some contrast regard to the effect of business experience on export 
behavior. One group of researchers suggested that younger firms are more 
interested in internationalization than older ones. The justification is that the 
founders find exporting the only feasible strategy available to increase sales and 
achieve growth, (Czinkota and Ursic, 1983). The other view that established 
companies are more likely to export, because of extensive experience in handling 
business operations and saturated home opportunities (Welch/Wiedersheim-Paul 
1980;Leonidou, 1998).  
 
2.7.1.6.2 Firm capabilities and Competencies 
Firm Competencies is  a major determinant which Influences export 
performance (Aaby And Slater,1989). Firm competencies can be expressed as export 
experience (Measured By Years of Exporting), Firm characteristics as firm size can be 
measured by annual sales volume (Dean, Mengüç et al, 2000), Export marketing 
capabilities influence  export performance (Zou, Fang, & Zhao, 2003). 
Competence is the "ability to create, gain access to, and coordinate tangible 
and non-tangible assets" Competencies have critical and general importance in the 
global business environment. Company possessing competencies is likely to increase 
it’s the strategic flexibility involved in international business, (Koch, 1997).  
 
Table (2.5) Core global business competencies & capabilities 
Core competencies in global business 
1. Company ability to attract and retain people representing superior level of 
professional competence and deploy them optimally in the long term.  
2. Ability to obtain, analyze and use global business information faster and 




3. Ability to adapt to, and operate effectively in, a number of business 
environments of foreign countries; 
4. Ability to attain and sustain a strategically meaningful, leading global 
position in product and/or process innovation in their competence groups; 
5. Ability to implement an effective flexible long term sourcing strategy 
capable of sustaining cost advantage over most global competitors; and 
6. Ability to effectively leverage company competitive advantages through 
global strategic alliances.  
Core capabilities in global business 
7. Efficient and reliable evaluation of foreign markets 
8. Empathy with foreign cultures.  
9. Establishing foreign contacts.  
10. Maintaining customers’ trust.  
11. High transactional efficiency.  
12. Selecting optimal market entry mode.  
13. Smooth and efficient management of the overseas based operations.  
14. Ability to conceive and negotiate mutually acceptable solution of business 
problems. Generating and sustaining high level of customer confidence in 
company professional efficiency.  
Source:  (Koch, 1997) 
 
Competitive advantage affects positively export. It needs certain resources and 
capabilities that are uniqueness, and it can present an offer to the market that provides 
more value to its customers than competing offers (Barney, 1991) In international 
business competition. Firms need not be confined to their domestic market. They can 
compete with global strategies in which activities are located in many countries. Firms 
must pay particular attention to how global strategies contribute to competitive 
advantage. Firms can enhance their competitive advantage through competing in 
international market (porter 1990). In global business competitive advantage is 
essential for internationalization process. Firms not only respond to globalizing 
markets, but also proactively act on opportunities to acquire resources and sell outputs 
wherever in the world they have the greatest value. (Oviatt and Mcdougall, 2005) 
Firm performance can affect the export performance, firm performance is 
the firm practice to translate business strategies into deliverable results. Strategic 
performance measurement systems combine financial, strategic, and operating 
business measures to gauge how well a company meets its targets(Ittner, Larcker 
et al. 2003). Firm performance is positively related to its level of exporting 
activities and it is gradually improved thought export process development. (Lu 
and Beamish 2001) high performance firms are found to be among those exporters 
with a greater percentage of export (Kaynak and Kuan 1993). 
Total quality management (TQM) is an approach in which all of the 
company’s people are involved in constantly improving the quality of products 
Features are a competitive tool for differentiating the company’s product from 
competitors’ products (Kotler, & Armstrong, 2012). 
Firm has a competitive advantage that may include patents, brand names, 
trademarks, intellectual property, licenses, and technical characteristics of the firm. 
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could rise firm ability to export to international market (Kirpalani 1990), Image 
support requirements are essential to compete in international market, In some 
industries, companies want to build and sustain the its image of as a leading global 
supplier. This requires licensing their inventions to increase their role as global 
providers of newest technology, and strong brand (Koch, 2001).  
 
2.7.1.6.3 Firm technology: 
Firm technology influence export, "High-touch" products are more likely to 
enter foreign markets through low-control entry modes such as export or indirect 
exporting, while "high-tech" are likely to enter foreign markets through high-
control modes such as wholly owned subsidiaries or joint ventures. (Bradley and 
Gannon 2000), Advanced technology has often been cited in literature as one of the 
factors that plays a key role in the firm’s internationalization venturing. High-
investment costs of advanced research and technology force these firms to look for 
foreign markets in order to amortize the investment across a broader market base. 
(Elena & Keith. 2011).  
Technology is associated with success in export markets, firms owning 
sophisticated technology are in a position to have efficient manufacturing 
processes and high quality product products (Cooper and Kleinschmidt, 1985). 
The impact of technology affect the whole industry, it influence on export 
performance. Firm uses technology to attain competitive advantage. Firm of high 
technology seem more exporting oriented (Christensen et al, 1987). Sophisticated 
technology facilitates the export. (Bradley and Ganno, 2000), Researchers have 
found that level of technology influence the export performance (Anderson, 
Gabrielsson, et al. (2004), Reid (1986) found very little relationship between 
technology and export performance.  
 
2.7.1.6.4 Firm Resources 
Financial resources are essential for initiating the export. Exporting requires 
substantial fund for additional production equipment, raw materials, consultation, 
and labor, fund is required for marketing in foreign market, lack of financial may 
hinder establishing export marketing programmers, such as marketing research, 
product adaptations, distribution and promotions, all of which can negatively affect 
export performance. (Leonidou, 1998) 
A firm's physical resources are important antecedents of performance and 
to gain competitive advantage, because it places primary emphasis on the 
intangible skills and resources of the firm (Porter 1996; Barney, 2001), Resources 
of the firm, like capital, financial, human and technological resources influence 
firm export, Limited resources can limit the firm freedom to decide to export 
(Bruhno and Schilt, 2001), Root (1994) states that the more abundant a company’s 
resources in management, capital, technology, production skills and marketing 
skills, numerous resource encourage export. In opposition, a firm with limited 
resources is constrained to comply with export demand, ultimately, Resources 
utilization must be joined with a willingness of the management to export. (Root, 
1994), Schlegelmilch and Crook (1988) find that the export intensity is positively 
related to the differential advantages and resources of the firm(Schlegelmilch and 
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Crook, 1988). The larger firm tended to be more successful in exporting. It had the 
advantage of greater financial resources enabling it more easily to give the longer 
credit required by export customers while small firm find it too costly to offer long 
time credit (Tookey, 1964).  
Bradley (2005) classifies the potential resources of the firm as; tangible 
resource and Intangible resource:  
 
Table (2. 6) Potential resources of the firm as; tangible resource and Intangible resource 
Firm Resources 
Tangible Resource Intangible Resource   
Financial Cultivate good supplier  
Physical Recruit good worker 
Legal (Trade, Marks &Licenses) Respond to challenging competitors 
Human Competitive advantage 
Organizational Ability to reduce cost 
Informational (E. G. Consumer And 
Competitor Intelligence) 
Ability to differentiate itself 
Relational (E. G. Supplier And 
Customer Relationships) 
Attractiveness of the industry in which firm 
competes.  
Source: Adopted from Bradley (2005: 34-36) 
 
Johanson and Vahlne (1977) found that firm resources enhance the 
internationalization process. Resources employed in development and production 
of products for international market constitute a commitment to that export. The 
more specialized the resources are to the specific market the greater is the degree 
of commitment of the firm to export (Johanson and Vahlne, 1977).  
 
2.7.1.7 Management determinant: 
Management characteristic is expected to have a significant role on exporting 
performance. (Schlegelmilch, 1986), Koch (2001) states that there is a significance 
role of management characteristic in involvement for the firm in international 
business and export, manager perceptions is the way think towards export, their 
experienced and thought, determine the decision of export process. Decision maker is 
important in this issue. The number of manager and employees involved in decision 
making plays critical rule, depending on its management style, and relevant 
international experience. (Koch 2001) management’s with proactive. Motives more 
success in export. (Baldauf, Cravens et al., 2000) 
Bradley (2005) enumerated the management determinants that represent the 
key success to internationalization as following:  
• Attitudes towards company growth.  
• Cognitive style of mangers.  
• Managerial aspirations for internationalization.  
• Commitment to international markets.  
• Managerial expectations and internationalization.  




Bruhno and Schilt, (2000) summarized the critical competencies of management 
influence the export as following ; International experience of managers, general ideas 
on how the managers should pursuit their international strategy, the competencies in the 
international market, the ability of the management to develop these competencies, the 
language skills amongst the management, the knowledge of different marketing 
channels and their pros and cons. (Bruhno and Schilt, 2001) 
Shaoming and Simona (1998) suggested a number of elements that most 
characteristic of management related to export as following:  
 
Management Characteristics:  
• Management Attitudes. 
• Export commitment. 
• International orientation. 
• Proactive export motivation. 
• Perceived export advantages. 
• Perceived export barriers. 
• Management international experience. 
• Management education/experience. (Shaoming Zou and Simona Stan, 1998) 
 
2.7.1.7.1 Managerial Attitudes Toward Exporting: 
Management's perception regarding the effects of exporting plays a major 
role in the exploration of the management attitudes towards exporting, The attitudes 
held by the management of a firm have been found to significantly affect the export 
behavior of a firm. (Bilkey and Tesar, 1977) 
Managers of firms that exported a large percent of their total sales is very 
favorable expectations regarding the effect of exporting on the firm growth compared 
with firms that exported a small percent of their total sales. (Cavusgil. Bilkey. & 
Tesar, 1979) 
Managers often become aware of the opportunities in international market by 
travelling to other countries where they can discover new business opportunities, 
manager with previous experience of internationalization will there for try to 
employed his experience in the company. (hollensen, 1998) 
 
2.7.1.7.2 Perceived barriers: 
Perceived barriers to exporting were found to be meaningful for developing 
exporting firms. Management expectation of certain of the perceived barriers tended 
to differ systematically by export stage. Management perception is varied according 
to export stage; that is, when firm develops  its advanced export stage, it greatly 
perceives these considerations as a barrier to exporting:  
- Difficulty in understanding international business practices. 
- Different product adaptation and standards and consumer standards in foreign 
countries. 
- Difficulty in collecting money from foreign markets. 





2.7.1.7.3 Management risk attitudes: 
The level to which the company will accept various international business 
risks depends on the management risk attitudes, Risks may be estimated by using 
appropriate method. The perception of risks associated with certain countries may 
influence management decisions considerably (Johansson, 1997). The less risk averse 
the management, the more likely it is for the company to select countries that show 
greater long-term prospects and promise to enhance export (adam, 2001). 
Some scholars adopted the view that although export activity is characterized 
by higher risks and costs than domestic business, foreign markets might contribute 
profitable alternatives for many companies (Simpson and Kujawa, 1974). 
Individual human decision makers are risk averse, that is, manager tends to 
take decision depending on certainty rather than decision depending on lack 
information or depending on gambling, Attitudes toward risk are usually related to 
culture individuals dimensions, personality, motivation, mood, and behavioral. 
(March and Shapira, 1987) 
The amount of risk the management is willing to take when initiating  
influences the success of export. Export is considered the least risky comparing to 
other entry mode like wholly owned subsidiaries or production facilities, which 
involves the most risk, due to the heavy resource committed. (hollensen 2001), The 
level of risk will depend on the context of the management perception associated 
with individual experience and education. (Koch, 2001) 
Simpson, & Kujawa, (1974) enumerated a variety of perceptions of 
managers regarding risk and cost/benefit expectations, as well as several managerial 
risk "characteristics associated with exporting. These factors are:  
1. Perception of risk in the export market vs. risk in the domestic market. 
2. Amount of international travel. 
3. Level and type of education. 
4. Expropriations. 
5. Foreign exchange and related controls. 
6. Communication barriers. 
7. Profit perception, domestic vs. export. 
8. General cost perception; domestic vs. export, plus specific cost variables 
including:  
a) executive time  
b) packaging  
c) insurance  
d) clerical time  
e) product adaptations  
f) shipping (Claude and Kujawa 1974)  
Aaby and Slater (1989) found that managers of firms which have an 
international vision, favorable perception and attitudes toward exports, is willing to 
take risk and has the capacity to engage positively in export activities is likely to lead 
a company to export success. In order to reduce risks, managers need to know which 
variables influence their export performance. The higher risk taking propensity 
results in better export performance.  
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2.7.1.7.4 Management commitment: 
Export commitment is a managerial mindset in which exporting is deemed to 
be of fundamental importance in generating the present and future growth of the 
firm. Export commitment will be significant, in which it enhances exporting. 
Management commitment link the strategic planning orientation. The greater the 
commitment, the greater the management is willingness to allocate firm resources to 
export activities. This will include the dedication of specific resources to achieve and 
execute of export plans. The result indicates a positive relationship between export 
commitment and export planning orientation. (Lukas, Whitwell et al., 2007) 
The concept of market commitment is assumed to contain two factors ; the 
amount of resources committed and the degree of commitment. The amount of 
resources could be operationalized to the size of investment in the market (marketing, 
organization, personnel, etc.), while the degree of commitment refers to the difficulty 
of finding an alternative use for the resources and transferring them to the alternative 
use. (Hollensen, 2008) 
  A high level of commitment can be a key to success once the firm has entered 
the foreign market (Leonidou, Katsikeas et al, 2007), Larger and more experienced 
firms appear to be more committed to international operations. (Hoang, B. (1998).  
Root (1994) states a high degree of commitment means that managers will 
select the entry mode for a target country from a wider range of alternative modes of 
entry than managers with low commitment. Therefore, a high commitment 
management  more likely affects export performance. (root 1994). Management 
commitment is necessary in order to build the distribution network and information 
channels indispensable for the firm to engage in the export learning process that 
improve the export performance. (Solberg, & Olsson, 2010) 
The aspect of management to export refer to the amount of resource 
committed. This refers to the amount assigned to marketing, investment in activates 
to export, employ individual and other functional area, information gathering of the 
target markets, and planning marketing strategy for export. The management in the 
firm has to devote financial, and human resource, to concentrate their attention on 
exporting performance. The aspiration and ambition of the manger play important 
role in determining the management commitment. (Bradley, 2005) 
Aaby and Slater (1989) conclude that export success is strongly related to top 
management commitment in some form or another, past performance is very likely to 
shape the degree of commitment to exporting, A firm’s commitment to exporting is 
expected to increase when managers have achieved past performance goals. It is 
important to examine whether past performance levels are of large, little or no 
consequence to the firm’s international commitment, firms exporting to more 
competitive environments more committed to their export operations. Firms 
operating in the most developed markets are under constant pressure to be committed 
to exporting activity.  
There was a significant amount of human resources involved in the exporting 
activity There was a significant degree of management commitment to exporting 
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There were more financial resources for exporting than those used for the domestic 
market. (Lages and Montgomery, 2004)  
Dean, Menguc et al. (2000) concluded in their research, an important barrier 
for New Zealand exporters might include management commitment to exporting and 
an important marketing strategy might include "pro-activeness in choosing an export 
market".  
Johanson and Vahlne (1977) have developed a model of firm 
internationalization process. The model lights particularly on the gradual process of 
internationalization and links between using knowledge about foreign markets and 
operations, and on its successively increasing commitment to foreign markets. The 
basic mechanism of internationalization  state aspects contain two states: Market 












Figure (2. 10 )The Basic Mechanism of Internationalization-State  
and Change Aspects 
source: (Johanson and Vahlne, 1977) 
 
2.7.1.7.5 Management International Orientation: 
Company strategic orientation reflects management experience, values and 
attitudes, orientation increases, or reduces, or eliminates company interest in the progress 
of internationalization, It determines company behavior or collaboration with their 
competitors. It is also likely to strongly influence the process of business 
internationalization. (adam, 2001), International orientation also vary markedly from one 
country to another. The international orientation of the decision maker is perceived as 
being the most important of personal characteristics. Individual with a high degree of 
international orientation will have a higher probability to understand the international 
business and they will be favor the export (Weidersheim-Paul et al., 1978). Other 
researchers find that; Key Decision-Maker Characteristics plays crucial role in a firm's 
export involvement and commitment and it depends on their international orientation 
(Bilkey and Tesar, 1977; Cavusgil and Nevin, 1981), dichtl, koeglmayr et. al (1990) find 
that as many as one-third of the small and medium sized firms with a primarily domestic 
focus in their country could be turned into successful exporters (Dichtl, Koeglmayr et al, 
1990). 
Dean. Menguc & Myers. (2000) find that the proactive firm has orientation by 











likely to be service oriented than are reactive firms. Proactive firms “world orientation” 
was found to be associated to both higher export growth and level of export.  
Narver. and Slater (1990) classified orientation into three behaviors components; 
customer orientation, competition orientation, and inter-functional orientation. The first 
two concern with activities of collecting information and the third one  concerns with 
activities of firm to intend to create superior value to customers. The orientation towards 
the management profitability is found to be positive.  
 
Table (2.7) Market orientation 
Customer orientation  Competition orientation Inter-functional orientation 
Customer commitment Sale people share competitor 
information 
Inter-functional customer calls 
Create customer value Respond rapidly to competitors 
action 
Information integration in 
strategy 
Understand customer needs Top management discuss 
competitors strategies 




Target opportunities for 
competitive advantage 





After sale service    
Source : Conceptualized by researcher from (Narver. and Slater ,1990) 
 
Jaworski and Kohli (1990) define Market orientation as Aeries of market 
information handle including information generation and dissemination, shared 
interpretation, organization responsiveness, They argued that market orientation 
comprises number of components:  
• Information generation. 
• Information dissemination, and 
• Shared interpretation. 
Day (1994) "also contributes a broad study of the barriers to market 
orientation. He argues that the processes of market sensing and customer linking are 
the most distinctive capabilities of market oriented", organizations, and the lack of 
such capabilities impedes market orientation development. researchers suggest that 
change initiatives geared toward the development of market orientation must 
recognize and confront negative organizational behaviors (such as conflict) and 
identify and foster positive behaviors (such as communication). (Lloyd. Piercy. 1999) 
 
2.7.1.7.6 Ownership, knowledge, experience, education: 
Management and the owner of the firm influence the export. Management 
specific knowledge of marketing operating in a international business facilitates the 
internationalization process. Their experience and market knowledge will reduce the 
fear of internationalization in certain countries. Their experience may also dissuade 
the organization of competing in a certain market. This knowledge will be invaluable 
to the organization in their internationalization process to select the proper country, 
and will minimize risk and uncertainty. (Madsen and Servais, 1997), concerning 
management capability to go internationalization, A major problem seems to be 
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language Proficiency and the availability of qualified personnel. (Dichtl, Koeglmayr 
et al, 1990) management graduated from a well known foreign educated institution 
are less likely to be dissuaded from international market, and will generally possess a 
greater experience they can utilize to enter in international market. (Chetty and 
Campbell-Hunt, 2004) 
 
2.7.1.7.7 International experience: 
Management international experience for international market exists in the 
marketing literature as a driver in a firm's internationalization. Management with 
international experienced are likely to seek internationalization of their firm, whereas 
Management with less experience are unlikely to do so, Management international 
experience are more likely to identify strategic markets to export, respond to 
changing international market environment, Experience in international operations 
enables firms to select better export markets, formulate suitable marketing strategy 
and take advantage of the comparative advantages of their company (Chih-Wen, 
2011). Personal visits to export markets is a valuable tool for improving export 
(Leonidou, Katsikeas et al, 2002). Most studies implicitly assume a direct correlation 
between duration of export activities and experiential knowledge accumulated in the 
internationalizing firm (Sharma and Blomstermo 2003), Knowledge experience more 
effective to improve export than Information provided by public and private 
institutions (Denis and Depelteau, 1985) firm with extensive experience appear to 
has more aggressive strategy in market (Hoang, 1998). 
Johanson and Vahlne (1977) find that the relevant experience of a firm 
concerning specific markets affects both business knowledge and institutional 
knowledge, thus; firm previous specific experience in one country can affect 
internationalization process in other countries. Their results show that Swedish managers 
feel that a deficiency in knowledge of language is a problem in the internationalization 
process of firms. the higher perceived cost of the internationalization process resulted 
from lack of knowledge (Jan Johanson et al, 1997).  
Cunningham, and Spiegel (1971) selected a number of variable related to 
Management Characteristics that influence the export  
• Personal visits to export markets. 
• Use of overseas agents. 
• Overseas distribution. 
• Facilities. 
• After-sales service. 
• Market research. 
• Quality and design of product. 
• Proficiency in foreign. 
• Language (s). 
• Advertising. 
• Overseas Exhibitions. (M. T. Cunningham, R. I. Spiegel, 1971) 
Hambrick and Mason's (1984) in their study "upper echelons perspective on 
organizational outcomes", emphasized on observable top managerial characteristics 
that affect the decision making in the firm. Examples of such characteristics are age, 
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tenure in the organization, functional background, education, socioeconomic roots, 
and financial position. They emphasized on background characteristics, rather than 
on psychological dimensions.  
Reid  (1981) found a number of variable of individual antecedents character 
influence export such as; type and level of education, foreign nationality, ability to 
speak foreign languages, number of foreign travel, was born abroad, lived abroad or 
worked abroad, attitudes, and preferences concerning foreign markets. These 
variables are likely to be associated with the exporting decision maker's and affect 
the way the decide to exercise export.  
 
Table (2.8) Some variable of management characteristics 
variable source variable source 





age group (McConnel1979; 
Ursic and Czinkota 
1989),  
foreign nationality  (Reid 1981) 
educational background Schlegelmilch 
1986) 
ability to speak 
foreign languages 
 (Reid 1981) 
level of education reid (1981).  Age of decision-maker (Cavusgil and 
Naor 1987) 
professional experience  (Reid 1983  (Cavusgil and 
Naor 1987) 




managerial risk tolerance 
(attitudes, and behavior) 
(Wiedersheim-Paul 





quality and dynamism  (Bilkey and Tesar 
1977) 
Tolerance for risk (Cavusgil and 
Naor 1987) 
perceptions of costs and 
profits in overseas markets 
Roy and Simpson 
1981 













Staff visiting overseas 
markets 
Tookey, D. A. 
(1964) 






Tookey, D. A. 
(1964) 
  
Conceptualized by researcher 
 
2.8 Palestinian Pharmaceuticals Industry: 
Overview of the country  
Palestinian population in Palestinian Territory (West Bank and Gaza WB/G) 
was estimated around 3. 851million (PCBS,2004), Population aged (0-14) years was 
estimated at 45. 8% of the total population in the Palestinian Territory. Around 1. 4 
million Palestinians are concentrated in an area not exceeding 365 square kilometers. 
Most are Palestinian refugees forced to leave their villages and towns that were 
occupied in 1948. It is expected that this number will increase greatly due to the high 
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natural increase characterizing Palestinian society. The main economic indicators 
show that the Gross Domestic Product for the West Bank and Gaza Strip in 2003 is 
4. 011 billion U. S. dollars, Economic deterioration in the Palestinian society is a 
result of Israeli measures imposed. (PCBS. 2004).  
The consecutive Israeli policy of destruction of the productive Palestinian 
sectors including the exports sector resulted the decline in the value of exports by 
17% in 2002 comparing to 1999, which drop to 241 million dollars. (PCBS. 2004) 
This context can explained the impact of Israelis continued occupation of Palestinian 
lands, that caused deterioration of the Palestinian economy, human crisis, social 
decline, destruction of ordinary life. (Roy,2004).  
2.8.1 Overview of the Palestinian Pharmaceutical Sector: 
The History of the Palestinian Pharmaceutical Industry PPI started in Late 
1960s, Palestinian Pharmaceutical commenced its work in difficult situation it can be 
considered unique in terms of its innovation and development when compared with 
other Palestinian industrial sectors. The industry in Palestinian territories "west 
bank/gaza" WB/G was established just after the 1967 War as a result of the isolation 
of the West Bank from the rest of the Arab World. Before the 1967 War, all 
pharmaceutical products were imported from foreign companies via importers in 
Jordan for west bank or from Egypt to distribute in Gaza strip. After 1967 war, the 
borders were closed, thus preventing the import of any products from Jordan and 
Egypt. The only products available were either produced in Israel or foreign product 
imported through Israeli agents. (Abu Alia, 2007) 
Due to this difficult situation and the urgent needs for pharmaceutical 
product, Palestinian pharmacists have started to prepare some drug in their 
pharmacies, nine pharmacists established small laboratories to manufacture simple 
products. At a later period, these labs merged to established new companies. 
Afterward, another new companies were founded. (Abu-Hijleh, 2006), In the mid-
nineteen seventies (1970s) the number of pharmaceutical firms reached to nine 9 
firms. (makhool, 1999), therefore, these nine laboratories merged to become three 
larger firms, Jordan Chemicals in Beit Jala, West Bank/Gaza Medical Company in 
Ramallah, and Jerusalem Pharmaceuticals in El-Bireh. High demands encouraged 
New companies to enter the field, including "Balsam" Company in 1972 and Birzeit 
Company in 1973. After  five years Eastern Medical Company and Gama merged, 
Pharmacare company was established in 1985 in Beitunia, and Megapharm in Gaza 
In 1993. "Birzeit Pharmaceuticals Company merged with West Bank/Gaza Medical 
Company and in early 1995, Jerusalem Pharmaceuticals Company merged with 
Balsam Pharmaceuticals Company". The objective of these mergers was to raise the 
standards of the pharmaceutical industry and help meet international standards in 
pharmaceutical manufacturing. (massar, 2002) 
 
Table (2.9) : local pharmaceutical manufacturers firms 
No. Company Location Year of established Status 
1 Bet Jala (Jordan Chemicals) Bet Jala 1968  
2 Jerusalem Pharmaceuticals  Al-Bireh 1969 balsam Merged with (2) 1995 
3 Eastern Chemical Company Al-Bireh 1970  
4 Birzeit Pharmaceuticals Company Birzeit 1973 
Birzeit-Palestine Pharmaceuticals 
merged with (4) 
5 Gama Beitunia 1973 stop 
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6 Pharmacare Beitunia 1986  
7 Al Razi Chemical Co.  Hebroun 1988  
8 Medical Arab Supply Gaza 1981 stop 
9 
Middle east pharmaceutical and 




10 AL-Jaleel Pharmaceuticals Company Al-Bireh 2007 
stop 
Source (BPC 2012; Adili, 2009; obeidallalla, 2000) prepared by researcher with amendment 
 
2.8.2 Pharmaceutical Registration  
Ministry of Health  MOH  has the responsibility of registration and 
monitoring pharmaceutical industry in Palestine. previously the Israeli occupation 
relied on the drug policies and procedures of the Israeli ministry of health plus mix 
regulation in West Bank and Gaza Strip. In the West Bank Jordanian Public Health 
Law No. 43, 1966, and the Jordanian Pharmaceutical Association Law No. 10/57". In 
the Gaza Strip, "the Egyptian Public Health Law 21/41. 1967 were Imposed 
(Obeidallah et al, 2000). Palestinian Authority Imposed health act number (20) in 
2004 to governing pharmaceutical activities. Palestinian health act Number (20) 
came into force on 2004 ( MOH. 2011).  
 
2.8.2.1 Drug registration requirements: 
In order to obtain a licence for manufacturing pharmaceuticals and cosmetics, 
companies are required to obtain a license to manufacture pharmaceuticals in 
Palestine, for either domestic sale or export, the Prerequisites for product registration 
are:  
• Company must first obtain approval from the Ministry of Industry and 
Commerce, accompanied with an economic feasibility study.  
• To complete an application form to obtain clearance for the line of manufacturing 
concerned.  
• To submit an application to acquire a quality control certificate.  
• To provide sufficient samples for three analyses of both the finished and the 
active ingredients of the products to be manufactured. (Obeidallah, et al 2000) 
• Company has to obtain approval from Drug Quality Assurance and Registration 
Division for the Plant Master File. The factory design must comply with GMP 
specifications 
• when all the legal and technical requirements have been comply with the health 
act, the factory will be granted a manufacturing licence by the MoH. (Obeidallah, 
et al 2000) 
 
2.8.3 Quality and Good manufacturing practices (GMP): 
Implementation of GMP in the Palestinian pharmaceutical industry started 
in1986, under the supervision of the Institute for the Standardization and Control of 
Pharmaceuticals in Jerusalem. According to Israeli standard, a guide to GMP 
standard was prepared in Arabic In1992, depended mainly on the European 
Community guidelines, and the Israeli Orange Guide, until 1999, no local company 
has been certified as GMP- compliant. but, some company are believed to be very 
close (Obeidallah et al 2000). The union of pharmaceutical industry carries out 
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support program including technical assistance and training to help pharmaceutical 
industry to comply with GMP. It implemented program that ensured all members 
were ISO 9001-2000 certified, the compliance with GMP will increase the 
competitive of products (Khoury, 2004) 
Currently, all six companies are ISO-9000 certified while five are ISO-14000 
certified. All Palestinian pharmaceutical companies are engaged with GMP 
development programs, according the international WHO guidelines. The Palestinian 
Ministry of Health adopted the Arab Guidelines on GMP for pharmaceutical 
products in 1999 and for regulations to manufacture drug products in 1995. The 
regulation is depend mainly on the WHO regulations on GMP. The Ministry of 
Health the Drug Registration and Inspection Department is in the process of guiding 
the pharmaceutical companies to enable them be certify as qualified companies. The 
Ministry aim is planning to implement the procedures so it will be able to grant GMP 
certificates to the companies. In meanwhile some companies are planning to apply 
for the European and later the American FDA-GMP certifications in the future. 
(Abu-Hijleh, 2006) 
 
2.8.4 Production and profitability 
The pharmaceutical industry productivity depends on human resources, and 
fund availability, With respect to human resources, there are 864 employees 
integrated into the pharmaceutical industries (male: 559, female: 305), (Awad Abu 
Alia. 2007). The technology being used by Palestinian companies is mostly 
semiautomatic (80% percent) and automatic (20% percent) (masar. 2002), The 
estimate of the Palestinian pharmaceutical industry value-added for 1998 is about 
28800$ for each worker, comparing with 8800$ in other industrial sector, this can be 
explained due to the intensive capital invested in pharmaceutical industry and the 
high qualification of the human resource. the industry has a profitability of 40% for 
each dollar of sales comparing with 24% to other local industry. (makhool. 1998) 
The pharmaceutical manufacturers are focusing their production on three 
medicinal categories; these are anti-infective, muscoskeletal and alimentary 
medicines. In addition to medicines production, two of the companies are producing 
veterinary medicines, and also two of the companies are producing some kinds of 
detergents and cosmetics. (PFI, 2009) 
 
Table (2.10) Distribution of Registered Drug Products According to Companies 
(Local/ Foreign), West Bank, Palestine, Mid Year 2012 
Company 
No. of Registered 
Drug Products Until 
31/12/2011 
No. of Registered Drug 
Products from 
01/01/2012-30/06/2012 
Total No. of Registered 





1252 17 1269 
Foreign 
Companies 1242 27 1269 
total 2494 44 2538 





2.8.5 The Pharmaceutical Sector Characteristic 
Palestinian Pharmaceutical Sector growth by 20-30 % annually, according to 
the Union of Palestinian Pharmaceutical Manufacturers, Palestinian pharmaceuticals 
manufacturers have expanded their capacity, but local Market size has grown 
slightly. as a result,  the companies  have started to search for expanding to 
international market. In year 2002, there are six major Palestinian companies with 
approximately $45 million in capital investment, The major part of sales is made in 
the local Palestinian market with zero sales to Israel. All raw material are imported 
from abroad. (Massar, 2002) 
The industry is considered one of the key strategic industries in Palestine. The 
pharmaceutical industry plays a major role in the Palestinian healthcare sector. The 
industry produces 1118 medicines (mostly generics) according to the ministry’s 
registry while the market registers about 4500 medicines available in the domestic 
pharmacies and hospitals. The total number of workers is estimated at 1200 workers. 
The industry contributes less than 1 percent of GDP, it is considered one of the 
highest in worker productivity ($44, 000 in 2005) as shown in table (2.11) (Abu-
Hijleh, 2006) The pharmaceutical industry in Palestine constitutes 7% of total 
Palestinian industrial output and contributes approximately 1% to GDP. According to 
a Massar survey conducted in 1998, the total value of annual supply is $65 million of 
which $25 million constitutes Palestinian pharmaceutical products and $40 million 
foreign and Israeli products (Massar. 2002).  
 
Table (2.11) Pharmaceuticals Sector General Information 












pharmaceuticals 6 90M$ <1 % 1200 55 44000$ 
Source (PFI. 2009) 
 
2.8.6 Market Share 
Different researches and articles have created more controversy among 
market share and production of Palestinian pharmaceutical industry. The Palestinian 
Federation of Industries (PFI) estimated The market share of pharmaceutical industry 
is about 55% of the total market in terms of quantities and 45% in terms of dollar 
value. Almost 90 percent of local industry sales are in Palestine in WB/G, the rest is 
exported to international market ; East Europe, Arab and African countries. One 
company has partnered strategically with a European company to facilitate product 
access to European markets. The total market size of medicine in Palestine is 
estimated at about 48 million dollars. It is distributed over private sector 71%, public 
sector 20%, and 9% for NGOs including UNRWA. (PFI. 2009) 
Abu-Alia (2007) founds that Palestinian pharmaceutical products constitute 
approximately 45% percent of the domestic pharmaceutical market. The generic 
products are more affordable than the expensive drugs imported, there are about 856 
registered product until year 2007. while the total number of drugs produced in 1983 
was 691 increased to reached 800 in 1995. (makhool, 1999). this conclusion is no far 
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from Abu-Hijleh. (2006) concludes that more than half of the local consumption is 
covered by Palestinian pharmaceutical products (Abu-Hijleh, 2006).  
Market Share Estimates from the Palestinian National Authority and 
pharmaceutical industry sources suggest that the local industry covers 35-40% of the 
Palestinian market while the shortage is covered by Israeli and foreign products. the 
foreign imported of pharmaceuticals in the Palestinian market may reach 
approximately $40 million per year.  
According to the table (2.12), the largest market share is captured by local 
manufacturers in most of the common pharmaceutical categories. (Massar, 2002).  
 
Table (2.12) Market share in Palestine 
 
Source Private sector UN(*UNRWA) Public sector 
Market share in Palestine as estimated in 1998 pharmaceutical 
Local company 55% 10% 30% 
Foreign company 30% 90% 37% 
Israeli company 15% 00% 33% 
Total 100% 100% 100% 
Market share in Palestine as estimated in 2008 pharmaceutical 
Local company 57 
Foreign company 22 
Israeli company 19 
other 2 
Total 100% 
Source:  (Dimensions,2008) (Makhool, 1999)  
 
2.8.7 Export Market: 
Palestinian pharmaceutical exports has been increasing gradually over the 
past several years. The Israeli occupation prevented Palestinian pharmaceutical to 
export to international market, Israel itself prevent the entry of Palestinian 
pharmaceutical to Israel market, the isolation of Palestine from the world and 
especially Arabic countries have been causing great lost to the industry, the need for 
certain certificate like "Certificate of a pharmaceutical product" issued from world 
health organization and "GMP" is essential to enter the international market. united 
states required a certificate from food and drug administration FDA, Europe union 
require GMP issued from any Europe country. (Makhool, 1998). 
 
Table (2.13) Export Percentage out of total sale and destination  
Percentage and destination No. Company Year 1998  
1 Birzeit Pharmaceuticals Company  
3% Iraq, Yemen, eastern Europe 
2 Pharmacare 20 eastern Europe 
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3 Jerusalem Pharmaceuticals  
15  
4 
Beit Jala Pharmaceutical N. A MENA region with 
a future plan for export to 
Europe 
Total Value of Registered Palestinian Exports of Pharmaceutical Products and Country of 
Destination for years 
 







Algeria 6,411 Algeria 6,410 Israel 8,556 
Israel 6540 Israel 6,821   
Jordan 507 Jordan 660   
Malta 1,366 Malta 258   
Oman 14 Israel 1009   
Poland 1,262     
Qatar 2     
United Kingdom 64     
total 16,529  17,093  8,556 
Source: Palestinian Central Bureau of Statistics 
2013.Foreign Trade Statistics. Ramallah ـ  Palestine.   
(*): The data excludes those  parts of Jerusalem which 
were annexed by Israel in 1967.   
(0): Value less than 500 USD. 
Value in million USD   
 
Source: Palestinian Central Bureau of Statistics 2013.Foreign Trade Statistics. Ramallah  ـ   Palestine 
;Makhool, 1999) 
 
The industry face difficulties to enter international market due to high 
competition from international corporation and the restriction of obtaining the 
requirement certificate. (makhool. 1999) although, pharmaceutical industry has seen 
substantial growth, increasing at a steady rate over the years. Palestinian 
pharmaceutical exports have increased from 4. 653$ million in 1996 to 16, 574 
million in 2011. as estimated by Palestinian Central Bureau of Statistics (PCBS. 
2011).  
 
Table (2.14) Sale Value of Registered Palestinian pharmaceutical in US DOLLAR  
 
year 2011 2012 
Pharmacare 14٫890٫646  16٫893٫346 
Bierziet 21,315640 22,868,435 
Jerusalem Pharmaceutical CO. 19.876.778.836 18,053,224.6914 
Beit Jala Pharmaceutical 6,700,000 7,400,000 




table (2.15) Value of Registered Palestinian pharmaceutical Exports in 1996 -
2011) 
Year 1996 1997 1998 1999 2000 2001 2002 2003 
Amount 4,653 6,638 7,813 10,390 10,774 9,714 7,746 9,921 
Year 2004 2005 2006 2007* 2008 2009 2010 2011 
Amount 13,554 12,351 14,180 19,836 12,746 18,445 17,117 16,574 
Source (Pcbs. 2011). * Value in Thousand USD 
 
Total (2.16) Economic indicators and manpower comparative for selected 
countries 
Country Palestine Lebanon Jordan Egypt Turkey Israel India 
Economic Indicators  
Companies Numbers 6 5 18 61 84 74 20.000 
Contribution In Gross Domestic 
Product (%) <1% <1% <1% <1% <1% 2% <1% 
Size Of Domestic Market 
(Million$) 90$-70$ 430$ 348$ 818.1$ 3000$ 200.1$ 857.4$ 
Domestic Market Share (%)  45-56% 3% 33%-45% 86% 41% 35% 7% 
Gross Revenue (Million $) 38$ 17$ 385$ 600.1$ 1380$ 742.3$ 500.6$ 
Total Export (Million) 3$ 5$ 270$ 44$ 150$ 300.3$ 100.3$ 
Manpower Indicators  
Contribution To Employment (%) 3% <1% <1% <1% <1% <1% <1% 
Number Of Employees 859 540 xxxxx 28.658 15.031 16.500 250.000 
Employee average salary per 
month ($) 550$ 750$ 525$ 450$ 870.1$ 450.2$ 450$ 
Source: (Dimensions consulting company, 2008, in Adili 2009) 
 
2.8.8 Challenges for Palestinian pharmaceutical industry: 
Considerable challenges face the pharmaceutical industry, there is need to 
protect Palestinian patients from counterfeit drugs that are smuggled into Palestine 
through Israeli borders and ports, (Abu Alia. 2007). Efforts must continue towards 
producing more variety of drugs to Bridge the gap between the production of 
Pharmaceutical Industry and market, Acquiring GMP certifications from local and 
international authorities is considered the visa to enter international markets. Market 
studies and registration of medicines are particularly needed. (PFI, 2009) 
The companies must benefit from an available qualified pharmacist, skilled 
labor pool and a wage structure that is competitive among peer countries. The 
Palestinian firms can focus on niche market to avoid strong competition with their 
peers from neighboring countries and other developed regions Israeli companies and 
other international pharmaceutical companies producing similar products are the 
main competition in the Palestinian market, whereas in the export market segment, 
Jordanian and Egyptian companies compete heavily with Palestinian exporter 
companies. Palestinian products are cost competitive as local companies are able to 
sell in low price and to provide bonus offers. (Abo Hijleh, 2006) 
The current process of trade liberalization and WTO’s Intellectual property 
Rights Agreement (IP) have made a major impact internationalization of Palestinian 
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industry. there is threat that the implementation of IP regime will discriminate 
against Palestinian pharmaceutical industry in favour of foreign companies that can 
afford the enormous funding required for research and marketing. There is an argues 
that the TRIPs regime poses challenges for the Palestinian pharmaceutical industry.  
 
Table (2.17) Summary of SWOT Analysis Palestinian pharmaceutical industry 
Strengths Weaknesses 
• relatively good market share  
 The market share of this industry is about 
55% of the total market.  
some firm obtained GMP 
The industry has invested a lot in infrastructure 
• Acceptably developed industry and modern 
technology utilization.  
• Availability of skilled, well-educated 
employees.  
• Good quality products with competitive 
prices.  
• Firms capable to expand.  
• Strong association representing 100% of the 
cluster with commitment to invest towards the 
cluster’s improvement.  
The total amount of assets in the sector is 
estimated at 90 million USD 
• Lack of GMP certification weakens access to 
markets.  
• Weak expertise in R&D for products.  
• Limited access to equipment and facility 
maintenance.  
• Focus on the production of similar 
pharmaceutical products.  
• High logistics/transportation costs and 
material handling.  
• Limited marketing strategy, both local and 
international.  
Local manufacturers cover only around one 
third of the Palestinian Essential 
Drug List.  




Export potential if GMP certified.  
• Growing demands locally and internationally 
for generics.  
• WTO accession (once ready).  
• Cooperation with Jordanian Pharmaceutical 
union (Center of Excellence of the JAPM).  
• Exploring/expanding new products lines (e. 
g., veterinary medicine, natural remedies, 
nutrient supplements).  
• Compliance with drug registration 
regulations (government tender).  
• Favorable trade agreements in some niche 
markets.  
• Political instability and closure.  
• Foreign and Israeli competition.  
• Weak legal and regulatory environment (e. g. 
GMP, drug registration).  
Palestine is not member in WTO.  
 
Source: (BPC 2012 ;abu alia 2009; Abo Hijleh, 2006) 
 
2.9 Global pharmaceutical industry: 
Medicines play a crucial role in protecting, curing and treating people’s 
health. The provision of appropriate medicines of assured quality, in accurate 
quantities and at reasonable prices is therefore a concern of global pharmaceutical 
industry policy makers. The World Health Organization published reports on the 
World Medicines Situation In 1988, 2004, and in 2011, The report described the 
Medicines movement. The aim of the report is to gather relevant information 
comprehensively to improve sharing of information of pharmaceutical industry.  
The report issued in 2004 indicates that there is increasing growth of the industry. 
Growth Trends from 1985-1999 indicate that the value of medicine production has grown 
four (4) times more rapidly than the world’s income. "The average annual growth rate of 
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pharmaceutical production over this period was just under 10. 5% at current prices, in 
comparison with an average annual growth rate of global gross national product (GNP) of 
under 7. 5%. The value of manufactured pharmaceuticals has thus grown substantially 
faster than the total value of goods and services". (World Health Organization. 2011; 
2004) 
The total value of global pharmaceutical production in 1999 was just over 
320 billion US dollars, the production is concentrated in major five countries, (USA, 
Japan, Germany, France and the UK), When measured in monetary terms, these 
countries account with over 90% of world production, global pharmaceutical 
production accounted for 1. 12% of global gross domestic product  GDP . when this 
percentage and figure calculated according to constant prices to adjust for inflation, 
the rate at which pharmaceutical production has outstripped GDP growth increases 
substantially. The average real growth rate of GDP was 3. 6% per annum and the 
average real growth rate of pharmaceutical. 
 
Table (2.18) Estimated global value of pharmaceutical production 1985–1999, in 
current and constant US$ billion 
Production and price 1985 1990 1999 
Pharmaceutical production current prices 82, 1 175, 9 327, 2 
Global GNP current prices 10, 766 22, 299 29, 232 
Global GNP constant (1995) prices 46, 2 140, 5 370, 1 
Global GNP constant (1995) prices 20, 302 24, 555 33, 672 
Source: (WTO, 2004) 
 
2.9.1 Global Pharmaceutical Market: 
The pharmaceutical industry is complex, dynamic, and highly globalized, 
with many Pharmaceutical Companies Operating In Multiple countries, (Howlett, 
Michels, et al. 1999), In global market there is great difference in price between 
original and licensed brands And generic drug, in a review of the "WHO/HAI pricing 
studies the “percentage difference in price between originator brands and lowest-
priced generics (brand premium) in the private sector was over 300% in lower-
middle-income countries and low-income countries", pharmaceutical expenditures 
Per capita in 2005/2006 ranged from US$ 431. 6 in high-income countries to US$ 7. 
61 in low-income countries, the world Measured Total Pharmaceutical Expenditure 
(TPE) accounts for 1. 41% to 1. 63%. there is need to provide drug to poor countries, 
in responding to this need, Millennium Development Goal  MDG,  8-E expresses a 
global commitment to ensure that availability of essential medicines. To achieve this 
goal an increase in spending on medicines in low- and middle-income countries may 
be required. (World Health Organization. 2011).  
 
2.9.2 Pharmaceuticals Market analysis  
The global pharmaceuticals market has maintained moderate growth for the 
last decade. The global pharmaceuticals market had total revenues of $782. 1 billion 
in 2011, representing a compound annual growth rate  CAGR  of 4. 9% between 
2007 - 2011, the European and Asia-Pacific markets grew of 3. 1% and 8. 8% 
respectively, The performance of the market is forecast to slowdown, with an 
anticipated of 4. 4% for the five-year period 2011- 2016, which is expected to drive 
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the market to a value of $971. 1 billion by the end of 2016. while, the European and 
Asia-Pacific markets will grow with CAGRs of 1. 8% and 7. 4% respectively, over 
the same period. (Marketline, 2012) 
The conventional mature markets of North America, Western Europe and 
Japan have accounted for just 16 per cent of global market growth, while The seven 
emerging markets of Brazil, China, India, Mexico, Russia, South Korea and Turkey 
are estimated to have contributed 51% per cent of global pharmaceutical growth in 
2009, Asia is becoming a centre of gravity for global pharmaceutical companies. 
(Tempest, B. 2010) 
 
Table (2.19) Region & leading country spending 
YEAR 2011 2009 
Country  Rank $ (Mill) Growth (%) Rank $ (Mill) Growth (%) 
United States  1 322, 290 3 1 301, 095 6 
Japan  2 111, 642 16 2 89, 865 17 
China  3 66, 805 22 3 45, 261 24 
Germany 4 44, 916 7 4 41, 287 -2 
France  5 41, 197 6 5 40, 452 -5 
Brazil  6 28, 465  23 10 17, 629 8 
Italy 7 28, 357  7 6 27, 085 -1 
Spain  8 22, 679 2 7 22, 722 1 
Canada  9 22, 294  3 9 19, 143 0 
United Kingdom  10 21, 564  6 8 19, 830 -11 
Source: (IMS. 2012) IMS (IMS Health is the world’s leading information)World 
Review 2012 Analysis  
  
2.9.3 Pharmaceutical companies: 
Pharmaceutical industry is high concentrated geographically, companies located in 
developed countries responsible for two-thirds of the value of medicines produced 
globally, A small number of transnational corporation dominate the global pharmaceutical 
production, trade and sales of medicines. Ten of these companies now account for about 
half of all sales, (World Health Organization, 2004).  
The pharmaceutical market is characterized by strong buyer power, with the ease 
of market entry strongly regulated by legal and regulatory frameworks. Major suppliers to 
the pharmaceutical market are company of active pharmaceutical ingredients  APIs. A 
number of leading pharmaceutical companies have major investments in pharmaceutical 
chemical manufacturing, providing them with fund and this reduces supplier power to 
some extent. These suppliers companies are supplied on a contractual basis and so 
pharmaceutical companies are likely to risk high switching costs if they consider transfer 
their business in other places. accordingly, pharmaceutical companies employ sourcing 
managers to downsize costs and to minimize supplier power. The development of new 
drug can cost pharmaceutical companies higher prices. If the novel drug successfully enter 
the market, companies can make a large amount of money. (Marketline, 2012) 
In 2007, the Pharmaceutical Research and Manufacturers of America (PhRMA) 
estimated that it takes between 10 and 15 years to introduce a new medicine from 
discovery to market at an average cost for R&D of US$ 800 million to US$ 1 billion. In 





Table (2.20) Major multinational pharmaceutical companies 
Company HQ location 
Revenue of  
pharmaceutical  






Pfizer NY, U. S.  46, 133 52, 516 87. 85% 
GlaxoSmithKline UK 31, 434 37, 324 84. 22% 
Johnson & Johnson NJ, U. S.  22, 190 47, 348 46. 87% 
Merck NJ, U. S.  21, 494 22, 939 93. 70% 
AstraZeneca UK 21, 426 21, 426 100. 00% 
Novartis Switzerland 18, 497 28, 247 65. 48% 
Sanofi-Aventis France 17, 861 18, 711 95. 46% 
Roche Switzerland 17, 460 25, 168 69. 37% 
Bristol-Myers Squibb NY, U. S.  15, 482 19, 380 79. 89% 
Wyeth NJ, U. S.  13, 964 17, 358 80. 45% 
Abbott IL, U. S.  13, 600 19, 680 69. 11% 
Eli Lilly IN, U. S.  13, 059 13, 858 94. 23% 
Takeda Japan 8, 648 10, 046 86. 09% 
Schering-Plough NJ, U. S.  6, 417 8, 272 77. 57% 
Bayer Germany 5, 458 37, 013 14. 75% 
Source: (Davidson and Greblov, 2005) 
 
2.9.4 Global Market share: 
World's pharmaceutical Market is unevenly distributed, United States is highest 
demand for pharmaceutical products, then Western Europe, and Japan. The United States 
accounted for approximately 33% percent of the total world market for ethical 
(prescription) pharmaceuticals in 1996, while Europe’s share amounted to about 29 
percent; Japan’s share was nearly 18 percent. (Howlett, Michels, et al , 1999) 
In 2010, only 18 per cent of the world ’ s population shared 88 per cent of the 
world’ s pharmaceuticals products, while 82 per cent of the world’s population has 
access to only 12 per cent of the world’s pharmaceuticals products (Tempest, 2010). 
Market Geography segmentation show big difference in market share, Americas 
accounts for 42. 2% of the global pharmaceuticals market value. Europe accounts for a 
further 28. 7% of the global market. (Marketline, 2012), In the United States 
pharmaceutical industry composed of approximately 700 companies that develop, 
manufacture, and market ethical pharmaceutical products, including both proprietary 
(brandname) and generic medicines, appears competitive. (Howlett, Michels, et al, 1999) 
 
Table (2.21) Global pharmaceuticals market geography segmentation: $ billion, 2011 
Geography 2011 Percentage % 
Americas 330. 2 42. 2 
Europe 224. 8 28. 7 
Asia-Pacific 217 27. 8 
Middle East & Africa 10. 1 11. 3 
Total 782. 1 100% 
Source: (Marketline. Global Pharmaceuticals Industry Profile, 2012) 
 
2.9.5 Pharmaceutical world trade regulation: 
Pharmaceutical industry continues to globalize, World Health Organization 
(WHO), world Trade Organization (WTO) and the World Intellectual Property 
Organization (WIPO), are responsible for pharmaceutical trade in the world. They are in 
 
 61 
line with the mandates given to them by governments and their respective areas of 
expertise, Rules for international trade are established at the multilateral level within the 
framework of the WTO. Some member of WTO, mainly developed countries, introduced 
the Pharmaceutical Tariff Elimination Agreement in 1994. According to this agreement, 
they eliminated tariffs on most finished pharmaceutical products, Since 1994, the WTO 
member have periodically updated the agreement’s mandate. Developed countries have 
applied tariffs on medicines of less than 0. 1 per cent on average since 2000. while 
developing countries, they have lowered their applied tariffs rates on medicines from 6. 7 
per cent to 4. 2 per cent gradually. A few of these developing countries especially which 
have local national manufacturing industries are apply relatively high tariffs on finished 
products to protect their industry. (WTO. WIPO. WTO, 2012). 
Pharmaceuticals industry is subjected to the regulation of WTO regarding 
manufacturing and import –export, The agreement that resulted from these 
negotiations to established WTO is called “Trade-Related Aspects of Intellectual 
Property Rights” TRIPs. TRIPs is administered by the WTO with the special 
assistance of the Council on Trade-Related Aspects of Intellectual Property. All 
member of WTO must enactment and effective enforcement of laws that adequately 
protect intellectual property, Pharmaceuticals was one industry sector that the WTO 
specifically addressed in the areas of patents and IP, Each WTO member is required 
to make patents available with respect to inventions in all fields of Pharmaceuticals. 
(Howlett, Michels, et al, 1999) 
Patent protection for pharmaceutical products is necessarily to entail the 
balancing between public healthcare and the corporate interests. (Gewertz, and R. 
Amado, 2004), Patents confer the right to the pharmaceutical companies or patentee 
to exclude others from manufacturing, compounding, using, offering for sale, selling 
in, or importing the patented invention into, the country where the patent rights are 
granted "Article 28 of the TRIPS Agreement". (WTO et al, 2012), Patent for New 
drug may be obtained for new chemical entities, novel manufacturing processes, or 
new use of existing drug, patent enable company to obtain adequate return on their 
investment. the patent application is filled when the drug shows promising 
pharmacological promising effect. (Gennaro A. 1995). Under the TRIPS Agreement, 
the available term of protection must expire no earlier than 20 years from the date of 
filing the patent application. (WTO. 2006), most significant impact of TRIPs is that 
the term for a U. S. patent has been changed from 17 years from the date the patent 
issued to 20 years from the date the patent application was field. (Howlett, Michels, 
et al, 1999) 
Original brands drug refers to products that are marketed by the originator of 
the drug, Products that are marketed under the terms of a licensing agreement with 
the originator company are defined as “licensed brands”. “Other brands” constitute 
two different types of product. The majority of “other brands” are branded products 
that are either compounded or manufactured and/or marketed by a company that is 
not the originator company of the molecule, and for which there is no evidence of a 
licensing agreement, for example, branded generics, pirate products and copy 
products, In 2008, The share of original and licensed brands was highest in high-
income countries but similar in both middle- and low-income countries. There has 
been modest decline (2–3%) in the percentage of original and licensed brand usage 
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since 2000. The higher percentage use of original and licensed brands in high-income 
countries no doubt reflects their higher use of patent products. (WTO,2011) 
Generic products accounted for just 14% of the global market in terms of 
value, although more than 40% of products sold in several large markets, although 
more than 40% of products sold in several large markets, including the United States, 
Germany and the United Kingdom, are generics. Generics have less than a 10% share 
of the market in terms of both volume and value in Italy, Belgium, Spain and 
Portugal. (OECD, 2008). Market size and the date of patent expiry play important 
rule for market entry decision, Original brand market share has been found to be 
directly proportional to the age of the original brand protection, major brand names 
typically losing half of their market share within a year of patent expiry in united 
states market. (Magazzini, and Pammolli, et al, 2004). 
 
2.9.6 summary 
This chapter presents theoretical basis reviewing the most important concepts of the 
internationalization  process. It mainly focuses on internal determinants affecting 
export performance. Moreover, the chapter presents an overview of international 
























This chapter describes the methodology that has been used in this study. The 
chapter describes the following techniques: the information about the study 
methodology, data collection, research design, research population, questionnaire design, 
validity and reliability of questionnaire, pilot study, and statistical data analysis.  
 
3.2 Research Design: 
- The study contain number of phase as shows in figure (3.1) to achieve the study aim, 
The first phase of the research thesis proposal includes identifying and defining the 
problems and establishment objective of the study and development research plan 
- The second phase of the research includes a summary of the comprehensive 
literature review. Literatures on claim management was reviewed.  
- The third phase of the research includes a field survey which was conducted with 
the "The influence of internal determinants of Palestinian pharmaceutical firms 
on export performance".  
-  The fifth phase of the research focuses on distributing questionnaire. This 
questionnaire was used to collect the required data in order to achieve the research 
objective.  
- The sixth phase of the research is data analysis and discussion. Statistical 
Package for the Social Sciences, (SPSS) was used to perform the required 
analysis. The final phase includes the conclusions and recommendations.  
- Seventy questionnaires were distributed to the research population and  fifty nine 























Figure (3.1) shows the methodology flowchart, which leads to achieve the 
research objective 
Topic Selection  Identify the Problem 



























3.3 Study methodology:  
This study is quantitative and qualitative study. The researcher adoptes 
descriptive analytical approach in conducting the research, as it is considered the 
most used in business and social studies. Saunders et. al. (2003) argues that the 
objective of descriptive research is accurately portraying a profile of persons, 
situations or events. 
 
3.4 Export Performance Measurement::  
In order to assess the validity of the hypotheses, it is necessary to develop 
measures of the constituent concepts, Although there is no coherent agreement about 
export performance measure, a number of models of export performance measure 
offer some different perspectives. Aaby and Slater (1989) observe that export 
marketing strategy and performance were conceptualized and operationalized in 
many different ways by different researchers, Cavusgil, & Zou, (1994). There is 
diversity of conceptualization And measurement of export marketing strategy and 
export performance, Zou, Taylor, & Osland, (1998). And Zou & Stan (1998) Have 
Developed comprehensive measurement scale to assess export performance.  
In this research, different sets of variables are used, Build on previous 
measure have been used, the study will follow mainly the measurement of Zou & 
Stan. (1998).  
3.5 Data Collection Methodology: 
In this study  secondary  and primary data were used.  
 
3.5.1 Secondary Data: 
To introduce the theoretical literature of the subject, the research uses the 
secondary data resource which included: previous studies, books, academic 
magazines, periodicals, websites and electronic versions, MOH reports, and 
published articles related to the research subject, this data is essential to gain 
understanding of the research field and to drew clear picture of the literature.  
 
 
3.5.2 Primary Data: 
In order to analyze the qualitative and quantitative data of the research, 
questionnaire is used as a tool for collecting primary data. Although questionnaires 
may be cheap to administer compared to other data collection methods, they are 
expensive in terms of design time and interpretation. The use of questionnaire  is 
justified  by a variety of factors related to this study as following: 
• the respondents  are very busy ; 
• difficulties  of reaching  the respondent in West Bank; 
• by using questionnaire, the respondents’ answers are not being contaminated 
or distorted; 
• time frame for collection the data and cheap cost. Saunders, & Thornhill, 
(2009). 
The questionnaire was initially written in English and then translated into 
Arabic. Numbers of  referees (university lecturers in international marketing) 
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assessed the content and face validity of the items; each referee was asked to assess 
how representative each item was of the final construct. The survey was revised 
according to their comments. It was then given to a pretest. 
Sample of 25 managers involved in export operations. We used the pretest 
results to refine the questionnaire further. To avoid translation errors.  
The questionnaire which is especially designed for this research consists of 
the following parts:  
1. The first part contains general information of Palestinian pharmaceutical firms.  
2. The second part contains the strategy of entry mode to international market.  
3. The third part contains the planning strategy to international market.  
4. The fourth part contains the marketing research strategy of international market 
5. The fifth part consists of four sections about the marketing strategy as follows:  
a. The first section is about product adaptation.  
b. The second section is about the promotion adaptation.  
c. The third section is about price adaptation.  
d. The fourth section is about distribution (palce) adaptation.  
6. The sixth part is about the measurement of export performance. 
All items pursued the semantics differential scale as the following:  
 
Level  Strongly disagree èèèèèèèèèèèèè Strongly agree  
Scale  1 èèèèèèèèèèèèè 10 
 
3.6 Research Population: 
The research population includes all Palestinian pharmaceutical exporter 
firms, the research attain to explore the opinion of top level managers (directors, 
managers, senior members, Export Executive, head of department, Export Personnel) 
who reflected their company's attitude and approach to the effect of internal 
determinants on export performance. The study has conducted  a comprehensive 
survey which was sent to them for filling it out.  
Questionnaires are sent through the e-mail to firms, and to the Union of 
Palestinian Pharmaceutical Manufacturers (UPPM) to ensure each firm has obtained 
hard copy upon request, The print-on-demand questionnaires available to participants 
by the help from UPPM, UPPM sent hard copies to Birzeit firm and to Beit jala firm. 
(59) questionnaires return and subjected to analysis.  
 
Table number (3.1) questionnaire sampling 
No. Company Return questionnaire 
1 Bet Jala 20 
2 Birzeit Pharmaceuticals Company  15 
3 Jerusalem Pharmaceuticals  11 
4 Pharmacare 13 




3.7 Test of Normality for each field: 
Table (3.2) shows the results for Kolmogorov-Smirnov test of normality. 
From Table (3.2), the p-value for each field is greater than 0. 05 level of significance, 
then the distribution for each field is normally distributed. Consequently, Parametric 
tests will be used to perform the statistical data analysis.  
 
Table (3.2) Kolmogorov-Smirnov test 
Kolmogorov-Smirnov Field Statistic P-value 
Modes of entry  1. 120 0. 162 
Strategic planning 0. 986 0. 285 
Market research 1. 138 0. 150 
Product Adaptation 0. 874 0. 429 
Promotion Adaptation  0. 638 0. 810 
Price Adaptation 1. 400 0. 060 
Distribution Adaptation 1. 210 0. 107 
Market strategies adaptation 0. 563 0. 909 
Strategic export performance 0. 677 0. 749 
All paragraphs of the questionnaire 0. 935 0. 346 
 
3.8 Pilot Study: 
A pilot study for the questionnaire was conducted for 26 respondents before 
collecting the results of the sample. It provides a trial run for the questionnaire, 
which involves testing the wordings of question, identifying ambiguous questions, 
testing the techniques that used to collect data, and test the validity  measuring the 
effectiveness of standard invitation to respondents.  
 
3.9 Validity of Questionnaire: 
Validity refers to the degree to which an instrument measures what it is 
supposed to be measuring. Validity has a number of different aspects and assessment 
approaches. Statistical validity is used to evaluate instrument validity, which include 
internal validity and structure validity.  
 
3.9.1 Internal Validity: 
Internal validity of the questionnaire is the first statistical test that used to test 
the validity of the questionnaire. It is measured by a scouting sample, which 
consisted of 25 questionnaires through measuring the correlation coefficients 
between each paragraph in one field and the whole field. 
 
Table (3.3) clarifies the correlation coefficient for each paragraph of the "Modes 
of entry" and the total of the field. The p-values (Sig.) are less than 0. 05, so the 
correlation coefficients of this field are significant at α = 0. 05, so it can be said that the 





Table (3.3) Correlation coefficient of each paragraph of "Modes of entry" and 
the total of this field 
No. Paragraph Pearson Correlation Coefficient 
P-Value 
(Sig.) 
1. Export entry modes (direct, indirect, agent, branch/subsidiary) .855 0.000* 
2. Contractual entry modes (licensing, franchising, technical agreement) .837 0.000* 
3. Investment entry modes (new establishment, acquisition, joint venture)  .796 0.000* 
* Correlation is significant at the 0. 05 level  
 
Table (3.4) clarifies the correlation coefficient for each paragraph of the 
"Strategic planning" and the total of the field. The p-values (Sig.) are less than 0. 05, so 
the correlation coefficients of this field are significant at α = 0. 05, so it can be said that 
the paragraphs of this field are consistent and valid to be measure what it was set for. 
 
Table (3.4) Correlation coefficient of each paragraph of "Strategic planning" 
and the total of this field 
No. Paragraph Pearson  Correlation Coefficient 
P-Value 
(Sig. ) 
1.  Our firm have Developed competitive export strategies .490 0.006* 
2.  Our firm have Establishment of exporting goals .568 0.002* 
3.  Our firm have Existence of an export product policy .697 0.000* 
4.  Our firm have Existence of an export promotion policy .867 0.000* 
5.  Our firm have Existence of an export distribution policy .920 0.000* 
6.  Our firm have Existence of an export pricing policy .762 0.000* 
7.  Our firm have Export production policy .660 0.000* 
8.  Our firm have R&D for export markets  .754 0.000* 
* Correlation is significant at the 0. 05 level  
 
Table (3.5) clarifies the correlation coefficient for each paragraph of the 
"Market research" and the total of the field. The p-values (Sig.) are less than 0. 05, 
so the correlation coefficients of this field are significant at α = 0. 05, so it can be 
said that the paragraphs of this field are consistent and valid to be measure what it 
was set for.  
 
Table (3.5) Correlation coefficient of each paragraph of "Market research" 







1.  We have knowledge about market when starting to export .504 0.005* 
2.  Firm Possession of proprietary technical knowledge will enhance export strategy  .506 0.005* 
3.  Firm Possession of a unique/patented product will encourage export strategy .554 0.002* 
4.  firm Extending life-cycle of products will positively encourage export strategy  .584 0.001* 
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5.  We have number of information sources to be used .717 0.000* 
6.   Our firm Obtaining knowledge about market, will encourage export strategy .437 0.015* 
7.  We depend on customer perception to produce product uniqueness  .656 0.000* 
8.  We depend on customer perception to achieve product quality  .872 0.000* 
9.  We depend on customer perception to achieve product and package design  .709 0.000* 
10.  We depend on customer perception to strengthen our product  .708 0.000* 
* Correlation is significant at the 0. 05 level  
 
Table (3.6) clarifies the correlation coefficient for each paragraph of the 
"Market strategies adaptation" and the total of the field. The p-values (Sig.) are 
less than 0. 05, so the correlation coefficients of this field are significant at α = 0. 05, 
so it can be said that the paragraphs of this field are consistent and valid to be 
measure what it was set for.  
 
Table (3.6) Correlation coefficient of each paragraph of "Market strategies 
adaptation" and the total of this field 




1.  Product’s brand name strategy  .807 0.000* 
2.  Product design  .796 0.000* 
3.  Product labeling  .558 0.002* 
4.  Product quality  .569 0.002* 
5.  Range of variety of main exporting product line  .745 0.000* 
6.  product precautions  .686 0.000* 
PRODUCT ADAPTATION 
1.  Advertising idea/theme  .821 0.000* 
2.  Media channels for advertising  .876 0.000* 
3.  Promotion objectives  .788 0.000* 
4.  Budget for promotion  .852 0.000* 
5.  Public relations emphasis  . 509 0. 006* 
6.  Direct marketing/mailing  . 682 0. 000* 
Promotion Adaptation  
4  Determination of pricing strategy  . 804 0. 000* 
5  Concession of credit  . 735 0. 000* 
6  Price discount policy  . 710 0. 000* 
7  Quality/price relationship  . 472 0. 009* 
PRICE ADAPTATION 
1.  Criteria to select the distribution system  . 968 0. 000* 
2.  Transportation strategy  . 940 0. 000* 
3.  Budget for distribution  . 941 0. 000* 
4.  Distribution network  . 966 0. 000* 
5.  Accomplishment of delivery deadlines . 831 0. 000* 
DISTRIBUTION ADAPTATION 
* Correlation is significant at the 0. 05 level  
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Table (3.7) clarifies the correlation coefficient for each paragraph of the 
"Strategic export performance" and the total of the field. The p-values (Sig.) are 
less than 0. 05, so the correlation coefficients of this field are significant at α = 0. 05, 
so it can be said that the paragraphs of this field are consistent and valid to be 
measure what it was set for.  
 
Table (3.7) Correlation coefficient of each paragraph of "Strategic export 
performance" and the total of this field 
No. Paragraph Pearson Correlation Coefficient 
P-Value 
(Sig.) 
1.  export has improve our global competition  .495 0.006* 
2.  export has Strengthen our strategic position  .742 0.000* 
3.  export has Significantly increase our global share  .755 0.000* 
4.  export has very profitable  .820 0.000* 
5.  export has generated a high volume of sale  .884 0.000* 
6.  export has achieved rapid growth  .921 0.000* 
7.  Our export venture has been very satisfactory  .914 0.000* 
8.  our export venture has been very successful  .701 0.000* 
9.  our export venture has fully met our expectations  .777 0.000* 
* Correlation is significant at the 0. 05 level  
 
3.10 Structure Validity of the Questionnaire: 
Structure validity is the second statistical test that used to test the validity of 
the questionnaire structure by testing the validity of each field and the validity of the 
whole questionnaire. It measures the correlation coefficient between one field and all 
the fields of the questionnaire that have the same level of the scale.  
Table (3.8) clarifies the correlation coefficient for each field and the whole 
questionnaire. The p-values (Sig.) are less than 0. 05, so the correlation coefficients 
of all the fields are significant at α = 0. 05, so it can be said that the fields are valid to 
be measured what it was set for to achieve the main aim of the study.  
 
Table (3.8) Correlation coefficient of each field and the whole of questionnaire 
No. Field Pearson Correlation Coefficient 
P-Value 
(Sig. ) 
1. Modes Of Entry  . 395 0.031* 
2. Strategic Planning . 695 0.000* 
3. Market Research . 779 0.000* 
4. Product Adaptation . 904 0.000* 
5. Promotion Adaptation  . 933 0.000* 
6. Price Adaptation . 345 0.046* 
7. Distribution Adaptation . 800 0.000* 
8. Market Strategies Adaptation . 830 0.000* 
9. Strategic Export Performance . 530 0.003* 






3.11 Reliability of the Research: 
The reliability of an instrument is the degree of consistency which measures 
the attribute; it is supposed to be measuring (Polit & Hunger, 1985). The less 
variation an instrument produces in repeated measurements of an attribute, the higher 
its reliability. Reliability can be equated with the stability, consistency, or 
dependability of a measuring tool. The test is repeated to the same sample of people 
on two occasions and then compares the scores obtained by computing a reliability 
coefficient (Polit & Hunger, 1985).  
  
3.11.1 Cronbach’s Coefficient Alpha: 
This method is used to measure the reliability of the questionnaire between 
each field and the mean of the whole fields of the questionnaire. The normal range of 
Cronbach’s coefficient alpha value between 0. 0 and + 1. 0, and the higher values 
reflects a higher degree of internal consistency. The Cronbach’s coefficient alpha 
was calculated for each field of the questionnaire.  
Table (3.9) shows the values of Cronbach's Alpha for each field of the 
questionnaire and the entire questionnaire. For the fields, values of Cronbach's Alpha 
were in the range from 0. 664 and 0. 956. This range is considered high; the result 
ensures the reliability of each field of the questionnaire. Cronbach's Alpha equals 0. 918 
for the entire questionnaire which indicates an excellent reliability of the entire 
questionnaire.  
 
Table (3.9) Cronbach's Alpha for each field of the questionnaire 
No. Field Cronbach's Alpha 
1. Modes of entry  0.719 
2. strategic planning 0.793 
3. Market research 0.800 
4. PRODUCT ADAPTATION 0.782 
5. Promotion Adaptation  0.813 
6. PRICE ADAPTATION 0.664 
7. DISTRIBUTION ADAPTATION 0.956 
8. Market strategies adaptation 0.900 
9. Strategic export performance 0.919 
 All paragraphs of the questionnaire 0.918 
 
3.12  Statistical analysis Tools: 
The researcher uses data analysis both qualitative and quantitative data 
analysis methods. The Data analysis will be made utilizing (SPSS 20). The 
researcher utilizes the following statistical tools:  
a) Kolmogorov-Smirnov test of normality.  
b) Pearson correlation coefficient for Validity.  
c) Cronbach's Alpha for Reliability Statistics.  
d) Frequency and Descriptive analysis.  







T-Test is used to determine if the mean of a paragraph is significantly 
different from a hypothesized value 6 (Middle value of scale). If the P-value (Sig.) is 
smaller than or equal to the level of significance, 0.05α = , then the mean of a 
paragraph is significantly different from a hypothesized value 6. The sign of the Test 
value indicates whether the mean is significantly greater or smaller than 
hypothesized value 6. On the other hand, if the P-value (Sig.) is greater than the level 
of significance 0.05α = , then the mean a paragraph is insignificantly different from 
a hypothesized value 6.  
 
3.12.2 The independent sample T-test: 
The Independent Samples T-test is used to examine if there is a statistical 
significant difference between two means among the respondents toward the 
influence of internal determinants of Palestinian pharmaceutical firms on export 
performance due to (Firm characteristic "traits" and management traits).  
 
3.12.3 The One- Way Analysis of Variance (ANOVA): 
The One- Way Analysis of Variance (ANOVA) is used to examine if there is 
a statistical significant difference between several means among the respondents 
toward The influence of internal determinants of Palestinian pharmaceutical firms on 
export performance due to (Annual sales volume of firm, Place of college education 
and education background). 
 
3.13 Conclusion: 
This chapter presents comprehensive description of the research methodology 
adopted in this research. The chapter shows the guideline that is implemented in the 
study through identifying the approach and tools used in the completion of this study.  
Finally, it can be said that the researcher proves that the questionnaire is 
valid, reliable, and ready for distribution for the population sample to measure the 
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4.1 Firm Characteristic "traits": 
         Firm age: 
Table (4. 1) shows that firm ages " More than 40" represents 75%, and "40 
years and Less " represents 25%, also the results manifest that majority of 
firms have established more than 40 years and more which indicate that these 
firm have long experience                                                                                                                            
 
Table (4. 1) Firm age 




out of total 
categories 
1 Bet Jala Chemicals More than 40 1968 45 
2 Jerusalem Pharmaceuticals  More than 40 1969 44 
3 Birzeit Pharmaceuticals Company More than 40 1973 40 
3 75%  
4 Pharmacare company 40 years and Less 1986 27 1 25% 
 total     100 
 
Company size: 
Table No. (4. 2) shows that all the companies that had been selected for the 
study employ 852 employees. Moreover, the smallest company of the research 
population employ 16% of the total population, the largest company employ 33% of 
the total employees of the population. the selection criteria that were set up by this 
research will analyze each company individually because the small size of the 
sample, to investigate effect of the company size on export performance.  
 




employees Frequency Percentages 
Less than 100 0 0 0 0 
Bet Jala Chemicals 140 1 16% 100- less than 200 Birzeit Pharmaceuticals Company 170 1 20% 
Jerusalem Pharmaceuticals  260 1 31% 
200- less than 300 Pharmacare company 282 1 33% 
Total  852 4 100% 
 
Annual sales volume of firm in $ Million: 
Referring to the annual sale volume (Table No. 4.3) in the firm, the majority 
of the respondents points out that the average of the annual sale exceeds $ 15 million. 
The researcher agrees with the opinion of (katsikeas, piercy, and loannidis 1996). Who 
state that the firm don’t tend to disclosed their sales to the public.  
 
Table (4.3) Annual sales in million $ US volume of firm 
Annual sales volume of firm Frequency Percent 
3-5 3 5.1 
5-10 7 11.9 
10-15 17 28.8 
15-20 14 23.7 
more than20 18 30.5 
Total 59 100.0 
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Number of countries firms exporting: 
Table (4.4) shows that the title of "Number of countries firm exporting" 
represents 91% of the firms export to more than 4 countries, variance of respondents 
to know exact export countries number may due to the position of the respondents.  
 
Table (4.4) Number of countries firm exporting 
Number of countries firm exporting Frequency Percent 
1 country 2 3. 4 
2 country 3 5. 1 
More than 3 countries 54 91. 5 
Total 59 100. 0 
 
4.2 Personal Traits: 
Education levels: 
Table No. (4.5) show that 3. 4% of the research population hold a diploma, 
degree, 69. 5% of the sample holding a bachelor degree, while 25. 4% are holding 
master degree, and 1. 7% hold PHD. 
In can be concluded that Pharmaceutical industry required highly educated 
professional employees.  
  
Table (4.5) Education levels 
Education levels Frequency Percent 
diploma 2 3. 4 
bachelor 41 69. 5 
master 15 25. 4 
Doctorate 1 1. 7 
Total 59 100. 0 
 
Place of college education: 
Table (4.6) shows that "Palestine" represents 61%%, "Arab countries" 
represents 25.4%, "Asia" represents 8.5%, "Europe" represents 3.4%, and "America" 
represents 1.7%, the results manifest that majority of respondents graduated from 
Palestinian universities. The entry to international market need people with 
international orientation, the majority of employees in the study are graduated from 
Palestinian university, the study will explore if the employees place of college 
education will affect the export performance.  
 
Table (4.6) Place of college education 
Place of college education Frequency Percent 
Palestine 36 61.0 
Arab countries 15 25.4 
Asia 5 8.5 
Europe 2 3.4 
America 1 1.7 




Instruction language in your last degree of education: 
Table (4.7) shows that Instruction language in the last degree of education 
"Arabic" represents 1.7%, "English" represents 96.6%, and "Other" represents 1.7%.  
The results indicates that majority of respondents obtained last degree from 
institution where the Instruction language is English. English languages considered 
one of the main language use in international communication, this can assist 
Palestinian firms to operate more efficiently in international market.  
  
Table (4.7) Instruction language in your last degree of education 
Instruction language in your last 
degree of education Frequency Percent 
Arabic 1 1.7 
English 57 96.6 
French - - 
German - - 
Other 1 1.7 
Total 59 100.0 
 
Education background (Majors): 
Table (4.8) shows that Education background "Pharmacy" represents 
33.9%, "Management" represents 27.1%, "Engineering" represents 6.8%, "science" 
represents 25.4%, and "others" represents 6.8%. The results indicates that majority of 
respondents have obtained degree related to science field. Pharmaceutical industry is 
highly sophisticated industry, thus the industry depends on pharmacists, Management 
professionals' and engineers, it could assume that this variety of employees will help 
the firm to perform international business effectively.  
  
Table (4.8) Education background 
Education background Frequency Percent 
Pharmacy 20 33. 9 
Management 16 27. 1 
Engineering 4 6. 8 
Science 15 25. 4 
Other 4 6. 8 
Total 59 100. 0 
 
4.3 Analysis of the variables of the study: 
Table (4. 9) shows the following results:  
The mean of the field “Modes of entry” equals 7. 28 (72. 81%), Test-value = 6. 
75, and P-value=0. 000 which is smaller than the level of significance 0.05α = . The T 
sign of the test is positive, so the mean of this field is significantly greater than the 
hypothesized value 6. It can be concluded that the respondents agreed to field of “Modes 
of entry".  
Table (4. 9) shows that the "Palestinian pharmaceutical companies' employees 
agreed with the presence of the positive influence of "mode of entry " on export 
performance; this results reveals that respondents prefer export mode, then contractual 
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mode and in the last investment mode of entry to international market, it is not separated 
strategy but it is coherent strategy depend in the right choice and the degree of 
commitment and risk, the entry process can be developed through evolution. The result 
shows there is a positive effect of the mode of entry on export performance, this agree 
with Zafar U. A., Osman M., Brian T., and James P. J. (2002). Douglas and Craig (1989) 
found that entry strategy reflects the evolution of internationalization of the firm.  
According to (Hill, Hwang et al. 1990) the entry mode depends on many internal 
and external factors like the international marketing strategy, environment factors, cost 
consideration, and global strategic objective. It cannot be stated categorically which 
alternative is the best. There are many internal and external conditions which affect this 
choice and company may use more than one of these methods at the same time. 
(hollensen. 2008).  
It can be concluded that Palestinian pharmaceutical companies' prefer export 
mode of entry because it is low risk and high flexible to them. This result is consistent 
with (puljeva and widen 2007) who indicated that the Swedish companies intend to 
initiate their internationalization through export before using more resource intense 
market entry.  
According to Madsen (1989) previous research has shown that no single entry 
strategy can be regarded as universally optimal. Therefore Palestinian firm can use blend 
of entry modes. Reid (1981) stats that Exporting is generally regarded as the dominant 
mode of entry into a Foreign market; according to Root (1994) the choice of market 
entry mode is one of the most critical strategic decisions firm, It affects 
internationalization process and affect the performance of the firm entry process is 
evolution process from export stage through the foreign production. Ultimately ;the 
Palestinian firms show different entry mode, as they can enter simultaneously as many 
markets as Pharmacare and Birzeit. It can be concluded that there is no certain formula 
for the entry mode is the best choice.  
 
Table (4.9) Means and Test values for “Modes of entry” 




(Sig. ) Rank 
1. Export entry modes (direct, indirect, agent, branch/subsidiary) 7. 60 75. 96 8. 18 0. 000* 1 
2. Contractual entry modes (licensing, franchising, technical agreement) 7. 29 72. 91 5. 80 0. 000* 2 
3. Investment entry modes (new establishment, acquisition, joint venture)  6. 85 68. 55 3. 34 0. 001* 3 
 All paragraphs of the field 7. 28 72. 81 6. 75 0. 000*  




Table (4. 10) shows the following results:  
The mean of the field “export planning” equals 7.46 (74.64%), Test-value = 
8.35, and P-value=0.000 which is smaller than the level of significance 0.05α = . The 
sign of the test is positive, so the mean of this field is significantly greater than the 
hypothesized value 6. It can be concluded that the respondents agreed to field of 
"export planning".  
The lowest mean of paragraph #8 “Our firm has R&D for export markets” 
equals 6. 95 can be justified in the light of the high expensive of the research in 
pharmaceutical industry, Palestinian companies can't afford the high cost of research. 
According to (Gassmann, et al. 2008) drug development costs per new drug approval 
is about 1. 5 $ billion in united state in year 2008.  
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The analysis results shows that "Palestinian pharmaceutical companies" 
respondents agreed with the presence of the positive influence of the “export 
planning” on export performance. This reveals that companies have " export 
planning" for export, the plan can assist and guide the employees to focus on 
exporting and enhance their performance.  
This result agree with the study conducted by Johanson, & Vahlne, (1977) 
which note that planning can be expected to affect export behavior, and agree with 
Madsen, (1989) states that there is a significant relationship between planning and 
export performance, and agree with Cavusgil, and. Zou (1994) who state that "poor 
performance in export markets was attributed to factors such as lack of proper 
attention to strategy planning". Lamont, (2002) agrees with Leonidou, Katsikeas, 
Palihawadana, & Spyropoulou, (2007) who stated that export markets should be 
based on a preliminary planning of the stated that activities that need to be 
undertaken to serve these markets. Bijmolt, & Zwart, (1994) who states that export 
planning seem to be more important influencing export performance. Lukas, 
Whitwell, & Hill, (2007) stated that There is strong support in the export literature 
for a positive relationship between export planning and export performance; Shoham 
(1999) states that the positive impact of export planning on export performance in his 
studies.  
 
Table (4.10) Means and Test values for “Export planning” 




(Sig. ) Rank 
1. Our firm have Developed competitive export 
strategies 7. 31 73. 05 6. 63 0. 000* 7 
2. Our firm have Establishment of exporting goals 7. 80 77. 97 8. 96 0. 000* 1 
3. Our firm have Existence of an export product 
policy 7. 80 77. 97 8. 96 0. 000* 1 
4. Our firm have Existence of an export 
promotion policy 7. 32 73. 22 6. 25 0. 000* 6 
5. Our firm have Existence of an export 
distribution policy 7. 34 73. 39 5. 59 0. 000* 5 
6. Our firm have Existence of an export pricing 
policy 7. 71 77. 12 8. 92 0. 000* 3 
7. Our firm have Export production policy 7. 49 74. 92 7. 52 0. 000* 4 
8. Our firm have R&D for export markets  6. 95 69. 49 4. 04 0. 000* 8 
 All paragraphs of the field 7. 46 74. 64 8. 35 0. 000*  
* The mean is significantly different from 6 
 
Market research: 
Table (4.11) shows the following results:  
The mean of the field “Market research” equals 7. 16 (71. 60%), Test-value = 
7. 08, and P-value=0. 000 which is smaller than the level of significance 0.05α = . 
The sign of the test is positive, so the mean of this field is significantly greater than 
the hypothesized value 6. It can be concluded that the respondents agreed to field of 
"Market research". 
The general results for all statements of the field show that the average mean 
of the field “Market research” equals 7. 16 (71. 60%), Test-value = 7. 08, and P-
value=0. 000 which is smaller than the level of significance 0.05α = . The sign of 
the test is positive, so the mean of this field is significantly greater than the 
hypothesized value 6, which means the respondent of the sample agrees that Market 
research utilization has appositive influence on export performance.  
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The ranking of export performance variable indicates that, the Palestinian 
companies mostly need to "Obtaining knowledge about market" to achieve high export 
performance, The second most affect export performance is " knowledge about market 
when starting to export". The " Firm Possession of a unique/patented product " is the last 
variable in the ranking may affect export performance. The results indicates that the 
respondents understand the importance of "market research effect on export 
performance, paragraph #3 “Firm Possession of a unique/patented product will 
encourage export strategy” equals 6. 67 (66. 67%), show less support from respondent to 
the paragraph, this can be justify by the reality of the high cost to Palestinian firm to 
obtain patent drug due to high research cost and shortage of research.  
The results agree with Singer, & Czinkota, (1994) which states that Export 
policy can be effective if there is information about the market, and agree with Leonidou 
(1998). States that An efficient marketing intelligence system may also greatly enhance 
export performance, by providing timely, accurate and reliable information on overseas 
corporate strategy, and consistent with Johnston and Czinkota (1982) concluded that A 
specialized advantage or know-how in one or more marketing activities was often cited 
as an important catalyst for beginning and sustaining export operations. and agree with 
Madsen, (1989) " market research is a means for developing guidelines for successful 
export marketing management performance, and agree with Leonidou, . et. al. (2007) 
states that export market research utilization generally translates to greater 
internalization of relevant knowledge regarding target export markets, and agree with 
Souchon, et. al. (2003) state that information use is crucial for effective export decision 
making and ultimately export performance, and agree with wheeler. et. al (2008) 
conclude that Export market research utilization generally translates to greater 
internalization of relevant knowledge regarding target export markets, and agrees with 
Cavusgil, and S. Zou (1994) and agrees with Zou, & Stan, (1998). Köksal (2008) states 
that the Turkish companies possess information and market research can positively 
improve their export performance.  
 
Table (4.11) Means and Test values for “Market research” 




(Sig. ) Rank 
1. We have knowledge about market when starting to 
export 7. 63 76. 27 8. 55 0. 000* 2 
2. Firm Possession of proprietary technical knowledge 
will enhance export strategy  7. 53 75. 25 9. 93 0. 000* 3 
3. Firm Possession of a unique/patented product will 
encourage export strategy 6. 67 66. 67 2. 17 0. 017* 10 
4. firm Extending life-cycle of products will positively 
encourage export strategy  6. 67 66. 72 2. 43 0. 009* 9 
5. We have number of information sources to be used 7. 32 73. 22 7. 48 0. 000* 4 
6.  Our firm Obtaining knowledge about market, will 
encourage export strategy 7. 98 79. 83 11. 32 0. 000* 1 
7. We depend on customer perception to produce 
product uniqueness  7. 20 72. 03 5. 72 0. 000* 5 
8. We depend on customer perception to achieve 
product quality  7. 07 70. 68 4. 77 0. 000* 6 
9. We depend on customer perception to achieve 
product and package design  6. 78 67. 80 3. 12 0. 001* 7 
10. We depend on customer perception to strengthen 
our product  6. 78 67. 80 3. 29 0. 001* 7 
 All paragraphs of the field 7. 16 71. 60 7. 08 0. 000*  
* The mean is significantly different from 6 
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Market strategies adaptation 
Table (4. 12) shows the following results:  
The mean of the field “Market strategies adaptation” equals 7. 19 (71. 87%), 
Test-value = 7. 21, and P-value=0. 000 which is smaller than the level of significance 
0.05α = . The sign of the test is positive, so the mean of this field is significantly 
greater than the hypothesized value 6. It can be concluded that the respondents 
agreed to field of "Market strategies adaptation".  
The results indicate that the " Market strategies adaptation" elements that has 
the greatest level of adaptation is product, followed by distribution, price, and 
promotion.  
Product adaptation is found to be the strongest effect on export performance, 
respondents emphasis on "Product quality", that is expected because pharmaceutical 
industry is "quality oriented", this slightly agree with Kacker, (1975). Most exporters 
in India enter into export venture with minimal Changes in the product design, in the 
case of Palestinian firms it is clear that the pharmaceutical products are subject to the 
tough standard of the international specification issued by world health organization 
WHO and other organization like food and drug administration FDA of united state 
of America, thus; they can concentrate on the using of quality standard and the other 
marketing product mix, the respondents show that the brand name not affect the 
performance, it can be explained that Palestinian firm as well as most developing 
countries have not own international brand name for drug.  
Product adaptation seems to have neutral effect according to Wheeler, Ibeh, 
& Dimitratos, (2008) The impact of adaptation strategies on the export performance 
of UK firm shows some neutral effects  reported for product adaptation.  
According to the research review by Miesenbock, (1988). Past literature 
indicates that unique or very sophisticated products and patents were found 
decisively associated with success in exporting. In most foreign markets, good 
product quality and design as well as good product marketing help to increase export 
success.  
Promotion adaptation is found to be the least effect market strategies 
adaptation on export performance. Results show that "Public relations emphasis"  
positively affects export it has no effect on export performance, that can be explained 
in the light of the medical advertisement depending mainly on the physician visit to 
the private clinic and hospital, so public relation is more effective in promotion, 
while using media and newspaper for medical promotion subjected to many 
restriction by the law.  
The results of promotion adaptation generally supported its effect on the export 
performance, this agree with Zou, & Stan (1998). Effects of promotion adaptation on 
various measures of export performance appear mixed. and dont agree with Cavusgil, & 




Results show that Price adaptation affect export performance. They show that 
"Quality/price relationship" strongly affects export performance, while "Price discount 
policy" has the least effect on export performance in this field. That indicates the 
respondents see there should be fair price for the high quality of the firm product, the 
appropriate price has good impact on consumer who find the price justify by the high 
quality of the drug, and they are not in favor for the discount policy, because the urgent 
need for the fund to increase the firm investment.  
This agrees with Madsen, (1989) On opposite grounds one can attempt to explain 
the weak impact that price competitiveness appears to have on export performance. Low 
price will tend to increase buyer uncertainty. It agree relatively to Kacker, (1975) pricing 
is not considered as a critical element in the export marketing of India exporters. Indian 
exporter regard international price level as something given or uncontrollable.  
Results show that distribution adaptation affect export performance. They show 
that "Accomplishment of delivery deadlines" strongly affects export performance, while 
"Criteria to select the distribution system" has the least effect on export performance in 
this field.That indicate the respondents see committed to deliver the product on time. 
This reflects high commitment from the employees. Respondents are aware about the 
turmoil situation in Palestine and they know the restriction on the transportation applied 
by Israeli occupation, thus they can't use rigid criteria for transportation and they 
strongly in favor to transportation strategy to cope with this difficult situation. This  
agrees with Wheeler, Ibeh, & Dimitratos, (2008) good distribution channel appears to 
impact favorably on export performance. 
General results indicate that there is an effect for market strategies adaptation on 
export performance with slight difference to each strategies. This  agrees with Madsen, 
(1989); Cavusgil, & Zou, (1994); Zou, & Stan, (1998); Leonidou, (1998). ; Wheeler, 
Ibeh, & Dimitratos, (2008). The previous research shows mix results of the effect of 
market strategies adaptation on export performance as following: Cavusgil and Zou 
(1994) it is not surprising that high product adaptation enhanced performance for export 
ventures; Tookey (1964). Export-oriented firms reported that they are willing to adapt 
their products more than other firms do; Cavusgil and Kirpalani (1993) reported that 
high product adaptation enhanced performance in initial market entry and in subsequent 
penetration ; According to Shoham, A. (2003) marketing mix element that has the 
greatest level of adaptation is distribution, followed by price, promotion, and product; 
Doherty, G., & Ennew, C. T. (1995). concluded in their research that, An exploratory 
analysis of the pharmaceuticals market in Europe; suggests that the conditions favouring 
standardization in marketing are relatively weak and where there is marketing 
standardization it is highest in relation to the core product features (formulation, dosage 
and tablet size). Other aspects of marketing such as communication pricing and 
packaging still appear to be relatively different across markets reflecting variation in 
market needs and market conditions. basic product is significantly more standardized 
than communications or packaging/pricing. There is no significant difference in the 
degree of standardization of communication and pack/price; Wheeler, Ibeh, & 
Dimitratos, (2008) stated that the impact of adaptation strategies on the export 
performance of UK firms appears to be mixed. As Table 2 shows, some neutral effects 




Table (4.12) Means and Test values for “Market strategies adaptation” 




(Sig. ) Rank 
1. Product’s brand name strategy  7. 14 71. 36 5. 81 0. 000* 6 
2. Product design  7. 40 74. 04 7. 25 0. 000* 4 
3. Product labeling  7. 36 73. 56 7. 32 0. 000* 5 
4. Product quality  8. 25 82. 54 11. 02 0. 000* 1 
5. Range of variety of main exporting product line  7. 56 75. 59 8. 84 0. 000* 3 
6. product precautions  7. 97 79. 66 9. 04 0. 000* 2 
Product Adaptation 7. 62 76. 17 10. 10 0. 000*  
1. Advertising idea/theme  6. 67 66. 72 3. 07 0. 002* 4 
2. Media channels for advertising  6. 00 60. 00 0. 00 0. 500 5 
3. Promotion objectives  6. 93 69. 32 4. 09 0. 000* 2 
4. Budget for promotion  6. 86 68. 62 3. 77 0. 000* 3 
5. Public relations emphasis  7. 33 73. 33 6. 86 0. 000* 1 
6. Direct marketing/mailing  5. 91 59. 12 -0. 27 0. 395 6 
Promotion Adaptation  6. 59 65. 88 2. 90 0. 003*  
1. Determination of pricing strategy  7. 24 72. 41 6. 50 0. 000* 3 
2. Concession of credit  7. 26 72. 59 6. 74 0. 000* 2 
3. Price discount policy  6. 93 69. 32 3. 96 0. 000* 4 
4. Quality/price relationship  7. 39 73. 90 6. 73 0. 000* 1 
Price Adaptation 7. 21 72. 12 7. 02 0. 000*  
1. Criteria to select the distribution system  7. 10 71. 02 4. 95 0. 000* 5 
2. Transportation strategy  7. 31 73. 05 6. 03 0. 000* 2 
3. Budget for distribution  7. 19 71. 86 5. 73 0. 000* 4 
4. Distribution network  7. 31 73. 05 5. 65 0. 000* 2 
5.  Accomplishment of delivery deadlines 7. 86 78. 57 9. 15 0. 000* 1 
Distribution Adaptation 7. 35 73. 46 6. 67 0. 000*  
 All paragraphs of the field 7. 19 71. 87 7. 21 0. 000*  
* The mean is significantly different from6 
 
Export Performance: 
Table (4. 13) shows the following results:  
The mean of paragraph #1 “export has improved our global competition” 
equals 7. 32 (73. 22%), Test-value = 7. 55, and P-value = 0. 000 which is smaller 
than the level of significance 0.05α = . The sign of the test is positive, so the mean of 
this paragraph is significantly greater than the hypothesized value 6. It can be 
concluded concluded  that the respondents agreed with this paragraph.  
The mean of paragraph #9 “our export venture has fully met our 
expectations” equals 6. 68 (66. 78%), Test-value = 3. 37, and P-value = 0. 001 which 
is smaller than the level of significance 0.05α = . The sign of the test is positive, so 
the mean of this paragraph is significantly greater than the hypothesized value 6.It 
can be concluded that the respondents agreed with this paragraph.  
The mean of the field “Strategic export performance” equals 7. 07 (70. 66%), 
Test-value = 6. 85, and P-value=0. 000 which is smaller than the level of significance 
0.05α = . The sign of the test is positive, so the mean of this field is significantly 
greater than the hypothesized value 6. It can be concluded that the respondents agree 
with field of “Strategic export performance ".  
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The mean of the field “export performance” equals (70. 66%), so the mean of 
this field is significantly greater than the hypothesized value 6. It can be concluded 
that the respondents agreed to field of “export performance " it indicates that 
respondents see internationalization is a successful strategy to achieve firm goal. 
This agrees with Johanson, & Vahlne, (1977) who state that many firms consider 
internationalization promising strategy.  
Paragraph #1 "export has improved our global competition" appears to have 
strong effect on export performance, it is obvious that PPI achieve good reputation in 
global market, this agree with Cavusgil and Zou, (1994) found that Marketing 
strategy  of firms' of international competence, Have emerged as key success factors 
in export marketing, paragraph #2 "export has Strengthen our strategic position" and 
paragraph #6 " export has achieved rapid growth " appears to have good agreement 
from the respondents that marketing strategy strengthen firm position in international 
market and contribute to the firm growth, it indicates that respondents know there is 
growth and improvement of firm abroad. They are involved in the growth of export 
and receiving the increasing order for export, results agree with Madsen, (1989) 
Export growth is mainly affected positively by close monitoring of market changes.  
Paragraph #4 " export has been very profitable " appears that there is 
moderately agree with this field to the profitability of export, in a study by Taylor, & 
Osland, (1998) state that profit consider the highest effect on export by Japanese 
firm, the justification of the results from respondents may be the firm don't disclose 
the profit generated from export separately, thus respondents not participate in 
budgeting and don’t know the profit. this agree with Madsen, (1989) note that Export 
profitability. On the other hand, it is primarily influenced by the extent of budgeting.  
While paragraph #9 " our export venture has fully met our expectations" 
shows that the respondents slightly satisfy with their expectation to the export results. 
That means that respondents  expected more successful results from the export 
venture.  
General results indicate that respondents satisfy with their marketing strategy 
and believe the internal determinants affect the export performance, the results agree 
with Cavusgil and Zou’s (1994) export performance is determined mainly by export 
marketing strategy, And agree with Shoham (1998) documented high correlations 
between objective and satisfaction-based measures of export performance. Results 
show that respondents strongly agree with the firm performance of the export venture 
in paragraphs related to achievement of strategic objectives " global competition, 
position in the global market, and global market share), and to less extent to these 
paragraphs related to firm financial goals (profit, sale). This reflects the opinion of 
the respondents toward the firm strategy and may be they are not in position to know 
exact profit and growth has been done due to export venture, (firm always reluctant 
to disclose actual export dinisty and the export percentage out of total sale). This 
agrees with Zou, S., Taylor, C. R., & Osland, G. E. (1998) who state that Measures 
such as export profit, sales, and sales growth are indicators of a firm's financial 
export performance, and Measures such as global competitiveness, global strategic 
position, and global market share are indicative of the extent to which the firm 




Table (4.13) Means and Test values for “export performance” 




(Sig. ) Rank 
1. export has improved our global competition  7. 32 73. 22 7. 55 0. 000* 1 
2. export has Strengthened our strategic position  7. 31 73. 05 7. 69 0. 000* 2 
3. export has Significantly increased our global share  6. 90 68. 98 4. 14 0. 000* 8 
4. export has been very profitable 7. 00 70. 00 5. 02 0. 000* 6 
5. export has generated a high volume of sale  7. 19 71. 86 6. 59 0. 000* 4 
6. export has achieved rapid growth  7. 20 72. 03 5. 57 0. 000* 3 
7. Our export venture has been very satisfactory  7. 03 70. 34 5. 57 0. 000* 5 
8. our export venture has been very successful  6. 97 69. 66 4. 92 0. 000* 7 
9. our export venture has fully met our expectations  6. 68 66. 78 3. 37 0. 001* 9 
 All paragraphs of the field 7. 07 70. 66 6. 85 0. 000*  
* The mean is significantly different from 6 
 
generally table No.(4.14 ) shows the value for  each  field and the whole 
fields which illustrate that  the average mean equal for the whole fields equal  7.232 
and the weight of Proportional mean (%) equal  64.97%  which is  greater than  " 
60%"  and the p- value equal 0.000 which is less than 0.05, which means the 
respondent of the sample agrees that the level of internal determinants affect on 
export performance  was statistically satisfactory.    
 
Table ( 4.14) The value for each field of internal determinants and the whole 
fields 





1. Means and Test values for “Modes of entry” 7. 28 72. 81 6. 75 0. 000* 
2. Export planning 7. 46 74. 64 8. 35 0. 000* 
3. Market research 7. 16 71. 60 7. 08 0. 000* 
4. Market strategies adaptation 7. 19 71. 87 7. 21 0. 000* 
5. export performance 7. 07 70. 66 6. 85 0. 000* 
6 All items 7.232 72.316 7.248 0.000 
 
4.4 Research Hypothesis: 
4.4.1 Hypothesis. 1.1: 
There is No significant differences among respondents at level α = 0. 05 
towards the export determinants and Export performance Due To Firms 
Characteristic (Firm size, firm age, firm sale).  
 
4.4.2 Hypothesis. 1.2: 
There is no significant differences among respondents at Level α = 0. 05 
towards the export determinants and Export performance Due To management 
Characteristic (Education Level, Place Of Education, Instruction Language, 
Education Background, Overseas Trip).  
Firm age: 
Table (4. 15) shows that the p-value (Sig.) is greater than the level of 
significance α = 0. 05 for the fields “Modes of entry and Strategic export 
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performance”, then there is insignificant difference among the respondents regarding 
to these fields due to Firm age. It can be concluded that the respondents’ show firm 
age has no effect on these fields.  
Table (4. 15) shows that the p-value (Sig.) is smaller than the level of 
significance α = 0. 05 for the total  fields, then there is significant difference among 
the respondents regarding these fields due to Firm age. It can be concluded that the 
respondents’ perception to "firm age" has significant effect on these fields.  
From table (4. 15), it can be concluded the following:  
Firms that were established and their ages are More than 40 years have positive effect on 
export. This indicates that firm age can positively affect export, the explanation as 
indicated in the table (4. 14) shows that older firms significantly concern about that the 
effect of the strategic planning, market research, marketing mix adaption on the export 
performance. This reflects that the older firm has the resource, experience, confidence to 
establish adaptation policy and to conduct marketing research more than younger firm, 
younger firms are in shortage of resource, experience to do that. This agrees with Autio, 
Sapienza, & Almeida, (2000) who found that The resource-based view predicts that 
older firms will have considerable more resources than younger firms. And agree with 
Brouthers, & Nakos, (2005) who found that older firms performed better in foreign 
markets, Perhaps the greater experience accumulated by older firms may assist them in 
international export markets, the study is Contrary to finding of Ursic and Czinkota 
(1984) The research reported that younger firms are much more favorably disposed 
toward and active in international marketing than older firm, and to Brouthers, & Nakos, 
(2005)found that Company age has been shown to influence export performance; 
younger firms appear to be better exporters, and (Das, 1994) who found that firm’s age, 
expressed as number of years in business, it appears to have either a negative effect, and 
to Zou, & Stan, (1998) also reported that firm’s age has an insignificant effect on export; 
according to Kaynak, & Kuan, . (1993) who found that Taiwanese firms with higher 
export profitability performance are newcomers in the export business, not experienced 
firms. Younger firms not preoccupied with export know-how are more likely to adapt to 
and succeed in the turbulent export environment.  
 
Table (4.15) Independent Samples T-Test of the fields and their p-values for Firm age 
Means 
No. Field Test Value Sig. 40 years and Less More than 40 
1.  Modes Of Entry  -1. 654 0. 104 6. 98 7. 60 
2.  Strategic Planning -2. 559 0. 013* 7. 04 7. 90 
3.  Market Research -3. 526 0. 001* 6. 64 7. 70 
4.  Product Adaptation -3. 175 0. 002* 7. 15 8. 10 
5.  Promotion Adaptation  -4. 352 0. 000* 5. 83 7. 37 
6.  Price Adaptation -2. 948 0. 005* 6. 74 7. 70 
7.  Distribution Adaptation -3. 303 0. 002* 6. 74 7. 97 
8.  Market Strategies Adaptation -4. 000 0. 000* 6. 61 7. 78 
9.  Strategic Export Performance 0. 924 0. 359 7. 21 6. 92 
 All paragraphs of the questionnaire -3. 115 0. 003* 6. 81 7. 62 





Company size: (by number of employees) 
Table (4. 16) shows that the p-value (Sig.) is greater than the level of 
significance α = 0. 05 for the fields “Modes of entry, strategic planning and Strategic 
export performance”, then there is insignificant difference among the respondents 
regarding to these fields due to Company size. We conclude that the respondents’ 
Company size has no effect on these fields.  
Table (4. 16) shows that the p-value (Sig.) is smaller than the level of 
significance α = 0. 05 for the other fields, then there is significant difference among 
the respondents regarding to these fields due to Company size. It can be concluded 
that the respondents’ firm size has significant effect on these fields.  
From table (4. 16 ), it can be conclude the following:  
Firm with  "140 employees" has greater effect on export performance comparing 
with other firms, while the firm with " 282 employees" has less effect, this 
completely agrees with results of export marketing literature indicated that the effect 
of the firm size on export performance appear to be mix and controversial, 
Miesenbock, (1988). Aaby, & Slater, (1989) stated that "there is little agreement 
regarding the impact of organization size  on export performance. They Concluded 
company size by itself is not an important factor unless it is linked to aspects such as 
financial strength or variables related to economies of scale"; Czinkota, & Johnston, 
(1983) broad generalizations concerning the size of firms an exporting appear to be 
inappropriate. 
Some Researchers supported the small firm size positively affect export 
performance, argue that small firms have flexibility and more capabilities to avoid 
risk by exit from export market with little cost, Bonaccorsi, (1992). Small firms 
reduce the risk involved in export activity is through ensuring they can exit with little 
cost. Second explanation is the small firms concentrate on export market and employ 
more resource to the export activities. This agree with Kaynak, & Kuan, (1993) 
Successful exporters are smaller firm size and characterized by employing more 
people in export operating units. The result of small is firm consistent with Das, 
(1994) who found that firms with higher export intensity were small.  
Miesenbock, (1988) states that Empirical findings of firm size effect have 
been mixed, but the results tend to show that large firm is easier to start export, the 
number of full time employees are found to correlate positively to export. Large size 
firm appears to be more favorable to export, and respondents agree that the size of 
large firm positively affects the export performance. The explanation can be 
understood in the light of the large firms which have more resource and experience 
to utilize it in export activities. The table shows that the large firm can conduct 
"market research, strategic planning, adopt product, more than small size firm. Autio, 
Sapienza, & Almeida, (2000) found that Larger firms tende to be more 
internationalized, Williams, (2011) With a larger resource stock, firms may perceive 
the risk of doing business abroad as lower because they will be better prepared to 
deal with challenges, therefore, there may be a greater motivation to engage in 
international business, Williams, (2011) states that size, not age, of the small firm is 
the most important factor in explaining export performance; Leonidou, (January 01, 
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1998) notes that the majority of the organizational factors revealed inconclusive 
associations with this dimension of exporting, particularly in relation to company 
size (whether measured in terms of number of employees, sales turnover, or total 
assets).  
 
Table (4. 16) One- Way Analysis of Variance (ANOVA) of the fields and their  
p-values for Company size 
Means No.  Field Test Value Sig. 140 170 260 282 
1.  Modes of entry  2. 525 0. 067 7. 56 7. 67 6. 48 7. 59 
2.  strategic planning 2. 631 0. 059 7. 98 7. 72 6. 80 7. 32 
3.  Market research 12. 835 0. 000* 7. 96 7. 11 5. 94 7. 44 
4.  PRODUCT ADAPTATION 9. 150 0. 000* 8. 10 8. 09 6. 47 7. 93 
5.  Promotion Adaptation  7. 846 0. 000* 7. 50 7. 09 5. 41 6. 31 
6.  PRICE ADAPTATION 9. 861 0. 000* 7. 93 7. 19 6. 00 7. 59 
7.  DISTRIBUTION ADAPTATION 5. 795 0. 002* 8. 02 7. 87 6. 18 7. 39 
8.  Market strategies adaptation 10. 095 0. 000* 7. 88 7. 58 6. 02 7. 29 
9.  Strategic export performance 2. 273 0. 090 7. 19 6. 31 6. 91 7. 55 
 All paragraphs of the 
questionnaire 7. 556 0. 000* 7. 77 7. 29 6. 31 7. 37 
* Means differences are significant at α = 0. 05 
 
Education levels: 
Table (4.17) shows that the p-value (Sig.) is greater than the level of 
significance α = 0. 05 for each field, then there is insignificant difference in 
respondents' answers toward each field due to Education levels. It can be concluded 
that the characteristic of the respondents Education levels has no effect on each field.  
An explanation for this may be that employees educational level are mostly 
Bachelor degree (69. 5%) and master has (25. 4%) of the total population, the 
background of their education is scientific, thus their perception toward export is 
similar.  
The results are not consistent with the literature marketing review, Simpson, 
& Kujawa, (1974).who Concluded that export of the firm influenced by the managers 
enjoy higher level of education, but their  study compare between exporter and non 
exporter, so result may not be relevant to this study result. Kau Ah Keng, (1993). 
concluded that exporting and non-exporting firms chief executives of exporting firms 
had statistically higher levels of education than their counterparts in non-exporting 
firms; Maurel, (2009) level of education, seem to play an important role in the 
improvement of the export performance; the result of the study relatively agree with 
Zou, & Stan, (1998) Concerning managers’ levels of formal education and general 
business experience, about a third of the reviewed studies found that this has a 




Table (4. 17): Independent Samples T-Test of the fields and their p-values for 
Education levels 
Means 
No. Field Test Value Sig. Bachelor and less 
High 
study 
1.  Modes Of Entry  -1. 860 0. 068 7. 07 7. 83 
2.  Strategic Planning -2. 080 0. 052 7. 75 8. 05 
3.  Market Research -1. 840 0. 071 6. 98 7. 64 
4.  Product Adaptation -0. 902 0. 371 7. 53 7. 85 
5.  Promotion Adaptation  -0. 174 0. 863 6. 57 6. 65 
6.  Price Adaptation -1. 887 0. 064 7. 02 7. 73 
7.  Distribution Adaptation -0. 918 0. 362 7. 23 7. 65 
8.  Market Strategies Adaptation -0. 954 0. 344 7. 09 7. 45 
9.  Strategic Export Performance -0. 884 0. 381 6. 98 7. 29 
 All paragraphs of the questionnaire -1. 581 0. 119 7. 07 7. 57 
 
Place of college education: 
Table (4.18) shows that the p-value (Sig.) is smaller than the level of 
significance α = 0. 05 for the fields “product adaptation, promotion adaptation, price 
adaptation and Market strategies adaptation”, then there is significant difference 
among the respondents regarding to these fields due to Place of college education. It 
can be concluded that the respondents’ Place of college education has significant 
effect on these fields.  
Table (4.18) shows that the p-value (Sig.) is greater than the level of 
significance α = 0.05 for the other fields, then there is insignificant difference among 
the respondents regarding to these fields due to Place of college education. It can be 
concluded that the respondents’ Place of college education has no effect on these 
fields. It can be concluded the following: For the fields" Product Adaptation, 
Promotion Adaptation, Price Adaptation and Market strategies adaptation ", Palestine 
has higher than other places of college education.  
An explanation of the support of pharmacists to adaptation is that the 
pharmacists graduated from Palestinian universities form (61%) of study population, 
pharmacists are more involved in management and production. They have sufficient 
knowledge of the specification of the drug manufacturing and marketing, The results 
show that there is focus on product adaptation, this reflects the high standard of the 
Palestinian graduates who have been selected for university admission according to 
their excellent marks and merit system. Another justification is that employees 
graduated from Palestinian university feel patriotic and display their enthusiasm for 
the export from Palestine. This agrees with Tookey (1964) who states that some 
American companies export for patriotic reasons. It appears that Palestinians 
graduates are more committed to export and believed it can achieved the objective of 
the firm. Dichtl et al. (1984) "managers who have committed themselves to exporting 
were involved in foreign experience "; Da Rocha, & da Cunha, (1990) found that The 
aggressive exporters had spent much more time abroad. 
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In contrast, many researchers concluded that international experience 
(education abroad, visit, living abroad, foreign language), positively affects export 
performance, Simpson, C., & Kujawa, D. (1974); Kaynak, & Kuan, (1993). Ruzzier, 
Antoncic Hisrich, & Konecnik, . (2007) who conclude that entrepreneurs who were 
most exposed to foreign cultures through travel or residence likely accumulate 
experiential knowledge of international market characteristics which benefit them 
when internationalizing their firms; Leonidou, Katsikeas; Piercy, (1998) state that 
educational level may affect export performance, ; Holzmüller, ., & Kasper, (1991) 
note that mangers in exporting firms had spent more time abroad than mangers in 
non exporting firms appear to affect positively export performance.  
 
Table (4.18) One- Way Analysis of Variance (ANOVA) of the fields and their  
p-values for Place of college education 
Means 
No. Field Test Value Sig. Palestine Arab countries Other 
1.  Modes Of Entry  2. 917 0. 063 7. 60 6. 55 7. 17 
2.  Strategic Planning 0. 191 0. 826 7. 52 7. 28 7. 56 
3.  Market Research 1. 609 0. 209 7. 37 6. 68 7. 13 
4.  Product Adaptation 3. 271 0. 045* 7. 91 6. 99 7. 48 
5.  Promotion Adaptation  3. 271 0. 045* 6. 93 5. 75 6. 65 
6.  Price Adaptation 5. 184 0. 009* 7. 58 6. 35 7. 19 
7.  Distribution Adaptation 2. 443 0. 096 7. 68 6. 69 7. 05 
8.  Market Strategies Adaptation 4. 188 0. 020* 7. 52 6. 45 7. 08 
9.  Strategic Export Performance 0. 457 0. 635 7. 01 6. 99 7. 44 
 All paragraphs of the 
questionnaire 2. 061 0. 137 7. 40 6. 74 7. 24 
* Means differences are significant at α = 0. 05 
 
Education background: 
Table (4.19) shows that the p-value (Sig.) is greater than the level of 
significance α = 0. 05 for the fields “Price Adaptation and Strategic export 
performance”, then there is insignificant difference among the respondents regarding 
to these fields due to education background. It can be concluded that the 
respondents’ education background has no effect on these fields.  
Table (4.19) shows that the p-value (Sig.) is smaller than the level of 
significance α = 0. 05 for the other fields, then there is significant difference among 
the respondents regarding to these fields due to education background. It can be 
concluded that the respondents’ education background has significant effect on these 
fields.  
Results of the total valid items show that " others" have strong positive effect 
of determinants on export, while ;the " Management" background employees show 
less support comparing to other, this may be due to that; other belong to owners of 
the firm and eager to support more and the percentage of them is (6. 8%) out of total 
population, so it doesn't reflect the exact opinion of the population, pharmacists who 
represent one third of the study population less support to the effect of determinants 
on export performance, this result reflects realistic opinion of the pharmacists toward 
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evaluation export performance. It is interesting that the results show more contestant 
between the group toward product adaptation.  
Reid (1981) argues that determinants like educational background is antecedents 
of attitudes towards export marketing; Leonidou,; Katsikeas,; Piercy, (1998) Educational 
Background may affect export performance; Maurel, (2009) found that Decision-maker 
characteristics i. e. educational background is positively affect export performance.  
 
Table (4.19) One- Way Analysis of Variance (ANOVA) of the fields and their  
p-values for education background 
Means No.  Field Test Value Sig. Pharmacy Management Science Other 
1.  Modes Of Entry  2. 955 0. 041* 7. 72 6. 58 7. 00 8. 00 
2.  Strategic Planning 6. 635 0. 001* 7. 78 6. 78 7. 03 8. 86 
3.  Market Research 4. 213 0. 009* 7. 51 6. 58 6. 81 8. 13 
4.  Product Adaptation 3. 492 0. 022* 8. 15 7. 11 7. 20 8. 08 
5.  Promotion Adaptation  3. 943 0. 013* 7. 20 6. 20 5. 77 7. 38 
6.  Price Adaptation 1. 394 0. 254 7. 34 7. 30 6. 67 7. 75 
7.  Distribution Adaptation 2. 892 0. 043* 7. 87 6. 55 7. 17 7. 95 
8.  Market Strategies Adaptation 3. 187 0. 031* 7. 66 6. 77 6. 69 7. 79 
9.  Strategic Export Performance 1. 144 0. 340 7. 32 6. 63 7. 23 7. 00 
 All paragraphs of the 
questionnaire 4. 140 0. 010* 7. 59 6. 69 6. 89 7. 89 
* Means differences are significant at α = 0. 05 
  
4.4.3 Hypothesis 2.1: 
There is no significant relationship at level α = 0. 05 between Mode of entry of 
Palestinian pharmaceutical firms and export performance.  
Table (4.20) shows that the correlation coefficient between Mode of entry and 
export performance equals. 438 and the p-value (Sig.) equals 0. 000. The p-value (Sig.) 
is less than 0. 05, so the correlation coefficient is statistically significant at α = 0. 05. it 
can be concluded there exists a significant relationship between Mode of entry and 
export performance.  
According to the results, the hypothesis "Mode of entry of Palestinian 
pharmaceutical firms positively influence export performance" is accepted, it appears 
that there is strong correlation. This indicates that the mode of entry affect export 
performance, this mean that employees of Palestinian pharmaceutical firm play 
important role in determining the right entry to international market, they believe the 
entry mode for their firms can achieve the desire result for their firms, this is consistent 
with Mayer, & Flynn,(1973) "firms success in international market is due to reasonable 
market selection and penetration approach that can be employed by smaller firm "fellow 
the leader". This approach keeps marketing cost down"; Reid,(1983) states that "The 
export expansion process is shown to be selectively influenced by a firm's administrative 
capacity to co-ordinate and control critical changes in transaction periodicity, growth and 
volume"; Root (1994) concludes that the choice of market entry mode is one of the most 
critical strategic decisions firm. It affects future decisions and performance in foreign 
markets; Hoang, (1998). indicates that export performance is significantly influenced by 




Table (4.20) Correlation coefficient between Mode of entry and export 
performance 
Hypothesis Pearson Correlation Coefficient 
P-Value 
(Sig. ) 
Mode of entry of Palestinian pharmaceutical firms 
positively influence export performance . 438 0. 000* 
* Correlation is statistically significant at 0. 05 level 
 
4.4.4 Hypothesis 2.2: 
There is no statistical relationship at significant level α = 0. 05 between Export 
planning of Palestinian pharmaceutical firms and export performance.  
Table (4. 21) shows that the correlation coefficient between Export planning 
and export performance equals. 400 and the p-value (Sig.) equals 0. 001. The p-value 
(Sig.) is less than 0. 05, so the correlation coefficient is statistically significant at α = 
0. 05. It can be concluded that there exists a significant relationship between Export 
planning and export strategy.  
According to the results, the hypothesis " Export planning of Palestinian 
pharmaceutical firms positively influence export performance " is accepted. it can be 
concluded that the importance of marketing planning can improve export 
performance, These results agree with most previous studies; Bilkey and Tesar 
(1977) found that formulated export plan is essential for success export performance; 
Gomez-Mejia,  (1988) export performance improves if the firm provides an 
international Orientation to its future plans and goals; Madsen (1989) concludes that 
a significant relationship between planning and control intensity and export 
performance; Cavusgil, & Godiwalla, (1982). The firm's commitment to long-range 
planning should provide for a durable survival and growth of its international 
activities; Hoang, (1998) suggests a positive connection between formal marketing 
planning and export performance. It has also been suggested that marketing planning 
is an incremental process; Walters (1993). concludes that there is an association 
between export performance and formal planning activity; Dwikat (2012) indicates 
that Palestinian pharmaceutical firms are planning for international marketing.  
 







Export planning of Palestinian pharmaceutical firms 
positively influence export strategy . 400 0. 001* 
* Correlation is statistically significant at 0. 05 level 
 
4.4.5 Hypothesis 2.3: 
There is no statistical relationship at significant level α = 0. 05 between 
Market research of Palestinian pharmaceutical firms and export performance.  
Table (4.21) shows that the correlation coefficient between Market research 
and export strategy equals. 494 and the p-value (Sig.) equals 0. 000. The p-value 
(Sig.) is less than 0. 05, so the correlation coefficient is statistically significant at α = 
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0. 05. We conclude that there exists a significant relationship between Market 
research and export strategy.  
According to the results, the hypothesis "Market research of Palestinian 
pharmaceutical firms positively influence export strategy performance" is accepted. 
it can be concluded that The Market research positively affects export performance, 
These result agree with most previous studies, according to Terpstra, (1983) who 
concludes that Marketing intelligence assists firm for achieving better economic 
goal, and helps  planning to solve problems rise in international market; Sood, & 
Adams, (1984) marketing research assists firm to choose and implement a rational 
market entry strategy; 
Souchon and Diamantopoulos (1996) concluded that, higher levels of 
information utilization are expected to increase company performance since 
companies learn to effectively manage competition, understand customer needs, and 
target profitable markets; Hoang, (1998). Concludes that Marketing research appears 
to be an important activity in facilitating a firm's international involvement; 
Johanson, & Vahlne, (1977) found that lacking information knowledge of 
international markets is considered a major obstacle in the development of 
international operations; Dowling, . et al (2000). Market research reduces uncertainty 
when conducting business in overseas operations and is valuable in determining an 
appropriate marketing mix, Dwikat, (2012) indicates that Palestinian pharmaceutical 
firms analyze targeting export market and investigate the marketing situation to 
enhance its export performance.  
 
4.4.6 Hypothesis 2.4: 
There is no statistical relationship at significant level α = 0. 05 between Market 
strategy adaptation of Palestinian pharmaceutical firms and export performance.  
Table (4.22) shows that the correlation coefficient between Market strategy 
and export strategy equals. 475 and the p-value (Sig.) equals 0. 000. The p-value 
(Sig.) is less than 0. 05, so the correlation coefficient is statistically significant at α = 
0. 05. It can be concluded  that there exists a significant relationship between Market 
strategy and export strategy.  
According to the results, the hypothesis " Market strategy adaptation of 
Palestinian pharmaceutical firms positively influence export performance " is accepted. 
it can be concluded that The Market strategy affect firm export performance, These 
result agree with most previous studies; According to Cavusgil, & Zou, (1994) support 
the contention that firms can achieve better performance in international markets through 
deliberate marketing strategy implementation; Shoham, (2003) state that export 
marketing mix are related positively to export performance. It means that the four 
components of marketing mix affect the export performance, but not equally for each of 
them; Zaiem, & Zghidi, . (2011). show that the companies can improve their 
performance at the international markets level with the implementation of an adequate 




Table (4.22) Correlation coefficient between Market strategy and export 
performance 
Hypothesis Pearson Correlation Coefficient 
P-Value 
(Sig. ) 
Market strategy adaptation of Palestinian pharmaceutical 
firms positively influence export strategy . 475 0. 000* 
* Correlation is statistically significant at 0. 05 level 
 
4.4.7 Hypothesis 3: 
There is no statistical effect at significant level α=0.05 of export internal 
determinants on export performance on Palestinian pharmaceutical industry. 
We use Stepwise regression and obtain the following results: 
R Square = 0. 278, this means 27. 8% of the variation in the export 
performance is explained by "Market research and Modes of entry".  
Table (4.23) shows the Analysis of Variance for the regression model. Sig. 
=0.000, so there is a significant relationship between the dependent variable " export 
performance " and independent variables " Market research and Modes of entry"  
 
Table (4.23) ANOVA for Regression 
 Sum of Squares Df Mean Square F Sig. 
Regression 21. 627 2 10. 813 
Residual 56. 169 54 1. 040 








Table (4.24) shows the regression coefficients and their P-values (Sig. ). 
Based on the Standardized Coefficients, the significant independent variable is " 
Market research and Modes of entry ".  
The regression equation is:  
Export performance = 3. 135+ 0. 320* (Market Research) + 0. 229* (Modes of 
entry).  
 





B Std. Error Beta 
T Sig. 
(Constant) 3. 135 0. 879  3. 567 0. 001 
Market Research 0. 320 0. 126 0. 334 2. 537 0. 014 
Modes of entry 0. 229 0. 108 0. 278 2. 109 0. 040 
 
From the results shown in Table (4. 23) "The Regression Coefficients"  can 
be concluded that; the change in export performance is estimated respect to changes 
in "Market Research" and mode of entry"., the independent variables explained 
approximately 27% of the effect in the dependent variable, "Market Research" 
emerged as the most highly effect on export performance, followed by " Modes of 
entry " . that mean Each additional unit of mode of entry and market research  is 
predicted to cause unit constant increase in export performance. This indicates that 
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Palestinian pharmaceutical firms have to pay more attention to these determinants to 
improve its export performance.  
The results are consistent with Hoang, (1998) export performance is 
significantly influenced by a firm's choice of market expansion strategy; Zou, & 
Stan. (1998) marketing research Utilization positively associated with export 
performance. Wheeler, Ibeh, & Dimitratos, (2008) found that, the reviewed result of 
UK empirical studies, indicated there is strong support for effect marketing research 
Utilization on export performance, All but 1 of the 13 findings reported on this 
determinant suggested positive associations with dimensions of export performance. 
The findings in this study contradict with other research as following: Berbel-Pineda, 
& Ramírez-Hurtado, (2011). In the study presented here we have revealed that a 
positive and significant relationship does exist between the market entry mode choice 
and export performance.  
 
4.4.8 Summary 
This chapter presented data analysis and discussion of the research hypothesis. The 
study results were discussed and linked to the results of similar studies. The results 
show that respondents agree with the existence of the positive impact for internal 














































This study of Palestinian pharmaceutical manufacturing export firms suggests that 
there is a relationship between internal determinants (firm characteristics, 
international marketing strategies and export performance. The research results 
indicate that export performance is significantly influenced by a firm's internal 
determinant in different degree.  
 
5.2 Conclusion: 
In this review, attempts have been made to conclude the current research 
fields of the effect of internal determinant of Palestinian pharmaceutical firms on 
export performance,, and the findings are illustrated as follows: 
 
Management Characteristics: 
The research population show that majority of 69. 5% of the sample obtains a 
bachelor degree, while 25. 4% have master degree. 61% of respondents' graduated 
from Palestinian universities, 25. 4%, from universities in Arab countries. 96. 6%, of 
the respondents' studies in institution teaching in English language, 33. 9%, of 
respondents' hold pharmacy degree, 33. 9%, " Management, and 27.1 %, 
Engineering.  
Respondents' graduated from Palestinian universities exert strong positive 
orientation of the internal determinant effect on export performance, this is 
contracted with the common notion imply that manager who lived, travel or studies 




Results show that A firm’s size, and a firm age are not obstacle for a firm to 
inhibit its ability to undertake export venture, although the engage in international 
market require reasonable resource, experience and finical capability, the small and 
younger firm achieves excellent performance in export performance. 
Mode of entry  
According to the data, (72.81%), of Palestinian pharmaceutical firms (PPF) 
respondents agree that, there is a positive statistical significant effect of mode of 
entry on export performance. This finding shows the importance of selecting mode 
of entry to international market. The finding reveal that the respondents believe that 
Palestinian pharmaceutical firms must adopt gradual process in entering international 
market through export, contractual, and ultimately investment mode, this is justify in 
the light of avoiding risk and attain high control. It can be concluded that that (PPF), 
follow this original pattern of traditional Uppsala internationalization. 
 Market research 
The result show that, (71.60%), of Palestinian pharmaceutical firms (PPF) 
respondents agreed that, there is a positive statistical significant effect of “Market 
research” on export performance. This indicates that respondents are convinced 
"Market research" can assist the firm in "Obtaining knowledge about market", 
gaining "knowledge about market when starting to export" and " Firm Possession of 




(74.64%), of Palestinian pharmaceutical firms PPF respondents agree that, 
there is a positive statistical significant effect of “Strategic planning” on export 
performance. This indicates the strategic planning for increasing involvement in 
international market appear to be important for achieveing the best result in export 
performance, it is not surprising that the respondents realize the role of planning to 
response to future challenge n international market and to avoid uncertainty in 
turmoil situation which is characterize the world market. 
Market strategies adaptation 
The result shows that, (71.87%), of Palestinian pharmaceutical firms' PPF 
respondents agreed that, there is a positive statistical significant effect of “Market 
strategies adaptation” on export performance. This indicate that respondents are 
convinced " Market strategies adaptation " can increase the competitive of the firm, 
market strategies adaptation can affect export performance positively, adaptation of 
the product by increasing "Product quality", to write sufficient precautions of the 
product and offer " Range of variety of main exporting product line" will increase 
export, Promotion Adaptation can be achieved by Public relations, Promotion 
objectives and budget. Distribution Adaptation can improve the export performance 
by accomplishment of delivery deadlines, good distribution network, enhance 
Transportation strategy, while Price Adaptation consider the least variable affect 
export performance of marketing strategy, although respondents show the price 
should be fairly connected to the quality of the product.  
Export Performance 
The results show that, (70. 66%), of Palestinian pharmaceutical firms' PPF 
respondents are satisfied with the export performance for their firms. This indicates 
that respondents are convinced that "internal determinates" affect positively export 
performance in different degrees. The respondents show variant degree of acceptance 
for the export performance, they see that "export has improved our global 
competition"; "export has Strengthened our strategic position" and " export has 
achieved rapid growth ". they are satisfied to less extent that " export has generated a 
high volume of sale"; " Our export venture has been very satisfactory". Respondent 
have neutral concept about " export has very profitable" and " our export venture has 
been very successful". The respondents' expectation toward the export performance 
came in the end of the performance measure. This mean the respondents expected 
more positive results from export venture.  
 
5.3 Recommendations:  
This research was an investigative study that focused on the effect of internal 
determinants on export performance. The study finds that Palestinian pharmaceutical 
firms need to improve their export performance. In light of the aforementioned 
results, the researcher recommends the following, wishing from firms, 
pharmaceutical association and governments to take them into account:   
 
Recommendations for Palestinian pharmaceutical firms: 
The entry mode of the firm to international market is a gradual process, it will be 
improved by acquiring more experience and gaining more confidence, There is no 
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strategy firmly better than other; it depends on the balance between internal determinant 
of the firm, and external determinants of the environment "local and international".  
There is a need to emphasize on strategic planning for international market 
for the Palestinian pharmaceutical firms (PPF) to achieve higher export performance. 
The planning can help firm to avoid uncertainty and discover the weakness and 
strength in their performance.  
Firm has to proceed in utilization of international marketing research, that can 
assist the firm to discover new potential consumer, attract more purchase request, 
and helps to maintain existing buyers. marketing research helps to catch the 
promising opportunities in international market.  
The decision whether to standardize or adapt the marketing strategy to 
achieve superior export performance will mainly depend on the set of circumstances 
that a firm  faces within a particular host market. Moreover, firm should be given 
priority to promotion adaptation, distribution adaptation, then to product adaptation.  
The firm should be aware that management commitment and management 
perceptions and attitudes towards export problems and incentives are good predictors of 
export success. Therefore; the increase involvement of management in formulation 
export strategy decision making is crucial to improve export performance. 
Recommendations for Government policy decision makers:  
The internationalization of the Palestinian firms can achieve more effective 
goal by having assistance from government policy, by number of ways. Government 
can provide information, grants, subsidies, trade insurance, and export promotion.  
Recommendations for pharmaceutical association: 
The recommendations are generally directed to Palestinian pharmaceutical 
firms PPF, In order to improve their effort in international marketing strategies, the 
PPF needs to improve the export performance and internationalization strategy as. 
Palestinian pharmaceutical industry and other association trade have to work to work 
collaboratively with Palestinian pharmaceutical firms to improve firms performance 
in international market.  
Recommendation for further studies: 
The present research investigates the effect of internal determinants on export 
performance, The researcher would like to point out that more research is needed in 
the area of the export performance due to the shortage research that had been 
conducted in this topic in the Arab World in general, and in Palestine in particular. 
The following are suggestions for further studies:  
• Internationalization of Palestinian pharmaceutical firm.  
• Mode of entry for Palestinian pharmaceutical firm.  
• The influence of internal and external factors on entry mode for Palestinian 
pharmaceutical  
• Palestinian pharmaceutical strategy for export.  
• Marketing strategy influence on export performance for Palestinian 





- Aaby, N. E., & Slater, S. F. (1989). Management influences on export 
performance: A review of the empirical literature 1978-88. International 
Marketing Review, 6(1), 7-26.  
- Adam, J. K. (1997). Definition and evaluation of competence, capability and skill 
gaps in international business. Journal of Marketing Practice: Applied 
Marketing Science, 3(2), 119-151.  
- Adam, J. K. (2001). Selecting overseas markets and entry modes: two decision 
processes or one? Marketing Intelligence & Planning, 19(1), 65-75.  
- Ahmed, Z. U., Mohamad, O., Tan, B., & Johnson, J. P. (2002). International risk 
perceptions and mode of entry: a case study of Malaysian multinational 
firms. Journal of Business Research, 55(10), 805-813.  
- Albaum, G. S. (1989). International marketing and export management. 
Wokingham, England: Addison-Wesley.  
- AlShibly, H., & Alzyadad, M. (2009). international export strategic Marketing in 
jordinian firm. journal of human science, 7(43).  
- Amine Lyn S, & Cavusgil S Tamer. (1993). Export Marketing Strategies in the 
British Clothing Industry. European Journal of Marketing European 
Journal of Marketing, 20(7), 21-33.  
- Anderson, S., Gabrielsson, J., & Wictor, I. (2004). International Activities in 
Small Firms: Examining Factors Influencing the Internationalization and 
Export Growth of Small Firms. [Article]. Canadian Journal of 
Administrative Sciences (Canadian Journal of Administrative Sciences), 
21(1), 22-34.  
- Autio, E., Sapienza, H. J., & Almeida, J. G. (2000). Effects of age at entry, 
knowledge intensity, and imitability on international growth. Academy of 
Management Journal, 43(5), 909-924.  
- Baldauf, A., Cravens, D. W., & Wagner, U. (2000). Examining determinants of 
export performance in small open economies. Journal of World Business, 
35(1), 61-79. doi: 10. 1016/s1090-9516(99)00034-6 
- Barney, J. (1991). Firm Resources and Sustained Competitive Advantage. Journal 
of Management, 17(1), 99-120. doi: 10. 1177/014920639101700108 
- Berbel-Pineda, J. M., & Ramírez-Hurtado, J. M. (2011). Does The Foreign Market 
Entry Mode Choice Affect Export Performance? The Case Of The 
Spanish Hotel Industry. [Article]. Ar Įjimo Į Užsienio Rinką Strategijos 
Pasirinkimas Turi Įtakos Eksporto Skatinimui? Ispanijos Viešbučių 
Sektoriaus Pavyzdys., 12(2), 301-316.  
- Bijmolt, T. H. A., & Zwart, P. S. (1994). THE IMPACT OF INTERNAL 
FACTORS ON THE EXPORT SUCCESS OF DUTCH SMALL AND 
MEDIUM-SIZED FIRMS. [Article]. Journal of Small Business 
Management, 32(2), 69-83.  
- Bilkey, W. J. (January 01, 1985). Development Of Export Marketing 
GuideLINES. International Marketing Review, 2, 1, 31-40.  
- Bilkey, W. J., & Tesar, G. (1977). The Export Behavior of Smaller-Sized 
Wisconsin Manufacturing Firms. Journal of International Business 
Studies, 8(1), 93-98.  
- Bonaccorsi, A. (1992). On the relationship between firm size and export intensity. 
Journal of International Business Studies, 23(4), 605.  
 
 100 
- Bonaccorsi, A. (1993). What Do We Know about Exporting by Small Italian  
- Bradley, F. (1995). International marketing strategy. London: Prentice Hall.  
- Bradley, F. (2005). International marketing strategy. London: Prentice Hall.  
- Bradley, F., & Gannon, M. (2000). Does the Firm's Technology and Marketing 
Profile Affect Foreign Market Entry? Journal of International Marketing, 
8(4), 12-36.  
- Brassington, F., & Pettitt, S. (2000). Principles of marketing. 2nd ed Harlow, 
England: FT/Prentice Hall.  
- Brekke, K. R., & Kuhn, M. (2006). Direct to consumer advertising in 
pharmaceutical markets. Journal of Health Economics, 25(1), 102-130 
- Brouthers, L. E., & Nakos, G. (2005). The role of systematic international market 
selection on small firms' export performance. Journal of Small Business 
Management, 43(4), 363-381. doi: 10. 1111/j. 1540-627X. 2005. 00142. x 
- Carl Arthur Solberg, & Ulf H. Olsson. (2010). Management orientation and export 
performance: the case of Norwegian ICT companies. Baltic Journal of 
Management, 5(1), 28 - 50.  
- Cavusgil, S. T. (1984). Organizational Characteristics Associated With Export 
Activity. Journal of Management Studies, 21(1), 3-22. doi: 10. 1111/j. 
1467-6486. 1984. tb00222. x 
- Cavusgil, S. T. (1985). Guidelines for export market research. Business Horizons, 
28(6), 27-33.  
- Cavusgil, S. T. (2012). International business: the new realities (2nd ed. ed. ). 
Boston: Prentice Hall.  
- Cavusgil, S. T., Bilkey, W. J., & Tesar, G. (1979). A Note on the Export Behavior 
of Firms: Exporter Profiles. Journal of International Business Studies, 
10(1), 91-97.  
- Cavusgil, S. T., & Naor, J. (1987). Firm and management characteristics as 
discriminators of export marketing activity. Journal of Business 
Research, 15(3), 221-235. doi: 10. 1016/0148-2963(87)90025-7 
- Cavusgil, S. T., & Nevin, J. R. (1981). Internal Determinants of Export Marketing 
Behavior: An Empirical Investigation. Journal of Marketing Research, 
18(1), 114-119.  
- Cavusgil, S. T., & Zou, S. (1994). Marketing Strategy-Performance Relationship: 
An Investigation of the Empirical Link in Export Market Ventures. 
[Article]. Journal of Marketing, 58(1), 1-21.  
- Cavusgil, S. T., Zou, S., & Naidu, G. M. (1993). Product and Promotion 
Adaptation in Export Ventures: An Empirical Investigation. Journal of 
International Business Studies, 24(3), 479-506.  
- Saunders, M. Lewis, P. and Thornhill, A. (2003) Research Methods for Business 
Students. 8th Ed. Prentice Hall.  
- Chetty, S., & Campbell-Hunt, C. (2004). A Strategic Approach to Internationalization: 
A Traditional Versus a "Born-Global" Approach. [Article]. Journal of 
International Marketing, 12(1), 57-81.  
- Chih-Wen, W. (2011). Global marketing strategy modeling of high tech products. 
Journal of Business Research, 64(11), 1229-1233. doi: 10. 1016/j. jbusres. 
2011. 06. 028 
- Christensen, C. H., da Rocha, A., & Gertner, R. K. (1987). An Empirical Investigation 
of the Factors Influencing Exporting Success of Brazilian Firms. J Int Bus 
Stud, 18(3), 61-77.  
 
 101 
- Christensen, C. H., da Rocha, A., & Gertner, R. K. (1987). An Empirical Investigation 
of the Factors Influencing Exporting Success of Brazilian Firms. J Int Bus 
Stud, 18(3), 61-77.  
- Cooper, R. G., & Kleinschmidt, E. J. (1985). The Impact of Export Strategy on Export 
Sales Performance. Journal of International Business Studies, 16(1), 37-55.  
- Cunningham, M. T., & Spiegel, R. I. (1971). A study in successful exporting. 
European Journal of Marketing European Journal of Marketing, 5(1), 2-
12.  
- Czinkota, M. R., & Johnston, W. J. (1983). Exporting: Does Sales Volume Make a 
Difference? Journal of International Business Studies, 14(1), 147-153.  
- Czinkota, M. R., & Ronkainen, I. A. (1994). International marketing strategy: 
environmental assessment and entry strategies. Fort Worth: Dryden 
Press.  
- Czinkota, M. R., & Ronkainen, I. A. (2007). International marketing. Mason, OH: 
Thomson/Southwestern.  
- Da Rocha, A., Christensen, C. H., & da Cunha, C. E. (1990). Aggressive and 
Passive Exporters: A Study in the Brazilian Furniture Industry. 
International Marketing Review, 7(5).  
- Dalli, D. (1995). The Organization of Exporting Activities: Relationships Between 
Internal and External Arrangements. Journal of business research., 34(2), 
107.  
- Daniels, J. D., Radebaugh, L. H., & Sullivan, D. P. (2006). International business: 
environments and operations. Upper Saddle River, N. J. : Pearson/Prentice 
Hall.  
- Das, M. (1994). Successful and Unsuccessful Exporters from Developing 
Countries: Some Preliminary Findings. European Journal of Marketing, 
28(12), 19.  
- Davidson Lawrence S, & Gennadiy Greblov. (2005). Pharmaceutical Industry in 
the Global Economy, . Indiana Economic Development Corporation.  
- Day, G. S. (1994). The capabilities of market-driven organizations. journal of 
Marketing, 58(4), 37-52.  
- Dean, D. L., Menguc, B., & Myers, C. P. (2000). Revisiting firm characteristics, 
strategy, and export performance relationship: A survey of the literature 
and on investigation of New Zealand small manufacturing firms. 
Industrial Marketing Management, 29(5), 461-477.  
- Dichtl, E., Koeglmayr, H. -G., & Mueller, S. (1990). International Orientation as a 
Precondition for Export Success. Journal of International Business 
Studies, 21(1), 23-40.  
- Dichtl, E., Leibold, M., Köglmayr, H. G., & Müller, S. (1984). The Export-
Decision of Small and Medium-Sized Firms: A Review. Management 
International Review, 24(2), 49-60. 
- Denis, J.-E., & Depelteau, D. (1985). Market Knowledge, Diversification and Export 
Expansion. Journal of International Business Studies, 16(3), 77-89. 
- Doherty, G., & Ennew, C. T. (1995). The marketing of pharmaceuticals: 
standardization or customization? Journal of Marketing Practice: Applied 
Marketing Science, 1(3), 39-50. doi: 10. 1108/eum0000000003888 
- Douglas, S. P., & Craig, C. S. (1989). Evolution of Global Marketing Strategy: Scale, 




- Dowling, P. J., Liesch, P. W., Flint, J. A., As-Saber, S. N., Chan, K., & Innes, P. 
A. (2000). Strategies in exporting firms: A study of Australian small to 
medium enterprises exporting to Asia. J Man Org Journal of 
Management & Organization, 6(2), 1-19.  
- Eickelpasch, A., & Vogel, A. (2009). Determinants of export behaviour of 
German business services companies. Lüneburg: Inst. für 
Volkswirtschaftslehre.  
- Elena, B. -S., & Keith, W. G. (2011). The role of firm-specific advantages in UK 
export initiation. The Multinational Business Review, 19(2), 168-194.  
- Ellis, P. D. (2007). Distance, Dependence and Diversity of Markets: Effects on 
Market Orientation. Journal of International Business Studies, 38(3), 374-
386.  
- Farhang, H. M. (1990). Foreign Market Entry Strategy: Behaviour of Swedish 
Companies in the Middle East. Luleå.  
- Floyd, D. (2002), ‘‘Investment decisions in Eastern Europe’’, European Business 
Review, Vol. 14 No. 3,  
- Gassmann, O., Reepmeyer, G., & Zedtwitz, M. v. (2008). Leading pharmaceutical 
innovation trends and drivers for growth in the pharmaceutical industry, from 
http: //public. eblib. com/EBLPublic/PublicView. do?ptiID=337070 
- Gennaro Alfonso, R. (1995). Remington: the Science and Practice of Pharmacy (19 
ed.): Mack.  
- Gertner, R., Gertner, D., & Guthery, D. (2007). The Implications of Export 
Performance Measurement for the Significance of the Determinants of 
Export Performance. Journal of Global Marketing, 20(1), 21-38.  
- Gomez-Mejia, L. R. (1988). The Role of Human Resources Strategy in Export 
Performance: A Longitudinal Study. Strategic Management Journal, 9(5), 
493-505.  
- Grönroos, C. (1999) ‘Relationship Marketing: Challenges for the Organization’, 
Journal of Business Research 46(3): 327–35.  
- Hambrick, D. C., & Mason, P. A. (1984). Upper Echelons: The Organization as a 
Reflection of Its Top Managers. The Academy of Management Review, 9(2), 
193-206.  
- Hill, C. W. L., Hwang, P., & Kim, W. C. (1990). An eclectic theory of the choice of 
international entry mode. Strategic Management Journal, 11(2), 117-128. 
doi: 10. 1002/smj. 4250110204 
- Hoang, B. (1998). A causal study of relationships between firm characteristics, 
international marketing strategies and export performance. Management 
International Review, 38 (special issue), 73–93.  
- Hoang, S. N. (1999). Multinational pharmaceutical investment in Asia: implications 
for Vietnam. (THESIS Presented to the Interdisciplinary Studies Program), 
University of Oregon 
- Hollensen, S., (2008). Essentials of global marketing. Harlow, Essex, England: 
Pearson Education.  
- Hollensen, S. (2011). Global marketing: a decision-oriented approach. Harlow, 
England; New York: Financial Times Prentice Hall.  
- Holzmüller, H. H., & Kasper, H. (1991). On a Theory of Export Performance: 
Personal and Organizational Determinants of Export Trade Activities 
Observed in Small and Medium-Sized Firms. MIR: Management 
International Review, 31(ArticleType: research-article / Issue Title: Frontiers 
of International Business Research / Full publication date: 1991 / Copyright 
© 1991 Springer), 45-70.  
 
 103 
- Howlett, E., Michels, D., Jonnard, A., Bretscher, C., Summers, J., Wanser, S., & 
Flynn, J. (1999). Review of global competitiveness in the pharmaceutical 
industry. Washington, DC: U. S. International Trade Commission.  
- Ittner, C. D., Larcker, D. F., & Randall, T. (2003). Performance implications of 
strategic performance measurement in financial services firms. 
Accounting, Organizations and Society, 28(7–8), 715-741. doi: 10. 
1016/s0361-3682 (03) 00033-3. 
- Javalgi, R. G., & Wright, R. F. (2003). An International Market Entry Model for 
Pharmaceutical Companies: A Conceptual Framework for Strategic 
Decisions. Journal of Medical Marketing: Device, Diagnostic and 
Pharmaceutical Marketing, 3(4), 274-286. doi: 10. 1057/palgrave. jmm. 
5040131 
- Johanson, J., & Vahlne, J. -E. (1977). The Internationalization Process of the 
FirmA Model of Knowledge Development and Increasing Foreign Market 
Commitments.  
- Johanson, J., & Vahlne, J. E. (2006). Commitment and Opportunity Development 
in the Internationalization Process: A Note on the Uppsala 
Internationalization Process Model. Management International Review, 
46(2), 165-178.  
- Johanson, J., & Wiedersheim-Paul, F. (1975). THE INTERNATIONALIZATION 
OF THE FIRM -- FOUR SWEDISH CASES. [Article]. Journal of 
Management Studies, 12(3), 305-322.  
- Johansson, J. (2009). Global Marketing: Foreign Entry, Local Marketing, and 
Global Management: McGraw-Hill/Irwin  
- Johansson, J. K., Douglas, S. P., & Nonaka, I. (1985). Assessing the Impact of 
Country of Origin on Product Evaluations: A New Methodological 
Perspective. Journal of Marketing Research, 22(4), 388-396.  
- Johnston, W. K. & M. R. Czinkota (1982) “Managerial Motivations as 
determinants of industrial Export Behavior” in export Management: an 
Intenational context, Czinkota, M. R. & G. Tesar, eds, New York: praeger 
publishers  
- Kacker, M. P. (1975). Export-Oriented Product Adaptation: Its Patterns and 
Problems. Management International Review, 15(6), 61-70.  
- Katsikeas, C. S., Deng, S. L., & Wortzel, L. H. (1997). Perceived Export Success 
Factors of Small and Medium-Sized Canadian Firms. Journal of 
International Marketing, 5(4), 53-72.  
- Kau Ah Keng, T. S. J. (1993). Differences between Small and Medium Sized 
Exporting and Non-Exporting Firms: Nature or Nurture. International 
Marketing Review, 6(4). doi: 10. 1108/EUM0000000001517 
- Kaynak, E., & Kuan, W. K. -y. (1993). Environment, strategy, structure, and 
performance in the context of export activity: An empirical study of 
Taiwanese manufacturing firms. Journal of Business Research, 27(1), 33-
49. doi: 10. 1016/0148-2963(93)90014-g 
- Keegan, W. J., & Green, M. C. (2005). Global marketing. Upper Saddle River, N. 
J. : Pearson/Prentice Hall.  
- Koch, . A. J. (January 01, 2001). Factors influencing market and entry mode 
selection: developing the MEMS model. Marketing Intelligence & 




- Kohli, A. K., & Jaworski, B. J. (1990). Market Orientation: The Construct, Research 
Propositions, and Managerial Implications. Journal of Marketing, 54(2), 1-
18.  
- Köksal, M. H. (2008). How export marketing research affects company export 
performance: Evidence from Turkish companies. Marketing Intelligence & 
Planning, 26(4), 416-430. doi: 10. 1108/02634500810879313 
- Kotler, P., & Armstrong, G. (2012). Principles of marketing. Boston: Pearson Prentice 
Hall.  
- Kotler, P., & Keller, K. L. (2006). Marketing management. Upper Saddle River, N. J. 
: Pearson Prentice Hall.  
- KOTLER, P., & KELLER, K. L. (2009). Marketing management. Upper Saddle 
River, N. J., Pearson Prentice Hall.  
- Lamont, D. F. (2002). Global marketing. Oxford, England: Capstone Pub.  
- Leonidou, L. C. (1988). Export initiation by indigenous manufacturers in a small 
developing economy The case of Cyprus. Spoudai, 38(1-2), 63-78.  
- Leonidou, L. C. (1998). Factors Stimulating Export Business: An Empirical 
Investigation. Journal of applied business research., 14(2), 43.  
- Leonidou, L. C., Katsikeas, C. S., & Hadjimarcou, J. (2002). Executive Insights: 
Building Successful Export Business Relationships: A Behavioral 
Perspective. [Article]. Journal of International Marketing, 10(3), 96-115.  
- Leonidou, L. C., Katsikeas, C. S., Palihawadana, D., & Spyropoulou, S. (2007). 
An analytical review of the factors stimulating smaller firms to export: 
Implications for policy-makers. International Marketing Review, 24(6), 
735-770.  
- Leonidou, L. C., Katsikeas, C. S., & Piercy, N. F. (1998). Identifying Managerial 
Influences on Exporting: Past Research and Future Directions. Journal of 
International Marketing, 6(2), 74-102.  
- Leonidou, L. C., Palihawadana, D., & Theodosiou, M. (2011). National Export-
Promotion Programs as Drivers of Organizational Resources and 
Capabilities: Effects on Strategy, Competitive Advantage, and 
Performance. [Article]. Journal of International Marketing, 19(2), 1-29.  
- Lloyd C. Harris, N. F. P. (1999). Management behavior and barriers to market 
orientation in retailing companies, Vol. 13 Iss: 2, pp. Journal of Services 
Marketing, 13(2), 113 - 131. doi: 10. 1108/08876049910266031 
- Lukas, B. A., Whitwell, G. J., & Hill, P. (2007). Export planning orientation and 
its antecedents: Evidence from exporting IT products. Journal of Business 
Research, 60(12), 1282-1289. doi: 10. 1016/j. jbusres. 2007. 05. 002 
- Madsen, T. K. (1989). Successful Export Marketing Management: Some 
Empirical Evidence. International Marketing Review, 6(4).  
- Magazzini, L., Pammolli, F., & Riccaboni, M. (2004). Dynamic competition in 
pharmaceuticals. The European Journal of Health Economics, formerly: 
HEPAC, 5(2), 175-182. doi: 10. 1007/s10198-003-0218-x 
- March, J. G., & Shapira, Z. (1987). Managerial Perspectives on Risk and Risk 
Taking. Management Science, 33(11), 1404-1418.  
- Maurel, C. (2009). Determinants of export performance in French wine SMEs. 
International Journal of Wine Business Research, 21(2), 118-142.  
- Mayer, C. S., & Flynn, J. E. (1973). CANADIAN SMALL BUSINESS 
ABROAD: OPPORTUNITIES, AIDS AND EXPERIENCES. Business 
Quarterly (pre-1986), 38(4), 33-33.  
 
 105 
- McGuinness, N. W., & Little, B. (1981). The Influence of Product Characteristics 
on the Export Performance of New Industrial Products. The Journal of 
Marketing, 45(2), 110-122.  
- McAuley, A. (2001). International marketing : consuming globally, thinking 
locally. Chichester; New York: Wiley 
- Mehmet Haluk, K. (2008). How export marketing research affects company export 
performance. Marketing Intelligence & Planning, 26(4), 416-430. doi: 
http: //dx. doi. org/10. 1108/02634500810879313 
- Miesenbock, K. J. (1988). Small Businesses and Exporting: A Literature Review. 
International Small Business Journal, 6(2), 42-61. doi: 10. 
1177/026624268800600204 
- Dimasi, J. A., Hansen, R. W., & Grabowski, H. G. (January 01, 2003). The price 
of innovation: New estimates of drug development costs. Journal of 
Health Economics (amsterdan), 22, 2, 151-185.  
- Narver, J. C., & Slater, S. F. (1990). The Effect of a Market Orientation on 
Business Profitability. The Journal of Marketing, 54(4), 20-35.  
- Naveed Malik, & Masood chaudhary. (2010). Factors Effecting Small and 
Medium Enterprises, Selection of Market Entry Mode. (master master), 
Blekinge Institute of Technology, MAM/Sektionen för Management 
Retrieved from http: 
//www.bth.se/fou/cuppsats.nsf/6753b78eb2944e0ac1256608004f0535/ac2
c533b061 c04 dac 12577a9005b4330?OpenDocument  
- Ogunmokun, G., & Ng, S. (2004). Factors Influencing Export Performance in 
International Marketing: A Study of Australian Firms. [Article]. 
International Journal of Management, 21(2), 172-185.  
- Onkvisit, S. (1993). International marketing: analysis and strategy (2nd ed. ed. ). 
New York: Macmillan Pub. Co.  
- Oviatt, B. M., & McDougall, P. P. (2005). Toward a Theory of International New 
Ventures. Journal of International Business Studies, 36(1), 29-41.  
- Poilt, D., and Hungler, B., (1985.) Essentials of nursing research; Methods and 
applications, J. B. Lippincott company.  
- Porter, M. E. (1980). Competitive strategy: techniques for analyzing industries 
and competitors. New York: Free Press.  
- Porter, M. E. (1990). The competitive advantage of nations. New York: Free Press.  
- Radebaugh, L. H. (2006). International accounting and multinational enterprises 
(6th ed. ed. ). Hoboken, N. J: John Wiley & Sons.  
- Reid, S. D. (1981). The Decision-Maker and Export Entry and Expansion. Journal 
of International Business Studies, 12(2), 101-112.  
- Reid, S. D. (1985). Exporting: Does Sales Volume Make a Difference? - 
Comment. Journal of International Business Studies, 16(2), 153-155.  
- Roberts, J. (1999). The internationalisation of business service firms: a stages 
approach. Service industries journal., 19(4).  
- Root, F. R. (1994). Entry strategies for international markets (Rev. and expanded. 
ed.). New York: : Lexington Books ;. 
- Roy, S. (2004). The Palestinian-Israeli Conflict and Palestinian Socioeconomic 
Decline: A Place Denied. International Journal of Politics, Culture, and 




- Said Abu Hijleh. (2006). The Palestinian Pharmaceuticals Cluster: 
Competitiveness Assessment Report, . [eight industrial and services 
clusters in Palestine]. Development Alternatives, Inc DAI United States 
Agency for InternationalDevelopment.  
- Samiee, S. (1990). Influence of firm size on export planning and performance. 
Journal of Business Research, 20(3), 235-248.  
- Schlegelmilch, B. B. (1986). Can Export Performance be Explained by Attitudinal 
Differences? Managerial and Decision Economics, 7(4), 249-254.  
- Schlegelmilch, B. B., & Crook, J. N. (1988). Firm-Level Determinants of Export 
Intensity. Managerial and Decision Economics, 9(4), 291-300.  
- Shaoming Zou, & Simona Stan. (1998). The determinants of export performance: 
a review of the empirical literature between 1987 and 1997. International 
Marketing Review, 15(5), 333.  
- Sharma, D. D., & Blomstermo, A. (2003). A Critical Review of Time in the 
Internationalization Process of Firms. [Article]. Journal of Global 
Marketing, 16(4), 53-71. 
- Shoham, A. (1998). Export Performance: A Conceptualization and Empirical 
Assessment. Journal of International Marketing, 6(3), 59-81.  
- Shoham, A. (1999). Bounded Rationality, Planning, Standardization of 
International Strategy, and Export Performance: A Structural Model 
Examination. [Article]. Journal of International Marketing, 7(2), 24-50.  
- Shoham, A. (1999). Executive Summaries. Bounded Rationality, Planning, 
Standardization Of International Strategy, And Export Performance: A 
Structural Model Examination. [Article]. Journal of International 
Marketing, 7(2), 4-4.  
- Shoham, A. (2003). Standardization of International Strategy and Export 
Performance. Journal of Global Marketing, 16(1-2), 97-120. doi: 10. 
1300/J042v16n01_05 
- Simpson, C., & Kujawa, D. (1974). The Export Decision Process: An Empirical 
Inquiry. Journal of International Business Studies, Spring, 107-117  
- Singer, T. O., & Czinkota, M. R. (1994). Factors Associated with Effective Use of 
Export Assistance. Journal of International Marketing, 2(1), 53-71 
- Sonia M. Suárez-Ortega, & Francisca R. Álamo-Vera. (2005). SMES' 
internationalization: firms and managerial factors. International Journal 
of Entrepreneurial Behaviour and Research, 11(4), 258-279.  
- Sood, J. H., & Adams, P. (1984). Model Of Management Learning Styles As A 
Predictor Of Export Behavior And Performance. The International 
Executive (pre-1986), 26(3), 14-14.  
- Souchon, A. L., Diamantopoulos, A., Holzmüller, H. H., Axinn, C. N., Sinkula, J. 
M., Simmet, H., & Durden, G. R. (2003). Export Information Use: A 
Five-Country Investigation of Key Determinants. Journal of International 
Marketing, 11(3), 106-127.  
- Souchon, A. L., & Diamantopoulos, A. (1996). A Conceptual Framework of 
Export Marketing Information Use: Key Issues and Research 
Propositions. Journal of International Marketing, 4(3), 49-71.  
- Sousa, C. M. P., Martínez-López, F. J., & Coelho, F. (2008). The determinants of 
export performance: A review of the research in the literature between 
1998 and 2005. International Journal of Management Reviews, 10(4), 
343-374. doi: 10. 1111/j. 1468-2370. 2008. 00232. x 
 
 107 
- Tamer Cavusgil, S., & Kirpalani, V. H. (1993). Introducing products into export 
markets: Success factors. Journal of Business Research, 27(1), 1-15. doi: 
10. 1016/0148-2963(93)90012-e 
- Tempest, B. (2010). A structural change in the global pharmaceutical marketplace. 
[Article]. Journal of Generic Medicines, 7(2), 113-117. doi: 10. 
1057/jgm. 2010. 11 
- Terpstra, V. (1983). Critical mass and international marketing strategy. Academy 
of Marketing Science. Journal (pre-1986), 11(3), 269-269.  
- Tookey, D. A. (1964). Factors Associated With Success In Exporting. [Article]. 
Journal of Management Studies, 1(1), 48-66.  
- Ursic, M. L., & Czinkota, M. R. (1984). An experience curve explanation of 
export expansion. Journal of Business Research, 12(2), 159-168. doi: 10. 
1016/0148-2963(84)90003-1 
- Walters, P. G. P. (1993). Patterns of Formal Planning and Performance in U. S. 
Exporting Firms. MIR: Management International Review, 33(1), 43-63.  
- Welch, L. S., & Wiedersheim-Paul, F. (1980). Initial Exports -- A Marketing 
Failure? [Article]. Journal of Management Studies, 17(3), 333-344.  
- Wheeler, C., Ibeh, K., & Dimitratos, P. (2008). UK Export Performance Research. 
International Small Business Journal, 26(2), 207-239. doi: 10. 
1177/0266242607086574 
- Wiedersheim-Paul, F., Olson, H. C., & Welch, L. S. (0000). Pre-Export Activity: 
The First step in Internationalization. J Int Bus Stud, 9(1), 47-58.  
- Williams, D. (2011). Impact of firm size and age on the export behaviour of small 
locally owned firms: Fresh insights. Journal of International 
Entrepreneurship, 9(2), 152-174. doi: 10. 1007/s10843-011-0073-2 
- Yung-Chul, K., & Leonard, J. K. (1993). Impact of Host Country Market 
Characteristics on the Choice of Foreign Market Entry Mode. 
International Marketing Review, 10 (2).  
- Zaiem, I., & Zghidi, A. B. Y. (2011). Product Adaptation Strategy and Export 
Performance: The Impacts of the Internal Firm Characteristics and 
Business Segment. [Article]. Contemporary Management Research, 7(4), 
291-312.  
- Zou, S., Fang, E., & Zhao, S. . (2003). The Effect of Export Marketing 
Capabilities on Export Performance: An Investigation of Chinese 
Exporters. Journal of International Marketing, 11(4), 32-55.  
- Zou, S., & Stan, S. (1998). The determinants of export performance: a review of 
the empirical literature between 1987 and 1997. [Literature review]. 
International Marketing Review, 15 (5). doi: 10. 
1108/02651339810236290 
- Zou, S., Taylor, C. R., & Osland, G. E. (1998). The EXPERF Scale: A Cross-
National Generalized Export Performance Measure. Journal of 
International Marketing, 6(3), 37-58.  
 
Thesis and dissertation:  
- Adili, Ala’ (2009) " Determinants and requirements of entering the Palestinian 
pharmaceutical industry into the international markets", unpublished MBA thesis, 
Alquds university, Palestine.  
 
 108 
- Barcelona, available at http: //ddd. uab. cat/pub/tesis/2010/tdx-0125111-
122935/mcs1de1. pdf  
- Bruhno, M. & SCHILT, M. (2001) Internationaliseringsprocessen i små och 
medelstora företag en beskrivande och jämförande studie Författare. EN 
beskrivande jamforande studie. (D-uppsats I Ekonomi). Linkopings universtet. 
Ekonomiska, institutionen, 581 83, Linkoping.  
- doctoral thesis, Faculty of Economic and Business Studies, Autonomous 
University of  
- Dwikat Said (2012)The relationship between strategic planning and excellence in 
performance of the Palestinian pharmaceutical sector", unpublished MBA thesis, 
Alquds university, Palestine.  
- Farra (2007) "Measuring the customer satisfaction on sales person performance at 
Palestinian pharmaceutical companies in the Gaza Strip Market" MBA 
unpublished thesis, Islamic University in Gaza.  
- Hazboun Roub K. (August 2006) "Strategic Application of CRM: The case of the 
Palestinian Pharmaceutical Industry" M. B. A. Dissertation Maastricht 
University, Netherland.  
- marketing strategy and export performance in Spanish small and medium-sized 
enterprises”,  
- Masroujeh Wassim (2009) "Critical Factors for Customer Satisfaction and 
Delight in the Palestinian Pharmaceutical Market", MBA unpublished thesis, 
Islamic University in Gaza.  
- Puljeva, Anna; Widén, Peter (2007) "The influence of internal and external 
factors on entry modes". Business Administration and Social Sciences / Industrial 
marketing and e-commerce, unpublished thesis, Lulea University. sweden 
- Stoian, M. (2010) “Internationalisation and international marketing Export 
behavior, international  
- Temraz Wesam (2012) impact of the prices of Palestinian pharmaceutical 
companies on the degree of customer sensitivity and the pricing polices". MBA 
unpublished thesis, Islamic University in Gaza.  
- Zaanen asem (2010) "The Effect of competitive advantage of national 
pharmaceutical companies on increasing market share in gaza strip". MBA 
unpublished thesis, Islamic University in Gaza.  
 
Publications and official website:  
- Abu Alia, Awad (2007)"The Palestinian Pharmaceutical Industry". This week in 
Palestine, Issue No. 110, June 2007, Palestine.  
www. thisweekinpalestine. com/i110/. . . /June%20-%20110%20-%202007. pdf.  
- Abu Hijleh, Said (2006) Pharmaceutical Cluster Assessment in the West Bank 
and Gaza. USAID Cluster competitiveness Assessment report, page. 107-129 
www. lacs. ps/documentsShow. aspx?ATT_ID=2146 
- Beit Jala Pharmaceutical Manufacturing Company: www.beitjalapharma.com  
- BPC (2012) Birzeit Pharmaceutical Company annual report official web site. 
Palestine. http: //www. bpc. ps.  
- Fortune magazine. (April. 2003): "FORTUNE 5 Hundred How The Industries 
Stack Up The Industries, By Performance", Fortune magazine. http: //money. 
cnn. com/magazines/fortune/fortune_archive/2003/04/14/340911/index. htm 
IMS (2012) IMS World Review 2012 Analysis.  
 
 109 
http: //www. ims consultinggroup. Com. 
- Dimensions Consulting Co. (2008), Dimensions health care consulting Co. 
Palestine Pharmacy Handbook ,Palestinian Pharmacist Association.in Dwikat 
Said (2012)The relationship between strategic planning and excellence in 
performance of the Palestinian pharmaceutical sector", unpublished MBA thesis, 
Alquds university, Palestine; Adili, Ala’ (2009) " Determinants and requirements 
of entering the Palestinian pharmaceutical industry into the international 
markets", unpublished MBA thesis, Alquds university, Palestine. 
- -Jerusalem Pharmaceutical Company Ltd. (Al-Quds) JPH: www.jepharm.ps 
Accesses 2012 
- Khoury, Bassem (2004) "Against All Odds: The Palestinian Pharmaceutical 
Industry". This week in Palestine, Issue No. 74, June 2007, Palestine.  
www. thisweekinpalestine. com/details. php?id=984&ed=91&edid=91 
Palestinian  
- Makhool Basim (1999) Palestinian pharmaceutical industry in Palestine reality, and 
future prospect. Palestinian Economic and Social Research Forum. Ramallah, Palestine.  
- MarketLine Industry Profile: Global Chemicals. (2012). MarketLine Industry 
Profile: Global Chemicals. [Article]. Chemicals Industry Profile: Global, 1-35.  
- Massar (1998) The Pharmaceutical Industry in Palestine Market Survey, Massar 
Associates (Ramalah, DAI & UPPM (The Union of Palestinian Pharmaceutical 
manufacturers), Palestine.  
- Massar (2002) Sector Report: Pharmaceutical Industry in West Bank/Gaza, 
Expanding Economic Opportunities, report prepared to USaid Mission To The 
West Bank And Gaza (Wb/G)So1 Margot Ellis, Cto, 2300 Clarendon Boulevard 
1110, Arlington, Virginia.  
- Massar (2005) The Palestinian Pharmaceutical Industry sector", Massar 
Associates, UPPM (The Union of Palestinian Pharmaceutical manufacturers) and 
Industry modernization center,, Ramalah, Palestine.  
- MOH (2011) General Directorate of Pharmacy Drug Control, Laws & 
Regulations Ministry of Health, Palestine.  
http: //pharmacy. moh. ps/index. php?page=1259072030 
- MOH (2012) Palestinian Center Of Health Information, Health Report Mid 2012. 
Ministry Of Health (MoH), Palestine.  
- Obeidallah, Waleed Barzeq, Hani; Mahariq, Mohammed. (2000) Drug situation 
analysis for the West Bank and Gaza Strip. WHO/EDM/DAP/2000. 1 world 
health organization.  
http: //whqlibdoc. who. int/hq/2000/WHO_EDM_DAP_2000. 1. pdf 
- OECD. (2008) Pharmaceutical pricing policy in a global market. Paris, OECD 
Publishing.  
- PCBS (2011) Medicinal and pharmaceutical products Source: Palestinian Central 
Bureau of Statistics 2013. Foreign Trade Statistics. Ramallah  ـ Palestine http: 
//www. pcbs. gov. ps/Portals/_Rainbow/Documents/exp%20division%20_E. htm 
- PCBS (2013) Palestinian Central Bureau of Statistics 2013.Foreign Trade 
Statistics. Ramallah 
- PFI. (2009)“The Current Status Sectors in Palestine” Outlook Based on 
Indicators", This report is made generous support people through the Agency for 
International Development (USAID). are the responsibility of Corporation and 




udy. pdf accessed 28. 7. 2011.  
-  Palestine Exchange, 2012. Companies Guide-2011. Nablus – Palestine. 
http://www.pex.ps. 
- WHO (2004)The World Medicines Situation. WHO/EDM/PAR/2004. 5  
http: //apps. who. int/medicinedocs/pdf/s6160e/s6160e. pdf 
- WHO (2011) The World Medicines Situation Report, 3rd edition, World Health 
Report, Geneva, WHO.  
- WTO. (2004) "World Development Indicators" WHO estimates from database of 
UNIDO, OECD Health Data, World Development Indicators, report of 1987, 
1992, 2001, International Financial Statistics Yearbook,  
- WTO. (2006) "Pharmaceutical patents and the TRIPS Agreement (2006) TRIPS: 
DRUG PATENTS, TECHNICAL NOTE. world trade organization.  
- WTO. (2008) "World Trade Report 2008, Trade in a Globalizing World".  
http: //www. wto. org/english/res_e/publications_e/wtr08_e. htm 
- WTO. (2011) World Trade Report 2012, Research And Analysis.  
http: //www. wto. org/english/res_e/publications_e/wtr12_e. htm 
- WHO, WTO, AND WIPO (2012), Promoting Access to Medical Technologies 
and Innovation, Intersections between public health, intellectual property and 
trade Geneva, WHO. World Health Organization, World Intellectual Property 
Organization and World Trade Organization.  























Appendix (A): Questionnaire in Arabic 
  
      
    غزة–الجامعة اإلسالمية 





  صحيفة استبيان 
  
"تأثير المحددات الداخلية لشركات الصيدلة الفلسطينية على أداء التصدير"  
  
  السادة الكرام،،،،
  
 وتأثيرهاصيدلة الفلسطينية المحددات الداخلية لشركات ال  " دراستي مساعدتكم في استكمال أود
  "  التصديرياألداءعلى 
 فـي اإلسالمية في الجامعة األعمال إدارة في الماجستيرهذه الدراسة الستيفاء متطلبات شهادة 
  رشدي وادي/  الدكتور إشرافغزة تحت 
حضرتك مدعو للمشاركة في هذا البحث، في حال موافقتك، سوف تسأل الستكمال االسـتبيان 
و تعامـل بـسرية، االسـتبيان " لمجهـول " تزودنا بها سوف تبنـى التيمعلومات المرفق، ال 
  .  و مشاركتك تحظى بتقدير عالي دقائق الستكماله،10 حوالي سيستغرق
  
  وتقبلوا فائق االحترام والتقدير
  
  الباحث
  وسام خالد االغا
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Appendix (B): Questionnaire in English  
 
 
The Islamic University of Gaza 
Faculty of commerce 





 Questionnaire  
 
" The influence of internal determinants of Palestinian 
pharmaceutical firms on export performance" 
 





Dear/ Madam Sir,  
 
LETTER OF REQUEST 
 
I wish to request your assistance toward my study of "The influence of internal 
determinants of Palestinian pharmaceutical firms on export 
performance". 
This research is a partial fulfillment for the requirement of a Masters degree in 
Business Administration from the Islamic University in Gaza under supervision of 
Dr. Rushdy Wady.  
 
You are invited to participate in this research. If you agree, you will be asked to 
complete the enclosed questionnaire. Any information you provide will be 
anonymous and confidential, Upon completion of the study, data will be treated as 
top confidential, The questionnaire should take around 10 minutes to complete and 
your participation would be greatly appreciated 
 
 
Thank you very much for your precious time.  
 
 
Yours faithfully,  
 
 





v First: General Information:  
 
 
Part one: organization /firm demographic characteristic خصائص / المنظمة: الجزء األول
 الشركة
Please circle/tick the appropriate number of categories for your business listing 
أو كتابة الرقم المناسب للتصنیف الذي بالئم شركتك ووضعك حسب رأیك/ برجاء تأشیر الخانة   
 
1. Firm age (establish year) =  سنة اإلنشاء(عمر الشركة بالسنة( =   
Less than 20 years Less than 30 Less than 400 Less than 50 More than 50 بر مناك  
£ £ £ £ £ 
 
2. Company size (Number of full-time employees) )عدد العاملین الدائمین ( حجم الشركة   
  
 Less than 100 أقل
 employees من
100- less than 200 200- less than 300 300 less than 400 More than 500أكثر 
£ £ £ £ £ 
 
3. Annual sales volume of firm $ Millionالمبیعات السنویة للشركة بالملیون دوالر أمریكي  
 more than20 اكبر من 15-20 10-15 5-10 3-5
£ £ £ £ £ 
   
  
5. Number of countries firm exporting عدد الدول التي تصدر لھا الشركة 
 1 2 3 4 More أكثر 
£ £ £ £ £ 
 
6. Education levels مستوى التعلیم  
  
7. Place of college education  مكان التعلیم 
 Palestineفلسطین Arab countries بالد
 عربیة
Asiaآسیا Europe أوربا Americaامریكا 
£ £ £ £ £ 
 
8. Instruction language in your last degree of education لغة التعلیم في أخر شھادة  
 Arabic عربي English انجلیزي French فرنسي Germanألماني Other أخرى  
£ £ £ £ £ 
9. education background الخلفیة التعلیمیة  
 Pharmacy صیدلة Management إدارة Engineering ھندسة Science علوم Other أخرى 




Part 2: Modes of entry لألسواق األجنبیة (طریقة الدخول: الجزء الثاني(   
High School ثانوي College كلیة  bachelor بكالوریس masterماجستیر Doctorate دكتوراه 




This part of questionnaire describe the export determinants and its influence on 
export strategy performance.  
Please, put the grade that you see appropriate form 1 to 10. Wherever the degree was 
close to 10, this indicates high approval on what was stated in each item and vice 
versa.  
 
 ھذا الجزء من االستبیان یصف محددات التصدیر التي تحفز أداء اإلستراتیجیة التصدیریة
 ھذا یدلل على 10ة قریبة ل  ، عندما تكون الدرج10إلى -1من فضلك، ضع الدرجة التي تراھا مناسبة من 
للجملة و العكس صحیح  مصادقة عالیة  
 






Item اقل) 1( أعلى) 10( الجملة  
1 lower higher(10) 
 ………………………………………………………………. .    
 5 
H2 Modes of entry لألسواق الدولیة (طریقة الدخول(  To what extent you agree or disagree 
with the following mode of entry as comply to your business 
  إلى أي مدي توافق أو ال توافق على طریقة الدخول التي تالءم أعمالك
1-10 
 
 Export entry modes (direct, indirect, agent, branch/subsidiary) 
)تابع/ مباشر، غیر مباشر، وكیل، فرع  (طریقة التصدیر  
 
 Contractual entry modes (licensing, franchising, technical agreement) 
) رخصة، حق امتیاز، اتفاق تقني (االتفاق/ طریقة دخول عبر التعاقد   
 
 Investment entry modes (new establishment, acquisition, joint venture)  




strategic planning (Export Planning Activityالتخطیط االستراتیجي ( تخطیط النشاط التصدیري  
1 Our export customer base has been clearly defined 
 قاعدة عمالئنا التي نصدر لھم واضحة ومحددة
 
2 Our firm have Developed competitive export strategies 
 عملت شركتنا طورت إستراتیجیة تصدیریة منافسة
 
3 Our firm have Establishment of exporting goals 
أھداف التصدیر حددت شركتنا  
 
4 Our firm have Existence of an export product policy 
سیاسة لدى شركتنا للمنتج والتصدیر ھناك  
 
5 Our firm have Existence of an export promotion policy 
سیاسة ترویجیة للتصدیر لدى شركتنا  
 
6 Our firm have Existence of an export distribution policy 
سیاسة ترویجیة للتصدیر لدى شركتنا  
 
7 Our firm have Existence of an export pricing policy 
 لدى شركتنا سیاسة سعریھ للتصدیر
 
8 Our firm have Export markets to be sourced 
سوق محدد للتصدیر  لدى شركتنا  
 
9 Our firm have Export production policy لدى شركتنا سیاسة إنتاجیة للتصدیر   





H4 Market research بحوث التسویق   
1 We have knowledge about market when starting to export 
 لدى الشركة معرفة عن السوق الذي سوف نصدر إلیھ
 
2 Firm possession of proprietary technical knowledge will enhance export strategy  
تسویق للتصدیرتمتلك الشركة القدرات التقنیة التي ستحسن إستراتیجیة ال  
 
3 Firm possession of a unique/patented product will encourage export strategy 
سیشجع اإلستراتیجیة التسویقیة ببراءة تسجیل/ تمتلك الشركة منتج ممیز  
 
4 Firm extending life-cycle of products will positively encourage export strategy  
ة دورة حیاة المنتج وھذا سیشجع ایجابیًا اإلستراتیجیة التسویقیةأطالت الشرك  
 
5 We have number of information sources to be used 
)لزیادة التصدیر(لدى الشركة عدد من مصادر المعلومات التي یمكن استخدامھا  .  
 
6  Our firm obtaining knowledge about market, will encourage export strategy 
 حصول شركتنا على المعرفة حول السوق، سیشجع اإلستراتیجیة التسویقیة
 
7 We depend on customer perception in producing unique  product 
تعتمد على إدراك الزبون في إنتاج منتج ممیز  شركتنا  
 
8 We depend on customer perception in achieving quality product  
  نعتمد على إدراك الزبون لتحقیق جودة المنتج
 
9 We depend on customer perception in achieving and package design  of product   
على إدراك الزبون إلنجاز تصمیم المنتج والغالف تعتمد شركتنا   
 
10 We depend on customer perception in strengthening our product  
تعتمد على إدراك الزبون لتقویة المنتج ركتناش  
 
H5 Market strategies adaptation إستراتیجیة موائمة السوق 
Question: Considering the marketing mix adaptation for export venture; 
 to what extent the following strategies are influence export strategy? 
بر موائمة المزیج التسویقي للتصدیر ، إلى أي مدى تؤثر االستراتیجیات التالیة على اإلستراتیجیة التسویقیةاعت: السؤال  
 
 PRODUCT ADAPTATION موائمة المنتج   
 Product’s brand name strategy للمنتج إستراتیجیة العالمة التجاریة    
 Product design تصمیم المنتج   
 Product labeling  المنتج) بطاقة بیان(وسم    
 Product quality جودة المنتج   
 Range of variety of main exporting product line للتصدیر مدي تنوع خطوط المنتج    
 product precautions للمنتج) سالمة طبیة( الوقایة    
 Promotion Adaptation موائمة الترویج   
 Advertising idea/theme  الكتابة / فكرة اإلعالن   
 Media channels for advertising القنوات اإلعالمیة لإلعالن   
 Promotion objectives  أھداف الترویج  
 Budget for promotion الموازنة الترویجیة   
 Public relations emphasis التركیز على العالقات العامة   
 Direct marketing/mailing  البرید االلكتروني/ التسویق المباشر    
 PRICE ADAPTATION الموائمة التسعیرة  
 
 
 Determination of pricing strategy التركیز على اإلستراتیجیة السعریة   
 Concession of credit الخصومات على الدفع   
 Price discount policy سیاسة الخصم على األسعار   
Margin )الفرق بین سعر البی وسعر الشراء(مش الربح ھا    













 Distribution Adaptation موائمة التوزیع   
 Criteria to select the distribution system محددات اختیار نظام التوزیع   
 Transportation strategy إستراتیجیة التوصیل   
 Budget of distribution موازنة التوزیع   
 Distribution network شبكة التوزیع   
 Accomplishment of delivery deadlines التسلیم في الموعد المحدد   
6  Export performance صدیريإستراتیجیة األداء الت   
Zou, S., Taylor, C. R., & Osland, G. E. (1998) 
To what extent do you agree or disagree with statement regarding the Strategic export 
performance achievement to your firm? 
 إلى أي مدى توافق أو ال توافق على العبارات التالیة بخصوص أداء اإلستراتیجیة التسویقیة لشركتك 
 
 export has improve our global competition حسن التصدیر منافستنا عالمیا   
 export has Strengthened our strategic position قوى التصدیر موقعنا االستراتیجي   
 export has Significantly increased our global share  التصدیر زاد حصتنا السوقیة عالمیا  
 export is very profitable دیر مربح جدًا لشركتناالتص    
 export has generated a high volume of sale ولد التصدیر حجم مبیعات عالي لشركتنا   
 export has achieved rapid growth لشركتنا نمو سریع حقق التصدیر    
 Our export venture has been very satisfactory كانت صادراتنا مشجعة للغایة  
 our export venture has been very successful كانت صادراتنا ناجحة للغایة   
 our export venture has fully met our expectations لبت صادراتنا كلیًا توقعاتنا   
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Appendix (D): Palestinian  Pharmaceutical Firm 
 
1.Birzeit Pharmaceutical Company 
 
The Palestinian Pharmaceutical industry is unique in terms of development. The industry boomed 
after the six days war in 1967, which resulted in closing borders with the Arab World. Prior to this 
event, pharmaceutical products were imported from foreign companies via importers in Jordan. After 
1967, imports from Jordan became problematic. The only products available were either Israeli or 
products imported through Israeli agents. 
 
The difficulty in obtaining medicine encouraged 9 pharmacists in the West Bank to establish small 
laboratories to manufacture simple syrups and anti-diarrheal products in 1969. Political and economic 
instability soon threatened the viability of capital investment in the pharmaceutical industry, and 
indeed in all industries. In 1970, these 9 laboratories merged in 3 larger companies, Jordan Chemicals 
in Beit Jala, Palestine Medical Company in Ramallah, and Jerusalem Pharmaceuticals in Al Bireh. 
Today, the Palestinian pharmaceutical industry consists of 6 companies, four in Ramallah, one in Beit 
Jala, and one in the Gaza Strip. With products covering more than half of the local consumption. The 
pharmaceutical industry is a key element of the Palestinian healthcare continuum.  
The Palestinian pharmaceutical industry employs more than 1,000 employees, 70 percent of them hold 
specialized university degrees in the different aspects of the industry. During the past decade, the 
industry has invested more than USD 50 million in modernizing the production processes and in 
improving the industry’s premises, leading the Palestinian pharmaceutical industry to increase its 
market share in the Palestinian market from 20 percent to 55 percent.  
In March 2008, and following decades of efforts and significant investments which aimed at the 
development of resources and production lines, and the institution of  ISO procedures, international 
and national compliance audits, Birzeit Pharmaceutical Company was granted the World Health 
Organization certificate of Current Good Manufacturing Practices. The award of this certification is a 
considerable achievement given the difficult working conditions faced by Palestinian companies due 
to the Israeli occupation and restrictions, and mainly the blocking of borders and interaction with the 
global world. The certification reflected the achievement of international standards in manufacturing 
practices in a critical industry, this certification assisted the Pharmaceutical Industry and strengthened 
its position in the local market and increased its ability to penetrate foreign markets. 
Today, foreign pharmaceutical companies have set aggressive marketing strategies focused on 
emerging markets and based on cost cutting and direct marketing. This strategy, was an outcome of 
the world economic crisis, the concentration on generic manufacturing in the world and the quest for 
new markets. Such strategy has affected the local generic manufacturers not only in Palestine but all 
over the emerging markets, which had to reconsider their pricing policy and follow direct marketing 
channels as well. 
About BPC 
Birzeit Pharmaceutical Company (BPC) is Palestine's leading manufacturer of generic medicines. 
With more than 300 products distributed among ten production lines and covering different 
therapeutic ranges. BPC targets all types of customers in the local Palestinian market including 
Ministry of Health, local health care organizations, international health care organizations and 
programs, end users (through pharmacies and physicians). BPC market is not limited to the Palestinian 
Territory, the company has a well established presence in different export markets – mainly Algeria 
and East Europe. 
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BPC combines many factors in order to maintain its success. These factors include: obtaining the 
latest quality standards certificates such as cGMP (Current Good Manufacturing Practices) and ISO 
quality systems, strong financial position of the company, highly educated and well trained staff 
members distributed among the different departments, management team with good experience and 
high credibility, many strategic investments and alliances; local and international, ongoing product 
development and market development initiatives, state of the art facilities with a total area of 16,000 
square meters, modern production lines operating according to the latest technology in this industry, 
and approved suppliers of raw and packaging materials. 
Mission: BPC realizes that the significance of the Palestinian Pharmaceutical Industry extends far 
beyond the size of the revenues; and therefore its vision is to be the backbone of the health care 
security system in Palestine and the region with superior quality products. 
Basic Information 
Registration No. : 562600122   
ISIN: PS2008111739   
Established Date: 1973   
Listing Date: 22/12/2004   
Location  Industrial Zone - 
Ramallah 
  
P.O. Box: 79   
tel 02-2987572/4   
Fax 02-2967205   
Email. contact@bpc.ps   
Web site: www.bpc.ps   
No. of Branches: 2   
No. of Employees: 265   
Year 2011 2010 2009 
Total Shareholders‘ 
Equity 31,930,959 31,124,325 28,827,932 
Paid-in Capital 13,066,14 years 2013 12,100,000 12,100,000 
Net Income 2,958,471 4,097,664 3,532,095 
Sale $ 2290000 2140000 2200000 
Our History 
BPC was established in 1974 in Birzeit village, 10km north of Ramallah as a private shareholding 
company with a total capital investment of USD 150,000. 
 
year  year  
1979 Birzeit Pharmaceutical Company became a public share 
holding company with a capital of USD 0.5 million. 
2005 BPC became listed in Palestine 
Securities Exchange.  
1992 The Company merged with the third largest 
pharmaceutical company in Palestine, Palestine Medical 
Company, in addition to establishing Medix Company 
for Beauty Care. Medix represents a number of 
international Companies, such as Maybelline, Vichy 
and INDOLA. 
2006 BPC expanded its market share 
through buying a share of 
Petrapharm Pharmaceutical 
Company in Algeria. 
2001 BPC acquired ISO 9001 certification. 2008 Continuous investment in 
quality lead BPC to acquire 
cGMP certification according 
to WHO standards. 
2002 BPC took over 73% of Eastern Chemical Company, and 
later in 2004, the remaining 27% was acquired. 
2010 BPC doubles its export market 
share which reflected on its 
revenues during 2010. 
2004 BPC acquired ISO 14001 certification.    
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Investor's relations / Financials 
BPC continues to succeed and grow despite the aggressive price competition strategy that had been 
followed by Pharmaceutical Companies all over the world. This competition has affected the overall 
Company’s pricing policy, however it didn’t affect its market-share, growth, assets and profits. 
Financial Analysis for the year 2010 
• BPC’s PE ratio (The valuation ratio of a company's current share price compared to its per-
share earnings) decreased from 13.1 in 2009 to 9.7 in 2010. 
• Earning per Share (Earnings per share serves as an indicator of a company's profitability), 
has increased from 0.25 in 2008 to 0.34 from in 2010. 
• Total assets have increased from JDs 34.7 in 2009 million to JDs 37.3 million in 2010. 
• The continuous increase in shareholders' equity is another sign of BPC's growth. Total 
shareholders' equity has increased from JD 29 million in 2009 to over JD 31 million in 2010.  
• As an industrial company, it is very important for BPC to keep monitoring its net profits, this 
can be seen from the increase in net profit value from less than JD 1.4 million in 2006 to JD 
4.3 million in 2010. 
strategic Investments 
Another important key to success is related to BPC's strategic partnerships, alliances, relationships 
with local, regional, and international companies, institutions, and bodies. The following sections 
provide brief descriptions of BPC's strategic relationships. 
Business in Algeria 
Late 2006, (BPC) bought a share of Petrapharm. Since that time the management of BPC put an 
investment plan to start production there. In early October 2008, the Algerian Ministry of Health had 
requested all manufacturing companies to meet the local pharmaceutical demand, hence not allowing 
any importation of foreign products already manufactured and or packed in Algeria. Such a decision 
would tremendously increase BPC's sales to Petrapharm during the coming years. Pending orders to 
Petrapharm had doubled in the year 2009. 
Lotus for Financial Investments 
In 2005, BPC and few of its main shareholders had established Lotus for Financial Investments, with a 
capital of USD 5 million. Lotus ranks the first among 9 brokerage companies in Palestine. 
Al Rafah Microfinance Bank 
BPC's main shareholders, and with the help of other local companies and investors, mainly Lotus for 
Financial Investments, PALTEL, and PADICO have established the first microfinance bank in 
Palestine, “Alrafah Microfinance Bank”. The position of Chairman of the Board is now given to BPC. 
 
Al Takaful Insurance Company 
In early 2007, BPC and 3 local insurance companies decided to establish an insurance company that 
covers insurances according to the Islamic Sharia'a. The company started its insurance activities on 
February 2008. The paid up capital is USD 8.5 million. 
 
Achievements 2011 
1. Increased domestic and export market share. 
2. Maintained product production with increased employee productivity. 
3. The company expanded facilities, completing several projects including: 
• Opened the Department of Pharmaceutical Solid Products. 
• Constructed a building dedicated to quality assurance and control. 
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• Isolated antibiotics-producing areas.  
• Invested in sterile pharmaceutical manufacturing facilities. 
• Expanded labs in response to increased Demand. 
• Developed production lines. 
 
Future 
1. International market expansion. 
2. Keeping pace with the rapid development of technology in the pharmaceutical industry by 
upgrading  facilities, machinery and equipment Acquiring the necessary certification to 
ensure high product quality and consumer safety.   
3. Product expansion to meet the needs of target markets. 
4. Increasing staff efficiency.  
5. The Company will continue to invest in the export  
markets. (http://www.bpc.ps) 
2.  Jerusalem Pharmaceutical Company Ltd. (Al-Quds) JPH 
Profile 
Jerusalem Pharmaceuticals produces more than two hundred medicinal products in all dosage forms as 
well as over -the-counter preparations and nutritional supplements. JPH also manufactures veterinary 
products, cleaning and personal care products in a separate and specialized manufacturing site at its 
subsidiary branch: Balsam. 
 
Achievements 2011 
1. Net sales of JOD 14,087,667. 
2. Net profit of JOD 1,728,555. 
3. Company assets reached JOD 35,360,263 
4. Opened Regional Office in Jordan for Export. 
5. The company focused on rehabilitation and development of the Jordan River Company in the 
Hashemite Kingdom of Jordan.           
6. Added new products to the production line. 
 
Future 
1. Achieve sales and profit growth. 
2. Expand to regional and Arab markets. 
3. Continued research and development. 
4. Raise the technical level and obtain the European GMP Certificate (Good Manufacture Practice). 
5. Continued development of internal systems and IT programs. 
6. Attract skilled personnel and provide ongoing training. 
7. The development of subsidiaries and new revenue streams. 
8. Establish new strategic partnerships. 
  
Basic Information 
Registration No. : 562600197   
ISIN: PS2001111694   
Established Date: 1969   
Listing Date: 20/01/1997   
Location  Nablus St. - Al Bireh    
P.O. Box: 3570   
Tel: 02-2406550   
Fax 02-2403246   
Email. info@jepharm.ps   
Web site: www.jepharm.ps   
No. of Branches: 4   
No. of  Employees: 246   





26,155,893 23,552,042 20,080,533 
Paid-in Capital (JOD) 5,000,000 5,000,000 5,000,000 
Net Income (JOD) 1,728,555 2,384,736 1,450,132 
Sale (JOD) 14,087,667.   
Jerusalem (AL-QUDS) Pharmaceuticals was established in1969 as a private company, then became a 
private shareholding in 1975. In order to meet the ever-expanding needs, it was transformed to a 
public shareholding in 1978. Jerusalem(AL-QUDS) Pharmaceuticals employs about 300 highly 
qualified personnel specializing in the areas of pharmacy, chemistry, microbiology, administration, 
engineering, accounting and many other related fields. The working capital of the company is about 
$10,000,000. 
Mission : 
Our mission is to reach world markets in supplying quality products at affordable prices by 
developing, manufacturing and marketing products that improve the quality of life for people around 
the globe.  Our success is founded on meeting the expectations of all our customers, our 
people and the communities in which we live and work. 
Marketing Department  
While aiming at achieving the company’s vision, the marketing department at Jerusalem 
Pharmaceuticals Co. sets its marketing objectives and interprets them into annually budgeted action 
plans that are tailored to respond to Jerusalem Pharmaceuticals customers and their needs. However, 
the marketing department does not stop there, it measures periodically the actual performance against 
the marketing sales and profit objectives and revise action accordingly and when deemed necessary. It 
also carries out continuous performance appraisal training courses for its staff. Moreover, the 
marketing department strives to grasp/comprehend the dynamics, strengths and weaknesses of the 
local and international competitive environment Jerusalem Pharmaceuticals is working under.  To that 
effect, the marketing department staff dedicates their efforts to identify their areas of strengths and 
make the utmost use of them to enable the company realize its threats and discard them as the latter 
prioritizes.  
Another major task of the marketing department at Jerusalem Pharmaceuticals Co. is to identify the 
company’s target groups and the means to approach them. The marketing department also decides on 
how will Jerusalem Pharmaceuticals products be presented at the market place through using 
innovative techniques.  The marketing department also works on enabling the department’s employees 
to achieve their own successes and satisfactions to guarantee the quality of the products Jerusalem 
Pharmaceuticals provides the medical profession with. Thus, a well-structured training development 
plan that allows personal input diversification that would result in a wide range of personal paths of 
successes was developed and is being implemented at Jerusalem Pharmaceuticals. 
Production 
Consistent production of medical products of the required quality, that comply with their approved 
specifications, and in accordance with the relevant manufacturing and marketing authorization by 
following clearly defined procedures and in compliance with the principles of Good Manufacturing 
Practices. 
Description of the department 
The different production operations are carried out according to pre-established instructions and 
procedures and in accordance with good manufacturing practice. Adequate and sufficient resources 
are made available for in-process controls. Appropriate technical and organizational measures are 
taken to avoid cross contamination and mix-ups, for example: Penicillin and Cephalosporin products 
are produced in segregated areas, appropriate air locks and air extraction are provided, testing for 
residues and use of cleaning status labels on equipment. The manufacture of sterile products is carried 
out in special areas entry to which is through airlocks for personnel, equipment and materials. Clean 
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areas are maintained to an appropriate cleanliness standard and supplied with air that has passed 
through filters of an appropriate efficiency. 
Product range: 
Sterile Dosage Forms (Ampoule, Eye/Ear/Nose Drops), Non-sterile Dosage Forms (Capsule, Tablet, 
Solution, Syrup, Suspension, Lotion, Powders for Suspension, Cream, Gel, Ointment, Suppositories). 
Personnel 
Persons responsible for production have an adequate background in relevant scientific disciplines, 
such as bacteriology, chemistry, medicine, pharmacy, together with sufficient practical experience that 
enables them to exercise their management function for the process concerned. Personnel working in 
clean, penicillin or cephalosporin areas are given specific training appropriate to their duties. 
Procedures relating to the health, hygiene practices and clothing of personnel are established and 
adapted to the different needs within the production area. All production personnel receive periodic 
medical examination. Every person entering the manufacturing areas wear protective garments 
appropriate to the operations to be carried out. 
Premises: 
There are five segregated production areas: 
1. Main Production Area: For the manufacture of major products. Area is about 4000 m2 
2. Clean Area: For the manufacture of sterile product (Ampoules, Eye/Ear/Nose Drops). Area is about 
300 m2. 
3. Penicillin Area: A separate building for the manufacture of penicillin drug products. 600 m2 
4. Cephalosporin Area: A segregated area for the manufacture of cephalosporin drug products. 600 m2 
5. Veterinary Area: A separate building for the manufacture of veterinary products. 800 m2. 
 
Walls, floors are made of concrete, most of portions are made of  bricks and gibs board. 
The floors finishing is of epoxy type, while the walls are oily painted. 
 
Production Equipment 
All machines used in the production area which have direct contact with the product are made of 
suitable material of construction such as stainless steel 304, 316, 316L.For each machine in the 
company there are written procedures for cleaning, operating, maintenance and , if required, 
calibrating procedure. 
Quality Control  
Quality Control is concerned with sampling, specifications and testing as well as the organization, 
documentation and release procedures which ensure that the necessary and relevant tests are actually 
carried out, and that materials are not released for use, nor products released for sale or supply, until 
their quality has been judged to be satisfactory. 
Company History 
The success story of Jerusalem Pharmaceuticals (Al-Quds) goes back to the early year of 1967.  
Following the occupation of the West Bank and  Gaza Strip when the Israeli authorities prohibited the 
imports of medications to occupied territories, this has encouraged founders who were importers  of 
pharmaceuticals by profession to establish JEPHARM (Al-Quds) in order to meet the increasing 
humanitarian needs of the Palestinian people. 
The offshoot of JEPHARM (Al-Quds) came to light in 1969 as a private pharmaceutical 
manufacturing company. In order to meet the ever-expanding needs of JEPHARM (Al-Quds) 
transformation into a private shareholding company in 1975, and into a public shareholding company 
in 1978 was an essential requirement. 
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JEPHARM (Al-Quds) employs more than 170 highly qualified personnel specializing in the areas of 
pharmacy, chemistry, microbiology, administration, engineering, accounting, and many other related 
fields. The working capital of the company is $13,000,000. 
 
What we do? 
JEPHARM (Al-Quds) product range spans the whole spectrum of ethical pharmaceuticals as well as 
over the counter preparations and nutritional supplements. Products are presented in different dosage 
forms such as Tablets, Capsules, Ampoules, Granules and Powders for suspensions, Suspensions, 
Syrups, Lotions, Powders, Suppositories, Ovules, Creams, Ointments, Gels, Emulgels, Ear/Eye/ Nose 
Drops, Solutions, Mouthrinseand Gargles. JEPHARM (Al-Quds) also started recently producing a 
wide range of veterinary products including vials, powders, oral liquids and fodder additives such as 
multivitamins and multiminerals. JEPHARM (Al-Quds) also manufactures detergents and cosmetics 
under license from French companies. 
Our people 
Jepharm (Al-Quds) team is comprised of highly trained personnel. Our  motto is: "Invest 
in your people and they will invest in you", as is reflected in our advanced training 
facilities and ongoing specialized training programs. The result is a remarkably efficient 
team of people whose loyalty to the company and healthcare community is unparalleled. 
These are the real fruits of our long labor and we recognize with gratitude their 
commitment and drive. 
Future prospects 
At Jepharm (Al-Quds) management looks into the future, they see a growing confidence in 
many aspects: Confidence in the people who run the business, where the will always be among areas 
in which their enthusiasm is at work, preparing the products of the future. The continual 
implementation of strategies to maintain leadership in pharmaceutical industry, while maintaining 
strong base of quality manufacturing. The continued implementation of good manufacturing practice 
GMP according to international standards regulations (WHO,FDA & MCA) and adaptation of 
ISO9000 series and introducing a total quality management system to reinforce the Quality system. 
Expanding products lines, establishing new production facilities and opening new markets regionally 
and worldwide. Introduction of new lines of pharmaceutical dosage forms. 
Looking for business and technical cooperation with multinational pharmaceuticals companies. 
Mission: 
    We believes that its stockholder’s satisfaction is its access toward globalization Developing, 
manufacturing and marketing products that improve the quality of life for people around the globe. 
Our success is founded on meeting the expectations of all our customers, our people and the 
communities in which we live and work. 
 
Vision: 
    Our vision is to continue providing quality pharmaceuticals to the medical professions and become 
their vendor of choice worldwide. This can be achieved by Making quality, integrity and excellence 
hallmarks of the way we do business. Attracting, developing and motivating the best people. 
Continually growing and improving are our business 
Objectives: 
Confidence in the people who run the business, where they will always be among areas in which their 
enthusiasm is at work, preparing the products of the future. 
• The continual implementation of strategies to maintain leadership in pharmaceutical industry, 
while maintaining strong base of quality manufacturing.  
• The continuous improvement of our quality and environmental management systems that 
covers all aspects of work in the company.  
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• The implementation of good manufacturing practice GMP according to International 
Standards & Regulations (WHO, FDA & MHRA) and adaptation of ISO (Quality and 
Environmental) series and introducing a total quality management system to reinforce the 
Quality system.  
• Expanding products lines, establishing new production facilities and opening new markets 
regionally and worldwide.  
• Looking for business and technical cooperation with multinational pharmaceutical 
companies. 
    Al Quds Pharmaceuticals will communicate its interest in quality and environment to it’s 
employees, suppliers, customers and interested parties.  
In order to achieve its quality and environmental policy, Jerusalem Pharmaceuticals has developed 
and is implementing quality and environmental management systems in full compliance with the 
international standards ISO9001and ISO14001.  
 
    Although policy making within AI-Quds is the prerogative of its board of directors, it is 
inconceivable to pass any policy statements to take any executive action that is not consistent with 
principles of the company’s QA regulations. All operations done by different departments including 
purchasing, R&D, QC, Production, Engineering and Marketing are executed in compliance with 
international regulations of cGMP and ISO 9001 & ISO14001 series guidelines. AI-Quds fosters a 
systematic and efficient quality system program that covers all matters that individually or collectively 
influence the quality of its products. 
 
3. Beit Jala Pharmaceutical Manufacturing Company BJP 
What started as the first small pharmacy in Tulkarem, Palestine in 1933 has successfully developed 
into a multinational pharmaceutical company with a diverse range of dependable and high quality 
pharmaceuticals.  Located in the outskirts of Bethlehem, Beit Jala Pharmaceuticals (BJP)'s GMP and 
ISO certified manufacturing plant produces and exports medicines throughout the region, and is 
networking with its sister companies in the Munir Sukhtian Group to reach other international markets 
as well.   
Beit Jala Pharmaceutical Manufacturing Company was founded in 1968 – formerly Jordan Chemical 
Laboratory – with a commitment to the constant development of human resources and activities to 
ensure product and service quality. Beit Jala Pharmaceutical Company (BJP) is located in Beit Jala, 
south to the holy city Jerusalem and west to Bethlehem the birthplace of Jesus Christ. BJP conducts its 
operations in accordance with Good Manufacturing Practices (GMP) and is ISO 9001:2008 and ISO 
14001:2004 certified by Lloyd’s Quality Register. 
Vision : To serve humanity in enabling a better and healthier quality of life. 
Mission : striving to  Manufacturing safe, pure, and effective branded generic drug pharmaceutical 
products for the domestic and global markets. 
Facilities: Especially designed in compliance with cGMP regulations, with total separation between 
the different dosage forms in all areas pertaining to weighing, manufacturing and packaging. 
The team at BJP consists of highly qualified and experienced personnel, trained to implement quality 
systems in order to continuously guide the company into producing the highest quality products 
delivered to customers and affiliates in an optimal, professional, and competitive manner.  
 
BJP has become a pioneer in seizing leading market positions in several markets, in addition to 
establishing alliances with affiliates to enhance its position and launch it towards the next decade.  
 
BJP currently operates in Palestine and looking forward to operate in a variety of geographical 




Our core values & core purposes are: 
• Serving humanity and the well being of people. 
• Providing world-class pharmaceutical products. 
• Ensuring prosperity and progress through research, alliance, partnership and affiliation with 
reputable global partners sharing same vision and ethics. 
• Achieving the highest levels of performance, job satisfaction and core competencies 
Company advantage 
GMP & ISO certified  
More than 120 registered products of different dosage forms 
Broad portfolio of therapeutic categories 
More than 140 experienced and talented employees. 
Research & Development Department  
A strong pipeline that enables applying for a marketing authorization of a significant number of 
products that provides regular sales growth in the domestic and global markets. 
Quality Control Department 
The QC department performs all physical, chemical testing of the active  pharmaceutical ingredients, 
in-process materials and finished products.  In addition to shelf life testing and monitoring. 
Production Department 
The plant is a multi production facility designed for the manufacturing of solid dosage forms, semi 
solids, liquids and sterile liquid dosage forms in the form of eye drops. The design enables storage, 
weighing, production and packaging of a certain dosage form separately in a downstream flow, 
eliminating the possibility of mix-ups and cross contamination. 
Human Resources 
Beit Jala Pharmaceutical Company success is based on a policy of recruiting high standard employees 
in various industry related backgrounds. 85% of the employees are holders of academic degrees. 
Marketing Department 
Marketing, with its two branches: Domestic Department and Export, provide a broad portfolio of both 
ethical and OTC products. Beit Jala Pharmaceutical Company is a major player in the local market. 
BJP established a remarkable marketing and distribution network to serve the local market 
professionally & successfully. The broad range of our products with the strong marketing network 
helped BJP to achieve leading positions among major local players. The marketing department works 
on fulfilling sales plans projecting and realizing a regular yearly growth of 10 - 13% in sales as a 
result of a constant growth in BJP Company’s range of products and from the continuous introduction 
of new products and markets. This department performs customer satisfaction evaluations on a regular 
basis to enable constant feed back to top management. 
Production 
Production lines for tablets, capsules, ointments and creams, syrups and suspensions, and 
suppositories were installed.  In 1978 the company started the production of four different types of eye 
drops that proved to be a success further on.  In 1992, decision was taken to start building a state of 
the art facility in compliance with cGMP guidelines and relevantly to refurbish the old facility, all 




Basic Information: Beit Jala Pharmaceutical Manufacturing Company 
Registration No. : 562601369   
ISIN:    
Established Date: 1969   
Listing Date:    
Location  Beit Jala, 81 Madarest St   
P.O. Box:    
tel 00972-2-2742855   
Fax 00972-2-2741072   
Email. info@beitjalapharma.com   
Web site: http://www.beitjalapharma.com   
No. of Branches:    
public offering Date: 12/8/2013   
No. of Employees: 140   
 2011 2010 2009 
Total Equity 36,605 (NIS)   
initial public offering 4650000 (JOD)   
Capital  10000000 (JOD)   
Sale by($) 7350000 6720000 6510000 
LOCAL SALE(INS) 24,615717 23,481,399 22,279,031 
FOREIGN SALE(INS) 796,028 1,115,861 336,778 
4.Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (PHARMACARE) 
Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (PHARMACARE) is a public company 
incorporated in 1986 and registered with the company’s registrar under number 562600288 according 
to the company’s law number (12) 0f 1964. The registered address of company ( management offices 
and factories) is: Beitunia-Ramallah, P.O.Box 677.  
The company’s activities include manufacturing, selling, distribution, export and import of medicines, 
cosmetics, chemicals and veterinary products. During 1999-2000, Dar AL-Shifa" had to secure 
financing tofinalize the most ambitious of its projects, represented in building its new factory. Of the 
different source of finance, Dar Al-Shifa'a chose for equity finance through cooperation with Mr. 
Michael Wirtz and his family owners of  Grunenthal GMBH, a reputable German company involved 
in pharmaceutical manufacturing . Dar AL-Shifa believes that alliance with Grunenthal company will 
help it to meet and confront the challenges of globalization. 
The agreement with their German partners stipulates the company to have two members in Dar Al-
Shifa'a board of directors thus will be strongly engaged in the company’s financial and administrative 
affairs. Technology support, training and knowledge transfer in additions for Dar Al-Shifa'a right in 
manufacturing and distribution some of  Grunenthal products which will ensure continuous growth in 
Dar Al-Shifa'a sales and enhancing Dar Al-Shifa'a ability to overcome the competition. 
At the end of 2011, Wirts family/ owner of Grunenthal GMGH decided to reduce their stake in Dar 
Al-Shifa"a (Pharmacare PLC) and as such Pharmacare management decided to include Bank of 
Palestine Ltd. And Reach for Investment & Development as shareholders. They have bought 8.35% 
and 3.9% for each of them of the company’s shares respectively, and the German partner maintained 
his shareholding which constitutes 23.92% of the company’s shares. 
During the first quarter of 2008 with the support from its German partners; the company obtained the 
European certificate of good manufacturing practice GMP after an inspection performed by the 
German ministry of health. 
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The company’s general assembly held a meeting on 30 June 2010, and set a date for listing of the 
company’s shares in Palestine securities exchange on 11 November 2010 which coincided with the 
company’s celebrations of its silver jubilee. 
The number of the company’s employees was 286 as of December 31,2011 and 211 as December 
31,2010. 
Trading & Financial Results Currency: USD 
Year Total revenues Total expenses Net income (Loss)  Dividends C a p i t a l Subscribed Capital Market Cap 
2011 19,464,154 3,626,456 2,028,890 - 8,462,623 8,462,623 - 
2012 15,364,226 4,102,762 2,027,972 - 8,462,623 8,462,623 - 
 
Basic Information 
Established In : 1986   
H.O. Location :  Ramallah-beitunia   
P.O. Box :  677   
Telephone :  022900680   
Fax :  022900189   
Web Site :  N/A   
E-mail :  pharmacare@pharmacare_ltd.com   
No. of Branches :  1   
Termination date 
of Board :  2015-04-23 
  
General Manager  Bassim Subhi Farah Khoury Nasr   
Auditors :  Saba & Co (Member of Deloitte Touche Tohmatsu) 
  
Chairman : Mr. Bassim Subhi Farah Khoury Nasr 
  
Registration No. 562600288   
Listing Date: 30/04/2013   
No. of 
Employees: 
286 for year 2011   
year 2012 2011 2010 
Total Shareholders‘ 
Equity    
Paid-in Capital 8,462,623 8,462,623  
Net Income    
sale 1805000 1987000 1931000 
 
Source : Palestine Exchange, 2012. Companies Guide-2011. Nablus – Palestine. 
http://www.pex.ps. Accessed 2013. 
 
Source : Firms web site and  Annual reports 
